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In the central nervous system, the axons of neurons are protected from damage and 
aided in electrical conductivity by the myelin sheath, a complex of proteins and lipids 
formed by oligodendrocytes. Loss or damage to the myelin sheath may result in 
impairment of electrical axonal conduction and eventually to neuronal death. Such 
demyelination is responsible, at least in part, for the disabling neurodegeneration 
observed in pathologies such as Multiple Sclerosis (MS) and Spinal Cord Injury. In the 
regenerative process of remyelination, oligodendrocyte precursor cells (OPCs), the 
resident glial stem cell population of the adult CNS, migrate toward the injury site, 
proliferate and differentiate into adult oligodendrocytes which subsequently reform the 
myelin sheath.  
Existing research indicates that OPC migration is directed by chemomigratory signals 
released from the site of injury and that the absence of OPCs is a feature of some MS 
lesions, suggesting that increased recruitment of OPCs to injury sites might improve 
remyelination, eventually leading to treatments of patient pathologies.  I hypothesized 
that as yet undiscovered migration cues for OPCs might be released at sites of 
demyelination, diffuse through the CNS tissue, activate distal OPCs and guide them back 
to sites of demyelination.  
In this thesis, I performed bioinformatics analysis of gene expression arrays and 
identified upregulated cell surface receptors on OPCs activated in a cuprizone model, and 
upregulated secreted factors in whole lesion sites from an LPC induced MS type injury 
model and a Spinal Cord Injury model. I then optimised the X-celligence system for the 
quantification of OPC migration in response to secreted factors identified in my 
bioinformatics screen. By combination of these techniques with immunofluorescent 
staining I discovered novel expression of the cell surface receptor CX3CR1 on OPCs, 
increased expression of the corresponding ligand CX3CL1 in both MS type injury and 
Spinal Cord Injury, increased directional migration of OPCs in response to low 
concentrations of CX3CL1, and increased maturation of OPCs into adult oligodendrocytes 
at high concentrations of CX3CL1.  
Taken together these results propose a system in which an increasing gradient of 
CX3CL1 released from the site of injury directs the recruitment, then maturation of OPCs, 
making CX3CL1 a master regulator of OPC led CNS regeneration.  
Lay Summary 
In the brain and spinal cord, the neurons which relay electrical signals are protected and 
insulated by the myelin sheath which is made by support cells known as 
oligodendrocytes. Loss of the myelin sheath can lead to the death of neurons which 
prevents the brain from sending signals properly and can cause disability in conditions 
like Multiple Sclerosis (MS) and Spinal Cord Injury.  
 
For lost myelin to be replaced repair brain cells scattered throughout the brain and 
spinal cord must migrate into the injury site, change into adult oligodendrocytes and 
make new myelin sheaths. In conditions like MS and Spinal Cord Injury this repair 
process does not always work properly because the repair stem cells do not find their 
way to the area needing repaired.  
 
The purpose of my project was to find a way to recruit more of these repair stem cells 
into injury sites. By analysing online databases, I identified chemical signals released at 
the site of injury and studied cells cultured in a dish to find out if adding these chemical 
signals increased repair, stem cell migration or the maturation of repair stem cells into 
oligodendrocytes.  
 
I found a protein called CX3CL1 which made the repair stem cells migrate and mature 
more quickly and it is hoped that we might be able to develop CX3CL1 into a drug to treat 
MS and Spinal Cord Injury in the future.  
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In the adult central nervous system (CNS), the process of remyelination is central to 
regenerative tissue repair. Successful remyelination requires the presence of 
oligodendrocyte precursor cells (OPCs) at sites of injury. OPCs at the injury site have the 
capacity to differentiate into adult oligodendrocytes and subsequently repair the myelin 
sheath, thus restoring protection, trophic support and increased conduction velocity to 
the axons. Inefficient remyelination results in impaired conduction of neural impulses 
and possible axonal destruction leading to the symptoms typical of neurodegenerative 
disorders such as Multiple Sclerosis (MS). Remyelination is known to be insufficient in 
MS and previous research (including in the Williams’ group) has shown that some MS 
lesions are either deficient or devoid of OPCs (Boyd et al., 2013a; Chang et al., 2002; 
Lucchinetti et al., 1999), due to a lack of OPC migration into lesion sites. In order to 
effectively contribute to remyelination, OPCs, which are distributed throughout the 
uninjured CNS, must become activated and migrate to the site of injury by following 
chemomigratory cues. Therefore, identification of chemical signals which improve the 
recruitment of OPCs to sites of injury may later lead to the development of regenerative 
therapies for pathologies such as MS.    
At the outset of this PhD project, I hypothesized that these chemomigratory stimuli were 
present after demyelinating injury during remyelination and could be recognised by 
their ability to increase OPC migration in vitro. To test this hypothesis, in this thesis: 
1) I identified possible modulators of OPC migration by bioinformatic analysis of 
microarray data from demyelinating injury. 
2) I optimised the X-celligence Real-Time Cell Analysis (RTCA) system for the 
specific requirements of the analysis of directional cell migration in OPCs. 
3) I identified the secretion of the chemokine fractalkine/CX3CL1 at the lesion site 
and the expression of its only known receptor CX3CR1 on OPCs and showed 
increased directional OPC migration at low concentrations of CX3CL1 and 
increased differentiation of OPCs into adult oligodendrocytes at a high 
concentration of CX3CL1. 
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In my introductory chapter, I will discuss the biology of OPCs and myelination, as well as 
the relevance of the regenerative process of remyelination in the context of 
demyelinating diseases in humans. 
1.1 Myelin 
1.1.1 Myelin and the Propagation of Electrical Impulses 
In the mature central nervous system, the electrically conductive axonal tracts of 
neurons are wrapped by spiralling layers (Geren and Schmitt, 1954) of oligodendrocyte 
membrane, providing insulation and made of a complex of proteins and lipids known as 
myelin. The presence of a distinguishable white or “marrow-like” substance associated 
with the outside of nerve fibres was first documented as early as the 16th to 17th centuries 
(reviewed in Boullerne, 2016).  The term “myelin” is derived from the Greek myelos 
meaning marrow, and was first used in 1854 by the German pathologist Rudolph 
Virchow (Virchow, 1854).  
1.1.2 Myelin Composition 
Myelin is a diverse composite made up of 70% lipids and 40% proteins. Of the protein 
content up to 30% is made up of myelin basic protein (MBP), 50% proteolipid protein 
(PLP), 4% 2’,3’-Cyclic nucleotide 3’-phosphodiesterase (CNP), 1%(CNS)/0.1%(PNS) 
myelin associated glycoprotein (MAG) and the remainder by myelin oligodendrocyte 
glycoprotein (MOG) and small amounts of other proteins (Baumann and Pham-Dinh, 
2001).   
The high lipid content of myelin gives myelin rich regions of the CNS a whitish 
appearance in formaldehyde fixed tissue. Consequently, these areas which are around 
40 – 50% myelin by dry weight (Baumann and Pham-Dinh, 2001), are known as the 
white matter in contrast to the sparsely myelinated grey matter. While the grey matter 
regions are chiefly functionally associated with processing and cognition, containing the 
neuronal cell bodies, the primary function of the white matter regions is to transport 
neuronal signals between the different grey matter regions. White matter regions 
include the Corpus Callosum through which the two cerebral hemispheres are 
connected, and the white matter tracts in the spinal cord containing the long axons of 
spinal cord neurons which relay information to and from to the brain.  
1.1.3 Myelin Function 
Within the nervous system, information is relayed through the propagation of electrical 
impulses along axonal tracts, however the escape of electrons from the nerve fibres 
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retards conduction velocity. In non-myelinated nervous systems, conduction velocity is 
improved by increasing axonal diameter, as exemplified by the super axons observed in 
organisms such as crustaceans, insects and cephalopods.  
In other organisms with highly developed nervous systems including mammals, 
conduction velocity is improved through the insulator process of myelination.  In 
contrast to the axonal tracts themselves, myelin is not electrically conductive and is 
therefore able to prevent the dissipation of electrical signals into the nervous system 
parenchyma.  
Each axon is wrapped by multiple segments of myelin sheath known as internodes which 
are periodically interrupted by brief unmyelinated breaks known as the nodes of 
Ranvier. Electrical signals travelling along myelinated tracts appear to “jump” between 
nodes of Ranvier via the process of saltatory conduction (derived from the Latin saltare, 
to leap or hop), which was first described in the mid-20th century, first reported by Tasaki 
in 1939 and corroborated by Huxley and Stämpfli in  1949. However, the electrical 
impulse only appears to jump between the nodes of Ranvier because of the high 
conduction velocity it is able to achieve as it is relayed through the myelinated 
internodes. 
This concerted direction of electrical impulses by myelin improves the efficiency with 
which neuronal signals can be propagated over long distances. Accordingly, the 
development of myelin is of great evolutionary significance because the increase in the 
distance over which nerve impulses could be efficiently propagated facilitated the 
adaption of large complex nervous systems in larger organisms such as mammals. 
While both the central nervous system(CNS) and peripheral nervous system(PNS) 
propagate electrical impulses along the axons of neurons, there is a significant 
divergence in the format of their myelin and the cell types which produce it.  
In the PNS, myelination is carried out by the myelinating Schwann cells. Each Schwann 
cell forms a close relationship with a single axon and produces only one myelin internode 
so that each axon is wrapped by multiple Schwann cells each separated by a node of 
Ranvier. Conversely, in the CNS myelination is carried out by the oligodendrocytes which 
have the capacity to produce multiple internodes and wrap as many as 40 axons 
concurrently (discussed in Baumann and Pham-Dinh, 2001).  
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1.1.4 Adult Oligodendrocytes are Unable to Regenerate 
Both Schwann cells and oligodendrocytes are glial cell types, which besides increasing 
electrical impulse conduction velocity, perform the dual functions of providing trophic 
support to the neurons and protecting axons from destruction. 
In the context of regeneration following a destructive insult, there are differences in 
functionality between the Schwann cells and oligodendrocytes. In PNS injury, adult 
Schwann cells retain their developmental plasticity and revert back to a stem cell like 
state, allowing for their capacity to proliferate, migrate along axon tracts and replace lost 
myelin (reviewed, Jessen and Mirsky, 2016).   
In contrast, once individual oligodendrocytes have wrapped their associated axons, they 
appear to be unable to form new myelin sheaths beyond the end of the developmental 
stage (Crawford et al., 2016). Thus, myelin sheaths lost via mechanical injury or 
inflammatory attack cannot be replaced by existing oligodendrocytes. Oligodendrocytes 
also provide trophic support to the neurons. through the production of factors which 
promote neuronal survival (Bankston et al., 2013). The loss of oligodendrocytes and 
myelin sheaths therefore, have pathological implications because, without the insulation 
of protective myelin, axons are unable to efficiency conduct electrical impulses, lack 
trophic factors provided by oligodendrocytes, and are at greater risk of destruction. 
1.2 Development 
1.2.1 Myelination in Development 
During the development of the human CNS, magnetic resonance imaging (MRI) has 
revealed that the essential process of myelination begins during gestation and extends 
well beyond early adult life (reviewed Baumann and Pham-Dinh, 2001; Boulanger and 
Messier, 2014). A 2012 study using histological examination of the myelinated fibre 
density in the somatosensory, motor and visual cortices of post-mortem human tissue 
from birth, childhood, adolescence and adulthood showed that full myelination in these 
regions was not complete until well into the third decade (Miller et al., 2012). More 
recently, it has also been shown that myelin continues to be laid down and remodelled 
over lifetimes, contributing to the plasticity of the adult CNS (O’Rourke et al., 2014; 
Young et al., 2013). 
This prenatal onset of myelination is dependent on the presence of newly differentiated 
oligodendrocytes which are derived from stem cell like progenitor cells. 
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1.2.2 Oligodendrocytes are the Terminally Differentiated Progeny of Increasingly 
Lineage Restricted Precursors 
Mature oligodendrocytes can be found throughout the adult CNS, however there has 
been significant debate in the literature as to where and when oligodendrocytes and 
their precursors first arise in the developmental CNS (discussed at length in Naruse et 
al., 2016a; Richardson et al., 2006).   
Oligodendrocytes ultimately trace their lineage back to the neuroepithelial cells of the 
embryonic neural tube which have the capacity to produce both neurons and glia as 
progeny. The dorsal region of the neural tube develops into the adult brain while the 
ventral portion matures into the spinal cord (reviewed in Grabel, 2012). A subset of 
neuroepithelia differentiates into the more lineage restricted neural stem cells (NSCs) of 
which all oligodendrocytes are progeny.    
NSCs have the plasticity to differentiate into neurons, astrocytes and oligodendroglia 
during development (McKay, 1997; Rao, 1999) and persist in neurogenic niches in the 
adult CNS, generating new neurons in areas such as the olfactory bulb and dentate gyrus 
of the hippocampus (Gage, 2000; Yamaguchi et al., 2016). NSCs perform their diverse 
functions at different temporal stages of CNS development, proliferating in the early 
embryo, differentiating into neurons in the mid embryonic period and producing 
oligodendroglia in the late embryonic stage and postnatally (Naruse et al., 2016a).  
Oligodendrocyte precursor cells are an intermediate cell type between NSCs and 
oligodendrocytes and similar to NSCs, are found in the adult as well as developmental 
CNS (Crawford et al., 2014; Dawson et al., 2003). The precise developmental timings of 
the differentiation of OPCs into adult oligodendrocytes are yet to be clearly defined, in 
part because the explosive proliferation of OPCs immediately prior to differentiation into 
oligodendrocytes, making lineage tracing experiments difficult (Naruse et al., 2016a; Raff 
et al., 1998).  Developmental OPC dynamics are further complicated by controlled OPC 
cell death, concurrent with the process of myelination. In a recent study,  in myelinating 
organotypic cerebellar cortex slices, OPC numbers were found to be curtailed by 
endogenous release of the neurotransmitter GABA (Hamilton et al., 2017).   
1.2.3 Developmental OPCs First Arise in Late Gestation to Early Neonatal Phase  
To investigate the true origins of OPCs in development, it was necessary to examine the 
behaviour of the NSCs from which OPCs originate in finer detail. During development, 
multipotent nestin expressing NSCs may leave the cycle of self-renewal in order to 
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become lineage committed fully differentiated cell types (Alvarez-Buylla et al., 2001; 
Okano and Temple, 2009).  In order to pinpoint the exact timing of differentiation of NSCs 
into OPCs, in a recent study by Naruse and colleagues used Cre-LoxP reporter systems to 
permanently green fluorescent protein (GFP) label cells expressing the NSC marker 
nestin or the oligodendroglial lineage marker oligodendrocyte transcription factor 2 
(Olig2) in separate mice at three developmental time points (Naruse et al., 2016b).  Cells 
labelled as nestin positive at E12 or E16 were found to produce few oligodendroglia 
when cortices were imaged at P30, however, over 80% of cells labelled as nestin positive 
at P10 were detected as oligodendroglia at P30 (although the actual number of cells is 
not given in the paper).  
Taken together, these findings suggest that NSCs which are destined to become 
oligodendrocytes cease expression of nestin and begin expression of Olig2 between just 
before E16.5 and P10. Thus, OPCs (intermediates between NSCs and oligodendrocytes), 
arise in the period from late gestation to the early neonatal stage.  
1.2.4 CNS Patterning in Development 
While the timely emergence of OPCs is essential to CNS development, the spatial 
distribution of oligodendroglial lineage cells within the embryo is also of immense 
importance. By the conclusion of the developmental stage, OPCs and adult 
oligodendrocytes have become distributed throughout the CNS, a process which is 
regulated by the orchestration of complex extracellular signals and intracellular 
responses.  
The CNS is derived from the neural tube, the dorsal portion forming the telencephalon 
which becomes the cortex, and the ventral portion forming the developing spinal cord. It 
was once thought that all oligodendroglial precursors arose in the mid-line of the ventral 
regions of both the nascent brain and spinal cord, before migrating outwards to reach 
the rest of the developing CNS tissue. However, more recent evidence has supported 
additional dorsal sources of OPCs in both CNS structures and contribution of both 
dorsally and ventrally derived OPCs to the adult OPC and oligodendrocyte population  
reviewed in Naruse et al., 2016a; Richardson et al., 2006). 
During the development of the CNS, the first positions of OPCs are dictated by the 
location of the NSCs from which they as derived. The positioning and differentiation of 
NSCs is directed by concentration gradients of morphogens which restrict them to the 
dorsoventral and anteroposterior axes (Hitoshi et al., 2002; Mehler, 2002; Shimogori et 
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al., 2004; Zappone et al., 2000). Significant signalling molecules include sonic hedgehog 
(Shh) which is indispensable for ventral patterning of both the developing spinal cord 
and telencephalon (Dessaud et al., 2008; Echelard et al., 1993; Fuccillo et al., 2004; Jessell, 
2000; Sousa and Fishell, 2010; Yu et al., 2013), while Wnts and bone morphogenetic 
proteins (BMPs) are released from spinal cord roof plate and cortical hem in the 
telencephalon thus directing dorsal patterning (Chizhikov and Millen, 2005; Liem et al., 
1997; Muroyama et al., 2002; Shimogori et al., 2004, 2004).  
1.2.5 Origins of OPCs in the Developing Spinal Cord 
1.2.5.1 Historical Ventral Perspective on OPC Origins – Spinal Cord 
There are two known sources of OPCs in the developing spinal cord, the historically 
established ventral source in the ventral motor neuron progenitor (pMN) domain and 
the more recent discovery of an OPC source in the more dorsal p0 domain. The idea of 
single ventral source for OPCs in the developing spinal cord was brought into question 
by the identification of glial restricted precursors (GRPs) (which demonstrated the 
potential to become oligodendrocytes or astrocytes but not neurons in vitro), in both 
ventral and dorsal regions of the embryonic spinal cord (Rao et al., 1998). 
Developmental oligodendroglia have been shown to express the established OPC marker 
platelet derived growth factor receptor alpha (PDGFrα) as early as E12. These PDGFrα+ 
OPCs arise in the pMN domain of the spinal cord, which contains specific neural 
precursor cells which are first destined to produce motor neurons but undergo a later 
fate change to produce OPCs (Richardson et al., 2000) (see figure 1.1 b)i-b)iv).  
Secretion of Shh from the floorplate of the notochord plays a pivotal role in the 
patterning of the developing ventral spinal cord (He and Lu, 2013) and the generation of 
OPCs and oligodendrocytes. The developing spinal cords of mice deficient in either Shh 
or two of its downstream target transcription factors NK2 Homeobox 6.1 (Nkx6.1) and 
NK2 Homeobox 6.2 (Nkx6.2), have been shown to be devoid of Olig2+ OPCs (Cai et al., 
2005; Vallstedt et al., 2005) (see figure 1.1 b)iii-iv and c)iii-iv).  
Another major player in the generation of OPCs in the ventral spinal cord is the basic 
helix-loop-helix (bHLH) transcription factor Olig2. Despite its widespread use as an 
oligodendroglial marker, the protein is also expressed by pMN neural precursors and is 
indispensable for the differentiation of motor neurons (Lu et al., 2000; Takebayashi et 
al., 2000; Zhou et al., 2000).  
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Olig2 knockout mice fail to produce either motor neurons or oligodendroglia in the 
spinal cord and perish within hours of birth (Lu et al., 2002; Takebayashi et al., 2002). 
There is evidence that the fate choice between motor neurons and oligodendroglia may 
be driven by phosphorylation of Olig2. Phosphorylation of the Olig2 bHLH domain 
results in the differentiation of motor neurons while dephosphorylation of Olig2 alters 
its range of binding partners and results in the generation of OPCs (Li et al., 2011).  Thus, 
Shh and Olig2 are the major drivers of the differentiation of OPCs from the pMN domain 
in the spinal cord.  
1.2.5.2 Dorsal Origin of OPCs in the Spinal Cord 
The historical view that OPCs were generated only in the ventral embryonic spinal cord 
has been challenged by contradictory reports of an OPC source in the dorsal spinal cord. 
Explants taken from both the ventral and dorsal regions of E11 spinal cord are capable 
of producing O4 positive oligodendroglia in in vitro culture, although this process is less 
rapid in dorsal explants (Sussman et al., 2000) (see figure 1.1 a)ii, b)ii and c)ii). The 
inability of the intermediate portion between the dorsal and ventral regions to produce 
O4 positive progeny rules out the possibility of invasion of progenitors from the ventral 
to dorsal region. Similarly to ventrally derived OPCs, the generation of oligodendroglia 
by cultured explants was shown to be Shh dependent.  
In their 2005 study, Cai and colleagues used an elegant system using knock outs of Nkx6 
proteins to demonstrate a second dorsal origin of OPCs in the developing spinal cord (Cai 
et al., 2005). Nkx6.1 and Nkx6.2, which are both downstream of Shh and upstream of 
Olig2, have been found to be functionally redundant in the differentiation of motor 
neurons (Vallstedt et al., 2001). Knock-out of both Nkx6.1 and Nkx6.2 resulted in the 
complete abolition of Olig2 expression at E10.5 and E12, however expression of Olig2 in 
Nkx6 double mutant could be detected in the dorsal region at E13.5 to E15.5 and 
throughout the spinal cord at E18.5 (see figure 1.1 b)ii and c)ii). Other markers of OPCs 
such as PDGFrα and SRY-Box 10 (Sox10) which are detectable throughout the spinal cord 
from E13.5 onward, had similarly delayed patterns of expression in Nkx6 double 
mutants with no detectable expression in either gene at E13.5 and E15.5 but expression 
throughout the spinal cord in both genes at E18.5.  Co-localisation of Olig2 and dorsal 
neuronal marker paired box protein 7 (Pax7) antibody in wild type mice, confirmed the 
dorsal source of OPCs in the developing spinal cord in vivo.    
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In contrast to the Sussman and colleagues explant study, Cai and colleagues found the 
generation of OPCs from the dorsal spinal cord to be independent of Shh signalling, this 
corresponds with earlier studies which found the spinal cord to be dorsalized and 
lacking in ventral regions in Shh knock-out mice (Chiang et al., 1996; Pierani et al., 1999) 
(see figure 1.1 b)iii-b)iv and c)iii-c)iv). Whether or not the dorsal source of 
oligodendroglia is Shh dependent is thus rendered somewhat irrelevant from a 
functional perspective, since the absence of sonic hedgehog signalling is incompatible 
with life. 
Further evidence for a dorsal source of oligodendroglia in the spinal cord is also 
supported by evidence from studies using Cre/loxP reporter systems in which the Cre 
recombination was placed under the control of the promotor for dorsally expressed 
genes, developing brain homeobox 1 (Dbx1), genetic screened homeobox protein 2 
(Gsh2) or murine msh homeobox 3 (Msx3) (Fogarty et al., 2005; Tripathi et al., 2011).  
Co-expression of OPC markers such as Olig2 and Sox10 with these dorsal markers in the 
developing spinal cord corroborates a dorsal origin for a proportion of spinal cord OPCs 
and subsequent oligodendrocytes. 
As summarised in figure 1.1, the evidence for both ventral and dorsal origins of OPCs in 
the spinal cord indicates that spinal cord oligodendroglia are derived from at least two 
regions, and that their genesis may be Shh dependent or independent. Regardless of the 
exact location of their origin, OPCs migrate out from the central ventral-dorsal line to 
dissipate throughout the spinal cord white matter by the end of development.  This 
ability to migrate is central to the importance of OPCs, an ability which is also retained 
by the OPCs in the adult brain. 
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Figure 1.1 OPCs arise in both the dorsal p0 domain and ventral pMN domain in the developing spinal 
cord. At E11, in a)i) normally developing spinal cord , a)ii) freshly dissected dorsal p0 and ventral pMN 
explants, a)iii) Nkx6.1/Nkx6.2 double mutant knock-outs and a)iv) Shh knock-outs, OPCs are yet to 
arise and there is no evidence of OPCs in either the p0 or pMN domains.  By E12, in b)i) normally 
developing spinal cord, Shh emanating from the floor plate of the notochord induces the emergence 
and dissemination of OPCs from the ventral pMN domain (illustrated as blue arrows) b)ii) At E12 OPCs 
(illustrated in blue) are observed to emerge from ventral pMN domain  explants (dissected at E11 and 
cultured until E12), while no such OPCs emanate from equivalent p0 explants b)iii) As a result of the 
absence of Nkx6.1 and Nkx6.2 (downstream targets of Shh signalling), the developing spinal cord does 
not fully respond to Shh patterning, and no OPCs arise from either the dorsal p0 or ventral pMN 
domains b)iv) In the complete absence of Shh, at E12, no OPCs arise and the spinal cord becomes 
dorsalised c)i) By E13.5-E15.5, in normally developing spinal cord, OPCs are seen to emanate from 
both the ventral pMN domain (represented as blue arrows) and the dorsal p0 domain (represented as 
purple arrows) c)ii) Similarly, OPCs can be seen to arise from both p0 (purple) and pMN(blue) derived 
cultured explants c)iii) At E13.5-E15.5, in the absence of Nkx6.1 and Nkx6.2, OPCs fail to arise from the 
ventral pMN region, but do arise from the dorsal p0 region, indicating an additional Shh independent 
dorsal origin for spinal cord OPCs c)iv) This dorsal origin is confirmed by the emergence of OPCs from 
the p0 region of dorsalised Shh knock-out spinal cord. (figure adapted from Naruse et al., 2016a) 
 
1.2.6 Origins of OPCs in the Developing Brain 
1.2.6.1 OPCs in the Developing Brain 
As in the spinal cord, in the telencephalon (the developmental pre-runner of the 
cerebrum), OPCs arise first in the ventral portion which goes on to become the basal 
ganglia, and later in the dorsal portion which later forms the cerebral cortex. As shown 
in figure 1.2a), OPCs first emerge at around E12 in the ventral ventricular and sub 
ventricular zones from the medial ganglionic eminence (MGE) to anterior 
entopeduncular area (AEP) under the direction of the morphogen Shh (Bulfone et al., 
1993; Kessaris et al., 2001; Naruse et al., 2016b; Woodruff et al., 2001) . Generation of 
OPCs in the ventral telencephalon is dependent on Shh signalling and knock-out of NK2 
Homeobox 2.1 (Nkx2.1) a critical upstream inducer of Shh, blocks the timely generation 
of PDGFrα positive OPCs in the ventral forebrain (Tekki-Kessaris et al., 2001).  
Traditionally, cortical OPCs were thought to arise only from Nkx2.1 expressing 
precursors by this Shh dependent ventral mechanism, and while some of these ventrally 
Page 13 Catriona Ford s1059067 
derived OPCs do migrate to the cortex (Kessaris et al., 2006; Nakahira et al., 2006), more 
recent evidence supports additional dorsally derived Shh independent sources. In the 
more dorsal cortical region in which Shh expression does not occur at any time, 
colonisation of the region by PDGFrα positive OPCs occurs by E17.5 to E20.5 in both wild-
type and Nkx2.1 knockout mice (Tekki-Kessaris et al., 2001). This Shh independent OPC 
patterning in the developing telencephalon can be explained by the occurrence of three 
waves of OPC generation. 
1.2.6.2 OPCs Arise in Three Sequential Waves in the Developing Forebrain 
Following the first wave of ventral OPC emergence (figure 1.2a)), a second wave of OPCs 
can be detected from E15.5 emanating from the MGE towards the more dorsal 
subventricular zones (figure 1.2c)), while a third wave colonise as far as the most dorsal 
regions of the developing cortex from around birth to early neonatal life (figure 1.2e)) 
(Kessaris et al., 2006).  
Each wave of OPC generation is orchestrated by patterning of a different morphogen, a 
phenomenon elegantly documented in a 2006 study using inducible Cre fate mapping 
systems to visualise PDGFrα positive OPCs derived from precursor cell expressing either 
Nkx2.1, Gsh2 or Empty Spiracles Homeobox 1 protein (Emx1) between E12.5 and P2 
(Kessaris et al., 2006).  Experiments using Nkx2.1 reporter mice recapitulated the 
established view of an initial wave of Shh dependent OPC emergence from Nkx2.1 
expressing precursors from around E12.5 some of which migrate to the cortical region 
(figure1.2b)). This was followed by a second wave beginning at around E15, in which 
OPCs derived from Gsh2 positive precursors emanate dorsally from the lateral ganglionic 
eminence (LGE) (figure1.2d)), and finally by a third wave, from P0 to P2 consisting of 
the emergence of OPCs from Emx1 positive precursors in the most dorsally located 
developing cortex (figure1.2f)). This process culminates in extensive coverage of the 
majority of cortical regions by OPCs derived from all three waves. 
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Figure 1.2 OPCs in the developing telencephalon emerge in three waves.  Distribution of OPCs in the 
telencephalon at a) E12-E15.5, c) E15.5-birth and e) Early neonatal life. OPCs arising at: E12.5-E15.5 
are derived from Nkx2.1 positive precursors emanating from the MGE b), E15.5-birth are derived from 
Gsh positive precursors emanating dorsally from the MGE and LGE d), Early neonatal life are derived 
from Exm1 positive precursors f), figure adapted from Naruse et al., 2016a. 
1.2.7 Origins of OPCs in the Developing Optic Nerve 
In addition to the spinal cord and brain, another region of the developing CNS which has 
provided insight into the activities of nascent oligodendroglia is the developmental optic 
nerve. As shown in figure 1.3, in a similar fashion to the developing spinal cord and 
telencephalon, optic nerve OPCs arise from progenitor cells under the direction of Shh 
secreted by retinal ganglion cells (RGCs) (Merchán et al., 2007), this time in the proximal 
preoptic area which is located most dorsally from the retina between the third ventricle 
and the optic chiasm (Gao and Miller, 2006; Ono et al., 1997).  OPCs can first emerge at 
the proximal end of the nerve at E14.5 from whence they dissipate out in a gradient from 
the optic chiasm toward the retina, so that they are homogeneously distributed over the 
whole optic nerve by E17.5 (Spassky et al., 2002).   
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Figure 1.3 Directional Migration of OPCs in the Developmental Optic Nerve At around E.14.5 OPCs 
emerge in the Preoptic Area, under the direction of Shh secreted by the Retinal Ganglion Cells.   OPCs 
then migrate from the Optic Chiasm to the Retina until they become dispersed in a gradient 
throughout the Optic Nerve by E17.5. 
Regardless of their spatio-temporal origins and direct precursors, by the end of the 
developmental stage, OPCs migrate throughout the CNS, some differentiating into adult 
oligodendrocytes and the rest remaining at the precursor stage forming the resident 
adult glial stem cell population. While the emergence of OPCs from their precursors is 
vital for the establishment of a OPC population, migration of developmental OPCs from 
their origin to their diverse final spatial and functional destinations in the adult CNS is 
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1.2.8 Developmental Migration of OPCs is Orchestrated by Chemomigratory 
Molecules 
During the developmental stage, many OPCs migrate some distance from their site of 
emergence to their eventual terminus. This migratory behaviour has been shown to be 
the result of environmental factors rather than an intrinsic property of the OPCs 
themselves since OPCs transplanted from one region of the CNS to another adopt the 
migratory patterns of the recipient region as opposed to the donor region (Olivier et al., 
2001). Directional migration or chemotaxis of OPCs is modulated via stimulation of their 
cell surface receptors by a variety of different factors including mitogens, chemokines, 
secreted growth factors and adhesion molecules in the extracellular matrix (ECM) 
(reviewed in de Castro et al., 2013). These chemical cues can be broadly split into two 
subtypes: chemoattractants which attract OPCs forwards and chemorepellants which 
repel OPCs preventing them from veering off track.  
Chemomigratory factors for developmental OPCs are presented to the cell surface 
receptors in a number of different ways. Some, operate via contact-mediated 
mechanisms in which factor of interest is chemically bound to a surface with which the 
migrating OPC must make physical contact (reviewed de Castro and Bribián, 2005). 
Examples include extracellular matrix proteins such as Laminin, Fibronectin, Tenascin-
C and Merosin (de Castro and Bribián, 2005; Frost et al., 1996; Garcion et al., 2001; 
Kiernan et al., 1996, 1999; Niehaus et al., 1999; Payne et al., 1996; Saga et al., 1992), 
transmembrane Semaphorins (classes 4, 5, 6 and 7) (Cohen et al., 2003), Neuregulins 
(Canoll et al., 1996; Milner et al., 1997), Ephrins (Prestoz et al., 2004) and 
Integrins(Milner et al., 1996, 1996; Niehaus et al., 1999; Tiwari-Woodruff et al., 2001).  
Other factors are secreted molecules with the ability to disperse through the CNS 
parenchyma which contact OPCs independently from the cell types which secrete them. 
Examples include the ubiquitous PDGFα (Armstrong et al., 1990b; Dubois-Dalcq and 
Murray, 2000; Fruttiger et al., 1999; Milner et al., 1997; Simpson and Armstrong, 1999; 
Zhang et al., 2004), FGF-2 (Armstrong et al., 1990b; Bansal et al., 1996; Dubois-Dalcq and 
Murray, 2000; Milner et al., 1997; Osterhout et al., 1997; Simpson and Armstrong, 1999), 
Epidermal Growth Factor (EGF) (Fricker-Gates et al., 2000), Hepatocyte Growth Factor 
(HGF) (Yan and Rivkees, 2002), Vascular Endothelial Growth Factor (VEGF) (Zhang et al., 
2003), Netrin-1 (Jarjour et al., 2003; Spassky et al., 2002; Sugimoto et al., 2001; Tsai et 
al., 2003), class 3 Semaphorins  (Cohen et al., 2003; Ricard et al., 2001; Spassky et al., 
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2002; Sugimoto et al., 2001) and Chemokine (C-X-C) Motif Ligand 1 (CXCL1) (Tsai et al., 
2002).  
1.3 Multiple Sclerosis 
One of the diseases where remyelination of axons is important is Multiple sclerosis (MS). 
MS is a CNS disease with both inflammatory and degenerative neuropathology and was 
first documented in 1868 by Jean-Martin Charcot (Clanet, 2008). It is a leading cause of 
disability in young adults and has one of the highest incidences of non-traumatic 
neurological disorders worldwide (Browne et al., 2014).  Despite improvements in both 
patient care and support services, between 2008 and 2013 the global prevalence of MS 
increased from 2.1 million to 2.3 million patients. Some of this augmentation in patient 
numbers can be attributed to earlier diagnosis and reporting and improved patient 
longevity (Browne et al., 2014).  Scotland has one of the highest incidences of MS 
worldwide with 8.55 cases per 100,000 population (mean national incidence rate 2010 
– 2015) (statistics from The Scottish MS Register 2016, 
http://www.msr.scot.nhs.uk/Reports/Main.html ). This reflects a worldwide trend in 
which cases of MS are most common in populations of European origin, distant from the 
equator. Such populations have a 0.1–0.2% lifetime risk of developing MS (Compston et 
al., 2005). While there is variability in the incidence and prevalence of MS across Europe 
(Kingwell et al., 2013), Europe is recognised as being a region of high MS incidence, with 
a reported incidence of ≥ 30/100,000 (Kurtzke, 2000) across the continent, which 
amounts to more than half the global population of known MS patients (Browne et al., 
2014). In more northern regions of both Europe and North America prevalence has been 
reported at 0.1-0.2%, while yearly incidence is reported as 5-6 per 100,000 of the 
population (Goodin, 2016a; Wynn et al., 1990). 
The underlying causes of MS are as yet poorly understood: the disease has not been 
exclusively linked to a single factor and appears to be multifactorial in its aetiology 
(Goodin, 2016a). While the disease does not follow a standard Mendelian inheritance 
pattern, in northern regions the siblings of MS probands have an increased risk of 
developing MS and monozygotic twins have a >200 fold increased risk (Ebers et al., 1995; 
Mumford et al., 1994; Willer et al., 2003), indicative of a strong genetic component. 
However, in southern populations the genetic link is weaker with the proband-wise 
concordance rate for monozygotic twins half of that in the north (French Research Group 
on Multiple Sclerosis, 1992; Islam et al., 2006; Ristori et al., 2006), suggestive of the 
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contribution of other aetiological components such as environmental factors and 
epigenetics.  
Neurological symptoms associated with MS include deficits in vision, sensory perception 
and muscular weakness and balance (Noseworthy et al., 2000), all of which are the 
external manifestations of CNS damage. Multiple Sclerosis is characterised by the 
appearance of plaques of demyelination in the white matter, although it is now known 
that demyelination also occurs in the grey matter. White matter plaques can be identified 
by magnetic resonance imaging.  
The pathologies associated with MS are the downstream result of the destructive attack 
of T-cells perpetrated against CNS components, most strikingly against myelin. Markers 
of MS in patients include the presence of oligoclonal immunoglobulin G in the cerebral 
spinal fluid (CSF), and gadolinium enhancing lesions in the CNS tissue during magnetic 
resonance imaging, indicative of inflammation as well as degeneration in the blood brain 
barrier (BBB) (Stys et al., 2012).  
MS is primarily identified, by the demyelinating lesions in the brain and spinal cord, 
resulting from the immune attack (Sriram, 2011; Wu and Alvarez, 2011). These lesions 
can be classified into several subtypes. Acute plaques represent the earliest stages of 
formation of the lesion and are hallmarked by inflammatory infiltration and the 
distribution of Major Histocompatibility Class II (MHCII) expressing microglia and 
macrophages containing lipids and actively involved in the stripping of myelin from the 
axons(reviewed Frohman et al., 2006). Chronic plaques represent long term damage, and 
have regions of reduced cell density and glial scarring and distinct lesion borders. 
Chronic active plaques exhibit actively occurring damage at their borders. Chronic active 
lesion borders feature inflammation, microglia, macrophages astrocytes and 
perivascular cuffing, and some remyelinating may occur (reviewed Frohman et al., 
2006). In chronic silent plaques, the demyelination and axonal destruction has already 
taken place, and no inflammation occurs at the border or elsewhere in the lesion. Chronic 
silent plaques are also devoid of remyelination or OPCs and feature the complete loss of 
oligodendrocytes and reduced density of axons (reviewed Frohman et al., 2006). In 
shadow plaques, the demyelination resulting from inflammatory damage has already 
been repaired by remyelination and myelin appears thinner than in normal appearing 
white matter (reviewed Frohman et al., 2006).  
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1.4 Regeneration 
1.4.1 The Role of OPCs in the Normal Adult CNS 
In the adult CNS, undifferentiated OPCs persist in their niche in the sub-ventricular zone 
(SVZ) (neural cell precursor derived OPCs) and are also found scattered throughout the 
adult CNS (parenchymal OPCs) making up 5-10% of the overall cell load.  
Until recently, parenchymal OPCs were thought to be almost completely responsible for 
regeneration by OPCs, however more recent evidence has suggested greater 
involvement of OPCs derived from neural precursor cells in the SVZ. In their 2014 study, 
Kilpatrick and Merson et al., used in vivo genetic fate mapping to discover the 
contribution of the two OPC types to the repair of cuprizone induced demyelination in 
the corpus callosum of mice (Xing et al., 2014).  
Two Cre transgenic mouse lines were used: Nestin-CreERT2 labelled OPCs derived from 
neural precursor cells in the SVZ (nestin being a marker of neural precursor cells) and 
Pdgfra-CreERT2 was used to label parenchymal OPCs, both transgenic lines were 
crossed with a fluorescent Cre reporter strain. In this way the fluorescence of 
regenerating OPCs were related back to the OPCs origin.  Neural precursor derived OPCs 
were found to significantly contribute to the number of myelin forming oligodendrocytes 
present during the repair of cuprizone induced demyelination (a 23 fold increase in the 
presence of SVZ/neural precursor derived OPCs in the corpus callosum 6 weeks after 
injury, as compared to uninjured controls), and the myelin of such cells was found to be 
thicker than myelin produced by parenchymal OPCs (Xing et al., 2014). 
The behaviour of OPCs in the uninjured CNS is still somewhat mysterious although there 
is evidence that they are a dynamic cell type capable of proliferation and migration 
(Dawson et al., 2003; Hughes et al., 2013). 
OPCs have also been found to make synapses with neurons (Bergles et al., 2000; Orduz 
et al., 2015). Neurons use synapses to transmit electrical or chemical signals from one 
cell to another, and contrary to the traditional view that synapses only existed between 
neurons, neurons are now known to use synapses to communicate with glia. In a 2000 
study, Bergles et al., showed that the stimulation of excitatory neuronal axons in the 
hippocampus, resulted in internal currents within OPCs. This process being mediated by 
the interaction of the neuron derived neurotransmitter alpha-amino-3-hydroxy-5-
methyl isoxazole propionic acid (AMPA), and AMPA receptors on the surface of OPCs at 
synapses (Bergles et al., 2000).  
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In a more detailed 2015 study, Angulo et al., found OPCs to make complex synaptic 
networks with interneurons, specifically through the targeting of neuronal subdomains 
rich in GABAA receptors with γ2 subunits by NG2+ OPCs. These fast spiking interneurons 
formed a complex web of interactions with OPCs, with microcircuit complexity peaking 
at pre-natal day 10, immediately prior to the differentiation of OPCs into 
oligodendrocytes (Orduz et al., 2015). This suggests that the oligodendrogenesis may be 
initiated by neuronally derived signals, although further research would be required to 
verify this possibility. 
While the differentiation of OPCs into adult oligodendrocytes has been extensively 
studied in development and regeneration (as will be discussed in depth in later sections 
of this thesis), there I also evidence the OPCs play an active role in the turnover of myelin 
in uninjured adult tissue. Proliferating and maturing OPCs have been found to make up 
5-20% of the total oligodendroglia in the uninjured adult CNS in mice (Kang et al., 2010; 
Rivers et al., 2008; Young et al., 2013), and there is variability in the pattern of 
myelination of neuronal axons by adult oligodendrocytes in different regions of the adult 
brain and there is evidence of the persistence of unmyelinated neurons (Olivares et al., 
2001; Tomassy et al., 2014). This variability in myelination, and incidence of 
unmyelinated axon tracts, allows for the optimisation of myelin coverage and thickness 
throughout adult life (reviewed in Mount and Monje, 2017). 
Similar to neuronal plasticity, increasing evidence shows myelination to be a dynamic 
process in which myelin thickness and coverage of axons is varies with the activity and 
functions of the neurons being insulated (reviewed in Mount and Monje, 2017).  In a 
2012 study, Makinodan et al., showed social isolation in juvenile mice, to result in 
thinning of myelin sheaths in the medial prefrontal cortex (Makinodan et al., 2012). 
Another recent study found that the acquisition of motor skills in adult mice results in 
the generation of new OPCs and oligodendrocytes. Mice lacking a functional myelin 
regulatory factor (Mrf) gene – thus unable to generate new OPCs and oligodendrocytes, 
were unable to develop and retain new motor skills (McKenzie et al., 2014). The 
emerging picture is one of more general myelination of neuronal axons during 
development, followed by the tailoring of myelin dynamics to neuronal activity 
throughout adult life. 
While the modification of adult myelination could represent a future avenue of for 
potential regenerative treatments, the migration of OPCs into regions of the adult CNS 
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requiring replacement or modulation of myelin is beneficial. PDGFα and FGF2 have long 
been known to be effectors of chemoattraction in OPCs derived from the adult and 
postnatal brain (Armstrong et al., 1990a; Decker et al., 2000; McKinnon et al., 1993; 
Milner et al., 1997; Zhang et al., 2004) 
1.4.2 The Role of OPCs in Regeneration 
In the adult CNS, OPCs are best known for their pivotal role in the regenerative process 
of remyelination. As previously mentioned, existing adult oligodendrocytes are unable 
to replace lost myelin sheaths, in light of this, OPCs are the primary source of new 
oligodendrocytes (Tripathi et al., 2010; Zawadzka et al., 2010) and might be best thought 
of as the resident glial stem cell population of the CNS, a pool of precursors from which 
new oligodendrocytes are generated. 
As previously mentioned, in the uninjured CNS, the axons of neurons are protected and 
nurtured by the myelin sheath produced by oligodendrocytes, and quiescent OPCs are 
scattered throughout the CNS parenchyma (see figure 1.4a))(Franklin and ffrench-
Constant, 2008). Following demyelinating injury, distress signals, including 
chemoattractants for OPCs are released from the injury site (see figure 1.4b)). 
Chemoattractants form a gradient emanating from the lesion site which contact distal 
OPCs and direct them towards the lesion site (see figure 1.4c)). As previously 
mentioned, in developmental myelination, OPC migration precedes OPC proliferation 
which occurs directly prior to differentiation into adult oligodendrocytes (Raff et al., 
1998) and it may be that the sequence of events is similar in remyelination. OPCs 
optimally placed in the vicinity of demyelinated axons differentiate into mature 
oligodendrocytes (see figure 1.4d)), ready to reform the myelin sheath, restoring 
protection and trophic support to the axon (see figure 1.4e)), thus preventing 
neurodegeneration(Franklin and ffrench-Constant, 2008). 
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Figure 1.4 Remyelination a) In the healthy CNS, the axons of neurons are protected and supported by 
the myelin sheath formed by oligodendrocytes, quiescent OPCs are distributed throughout the CNS 
tissue b) Following a demyelinating insult resulting in the destruction of myelin an the loss of 
oligodendrocytes, chemical distress signals including OPC chemokines, are released from the lesion 
site c) OPC chemokines form a liquid gradient emanating from the lesion site, which directs OPCs 
towards the site of demyelination d) OPCs in proximity to the denuded axon begin to differentiate e) 
OPCs fully differentiate into new mature oligodendrocytes, which replace the lost myelin sheaths 
restoring protection and trophic support to the axon 
1.4.4 Models of Demyelination 
In the study of the regenerative process of remyelination a number of models have been 
developed which recapitulate various aspects of MS pathology. In the Experimental 
Autoimmune Encephalomyelitis (EAE) model, a myelin proteins such as myelin basic 
protein (MBP), myelin oligodendrocyte glycoprotein (MOG) or proteolipid protein (PLP) 
are used as antigens in conjunction with an adjuvant to boost the immune response, to 
immunise rodent models (Pachner, 2011). This causes an episode of inflammatory attack 
in the CNS resulting in demyelination and paralysis followed by full recovery, this 
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recapitulates the short inflammatory episodes experienced by MS patients in the 
relapsing and remitting phase of the disease.   
Another widely used model of remyelination, is cuprizone induced global demyelination. 
Cuprizone is a toxin which is administered to rodents by feeding and results in 
demyelination of highly myelinated tracts in the white matter over a period of weeks and 
cessation of cuprizone treatment is followed by effective remyelination(Blakemore and 
Franklin, 2008; Blakemore and Patterson, 1978; Ludwin, 1978). The cuprizone model 
recapitulates the latter stages of MS progression in which demyelination leads to 
neurodegeneration, and is also an excellent model for the study of the process of 
remyelination.  
Focal demyelinating lesions can also be induced by toxin treatment. Injection of the 
demyelinating agent lysophosphatidyl choline (LPC) into the brain or spinal cord, 
induces the formation of a small region of demyelination. This model is used to 
recapitulate the formation of contained demyelinated plaques in MS patients (Woodruff 
and Franklin, 1999). Following injection of LPC, it takes 28 days for full remyelination to 
occur, and the focal nature of the lesion formed makes an attractive model to study the 
infiltration of OPCs and microglia into the lesion from out with the region of 
demyelination. 
1.4.3 Failure of OPC Differentiation Contributes to Failure of Remyelination  
The process of remyelination has been found to be more effective in murine models than 
in humans, and is inefficient in MS patients. This failure in remyelination may be 
attributed to the failure of OPCs to differentiate into mature myelinating 
oligodendrocytes and a number of factors have been found to inhibit OPC differentiation 
in animal models.  
LINGO-1 has been shown to inhibit the differentiation of OPCs in the spinal cord of EAE 
mice (Mi et al., 2005), and the treatment of OPCs with a LINGO-1 antagonist, resulted in 
increased OPC differentiation and remyelination following induction of focal 
demyelinating lesions using LPC (Mi et al., 2009). Wnt signalling has also been found to 
negatively impact OPC differentiation through the signal transducer β-catenin. 
Transgenic mice over expressing β-catenin were found to exhibit delayed OPC 
differentiation and hypomyelination in development and Wnt activity was detected in 
human MS lesions. Other examples of negative regulator include FGF-2, Hyaluronan and 
BMPs. 
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In contrast, other factors have also be found to increase the differentiation of OPCs. In 
their 2011 study, Huang, Jarjour et al., discovered increased expression of RXR-γ during 
remyelination and showed that OPCs express RXR-γ and that loss of RXR-γ resulted in 
impaired OPC differentiation in LPC induced lesions (Huang, Jarjour et al., 2011).  
Another factor found to improve OPC differentiation is CXCL12, which has two 
functionally distinct receptors, both of which are expressed by OPCs. Stimulation of the 
G-protein coupled receptor CXCR4 by CXCL12, initiates an intracellular signalling 
cascade, culminating in the alteration of gene expression. In contrast CXCR7, scavenges 
CXCL12, thus reducing the binding of CXCL12 to CXCR4. It has been demonstrated that 
agonism of CXCR4 and antagonism of CXCR7, increase OPC differentiation in 
demyelinating injury (Williams et al., 2014). 
1.4.4 Inefficient Recruitment of OPCs to Demyelinating Lesions Contributes to the 
Inhibition of Remyelination and is Orchestrated by Chemomigratory Regulators 
Lack of remyelination in MS lesions, could also be the result of inefficient migration of 
OPCs into sites of demyelination. There is some debate as to the contribution of OPC 
migration as opposed to proliferation during remyelination. Irradiation sufficient to kill 
all dividing cells in the spinal cord has been shown to impede remyelination and this has 
been suggested as evidence that loss of proliferation is responsible for blocking 
remyelination(Blakemore and Patterson, 1978). However, since more recent evidence 
shows that non-activated OPCs in uninjured adult tissue are still actively dividing cells 
(Hughes et al., 2013), it is clear that irradiation would kill these quiescent OPCs, thus 
stopping migration as well as proliferation.   
It has also been postulated that improvement of OPC recruitment to lesion sites has no 
effect on the efficacy of remyelination. In a 2004 study, the gene for platelet derived 
growth factor alpha (PDGFα), a known chemoattractant for OPCs, was placed under the 
control of the glial fibrillary acidic protein (GFAP) gene promoter (Woodruff et al., 2004). 
The authors found that following lysophosphatidylcholine (LPC) induced demyelinating 
injury there was no improvement in remyelination in GFAP-PDGF-A mice as compared 
to control wild-type mice. However, figures within the paper show clearly that GFAP 
expression is limited to the periphery of the lesion and does not penetrate the central 
lesion where demyelination is most pronounced. It can therefore be concluded that far 
from proving that increased migration of OPCs into lesion sites has no effect on 
remyelination, the results show that misdirection of OPCs to the periphery of the lesion 
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rather than to the demyelinated axons does not improve remyelination. Thus, 
highlighting the importance of nuanced directional chemokinetic signalling in the 
recruitment of OPCs. 
1.4.4.1 Semaphorin-3F is a Chemoattractant for OPCs and Semaphorin-3A is a 
chemorepellent for OPCs following demyelination 
Previous research in the Williams and Lubetzki labs found some MS lesions, particularly 
chronic active lesions, to be completely devoid of OPCs (Boyd et al., 2013a).  These 
studies also showed that the addition of OPC chemorepellent Semaphorin-3A (Piaton et 
al., 2011; Williams et al., 2007) to LPC induced sites of focal demyelination in the corpus 
callosum of mice, resulted in decreased OPC recruitment and remyelination. In contrast 
the addition of OPC chemoattractant Semaphorin-3F (Piaton et al., 2011; Williams et al., 
2007), had exactly the opposite effect, increasing both OPC recruitment and 
remyelination(Boyd et al., 2013a).  
1.4.4.3 FGF8 is a Chemoattractant for OPCs Following Demyelination 
Fibroblast growth factor 8 (FGF8) is necessary for CNS development at the embryonic 
stage, but is not known to be expressed in the adult CNS. OPCs were found to migrate 
towards FGF8 soaked heparin beads in Matrigel cultures and transplanted FGF8 soaked 
heparin beads in cuprizone induced demyelination, increasing the expression of NG2 and 
MBP(Cruz-Martinez et al., 2014). 
1.4.4.4 Netrin-1 is a Chemorepellant for OPCs Following Demyelination 
The developmental OPC chemorepellent Netrin-1 (Jarjour et al., 2003), has been shown 
to occur in chronic demyelinatinating MS plaques (Bin et al., 2013). In their 2014 study,  
Tepavčević  et al., discovered that in the early stages of demyelination in human MS 
lesions, astrocytes express Netrin-1 and OPCs express Netrin-1 receptors Deleted in 
Colorectal Cancer (DCC) and Unc5A. Conversely, in LPC induced focally demyelinated 
lesions which fully remyelinated, Netrin-1 expression was not detected until after OPC 
recruitment. OPCs were shown to migrate away from Netrin-1 in in vitro trans-well 
migration assays. The addition of Netrin-1 functional blocking antibodies to LPC induced 
lesions increased OPC numbers in the lesion site, and increased expression of Netrin-1 
by lentiviral induction during the early stages of LPC lesion induction, when OPCs should 
be migrating, resulted in a decrease in OPC recruitment to the lesion site (Tepavčević et 
al., 2014). There is also evidence that the chemorepellent function of Netrin-1 results in 
the expulsion of OPCs from the sub-ventricular zone following demyelinating injury, thus 
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releasing OPCs to migrate into demyelinated lesions in the Corpus Callosum (Cayre et al., 
2013).  
1.4.4.5 Prostacyclin is a Chemoattractant for OPCs Following Demyelination 
Another factor which has been found to increase OPC migration following demyelinating 
injury is prostacyclin (prostaglandin-I2, PGI2). The prostacyclin receptor (IP receptor) 
was shown to be expressed by OPCs and OPCs were found to migrate up a gradient of 
prostacyclin analogs in trans-well assays in vitro (Takahashi et al., 2013). Expression of 
the IP receptor was also found in MS brain autopsy tissue, and administration of an IP 
receptor antagonist, reduced the number of OPCs migrating and ultimately reduced MBP 
expression in LPC induced demyelinating lesions in the spinal cord.  
1.4.4.6 FGF-2 is a Chemoattractant and Anosmin-1 is a Chemorepellant for OPCs in 
Demyelinating Lesions 
In the developing CNS, FGF-2 is a chemoattractant for OPCs, while Anosmin-1 is a 
chemorepellent, both factors acting on OPCs by binding to the cell surface receptor FGFR-
1 (Bribián et al., 2006, 2008). In a 2011 study, Clemente et al., reported the expression of 
FGF-2 in the active lesions and periplaque of chronic lesions in post mortem human MS 
tissue. In the same tissue, the authors also reported the upregulation of Anosmin-1 in 
chronic lesiona, and its absence in active lesions. It was also found that OPCs isolated 
from the cerebral cortices of adult mice migrated towards FGF-2 and away from 
Anosmin-1(Clemente et al., 2011).  
1.4.4.7 CCL2 is a Chemoattractant for OPCs Following Demyelination 
In a recent study, the chemokine CCL2 was found to be upregulated in OPCs isolated from 
cuprizone demyelinated brains, and also during LPC induced focal demyelination 
(Moyon et al., 2015). In vitro studies showed that OPCs migrated up a gradient of CCL2 
and videomicroscopy revealed that OPC non-directional OPC motility was also increased 
in response to CCL2. Transplantation of OPC like CG4 cells overexpressing CCL2, 
migrated away from the site of injection in the Corpus Callosum and CCL2 was shown to 
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Factor Receptor on OPCs Effect on OPCs References 
Anosmin-1 FGFR1 Chemorepellant (Clemente et al., 
2011; Murcia-
Belmonte et al., 
2016) 
CCL2 N/A, CCL2 




(Moyon et al., 
2015) 
FGF-2 FGFR1 Chemoattractant (Clemente et al., 
2011) 
Netrin-1 Unc5a, DCC Chemorepellant (Tepavčević et al., 
2014,) 
PDGFα PDGFRα Chemoattractant (Redwine and 
Armstrong, 1998; 







Chemoattractant (Takahashi et al., 
2013) 
Semaphorin-3A Neuropilin-1 Chemorepellant (Piaton et al., 
2011; Williams et 
al., 2007) 
Semaphorin-3F Neuropilin-2 Chemoattractant 
Table 1.1 Summary of known modulators of OPC migration in demyelinating 
lesions 
As summarised in table 1.1, a variety of factors which modulate the migration of OPCs 
in demyelinating injury have already been identified. However, I hypothesized that 
other, perhaps more potent chemoattractants might be as yet undiscovered. In this 
thesis, I describe how the search for novel modulators of OPC migration led me to 
discover and validate a master regulator of OPC led regeneration, augmenting not only 
OPC migration, but also OPC maturation. 
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2.1 Bioinformatic Methods 
All data was analysed using the statistical computing software R version 3.3.2 “Sincere 
Pumpkin Patch” (R Core Team, 2016), with the aid of the microarray specific packages 
downloaded from Bioconductor (Gentleman et al., 2004), Limma (Ritchie et al., 2015) 
and Affy (Gautier et al., 2004). The Illumina specific Beadarray (Dunning et al., 2007) was 
used to parse the Illumina beadchip array data from Huang, Jarjour et al., 2011, and 
Ggplot2 (Wickham, 2009) was used to generate the Principal Component Analysis plots. 
See Appendix 3 for full R code 
 
Selection of genes by adjusted pvalue was performed in Microsoft Excel using the following 
formula: 
=AND(B2>I$2,C2>I$2,D2>I$2,E2>I$2,F2>I$2,G2>I$2)   
This formula returns TRUE if all the pvalues are greater than 0.05 and returns false if any of 
them are above 0.05.  
Pearson correlation coefficitents for used for analysis of correlation with PDGFα were also 
calculated in Microsoft Excel using the following formula: =CORREL(C$1820:H$1820, 
C2:H2) 
2.2 Wet Laboratory Procedures 
Details regarding all reagents, kits and antibodies used in the methods for this thesis can 
be found in chapter 2.2.9.  
 
All experiments were carried out in line with Home Office guidelines, under personal 
licence IF27165BD (Catriona Ford) and project licence 60/4524 (Anna Williams). 
2.2.1 - Animal housing and husbandry 
All oligodendrocyte precursor cells (OPCs) used in this thesis were extracted from wild 
type Sprague Dawley rats housed at the University of Edinburgh. 
2.2.2 – Termination 
For OPC extraction, the animals were terminated at postnatal day 0-2 by an 
intraperitoneally administered overdose of Euthatal (150mg/kg). 
2.2.3 Preparation of primary rat OPCs from neonatal brain tissue 
The shake-off method for the culture of rat OPCs was first developed by McCarthy and 
de Vellis in their 1980 study, which included the characterisation of OPCs produced using 
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this method. Using both light and electron microscopy to characterise the cells in the 
cultures by morphology, the authors found post shake-off oligodendroglial cultures to be 
of around 98% purity, with isolated clumps of contaminating astrocytes, a result 
confirmed by both enzymatic and pharmacological characterisation (McCarthy and de 
Vellis, 1980).  
The shake-off method used in this thesis, is the method described in Milner and ffrench-
Constant’s 1994 publication, in which in addition to being shaken-off, mixed glial 
cultures were further refined by a 20 minute incubation period in petri dishes post 
shake-off (Milner and ffrench-Constant, 1994). During this step, contaminating microglia 
adhere to the petri dish, leaving a near pure OPC population in the culture media. By 
morphological analysis, the authors found the culture to be greater than 95% 
oligodendroglial cells. After 4 hours in culture, immunostaining for the oligodendrocyte 
specific marker GalC, found less than 10% of the cell population to be oligodendrocytes, 
making the culture more than 90% OPCs.  Further characterisation of markers expressed 
by OPCs in this culture can be found in figure 4.16b) and figure 5.5. 
This method of primary OPC isolation is as follows: 
P0-P2 Sprague Dawley rat brains were dissected into ice-cold MEM, the midbrain, 
hindbrain and meninges were removed leaving the cerebral cortices which were pooled 
in 1ml ice cold MEM, before mincing with fine scissors. 
A papain enzyme mix of papain (1.2U/ml), L-cysteine (0.24mg/ml in MEM) and DNaseI 
Type IV (40µg/ml in PBS) in 1ml MEM was pre-warmed for 10 minutes at 37°C to 
activate the papain, before sterile filtration and addition to minced cortices in 1ml MEM. 
Cortices were then digested at 37°C for 1 hour. 
Digested cortice suspension was diluted tenfold in OPC media (Dulbecco’s modified 
Eagle medium (DMEM) with 10% FBS, 1% pen/strep) to stop digestion, spun down (5 
minutes at 1000 RPM), half of the medium removed then triturated gently 3-4 times with 
a 19-gauge needle followed by 3-4 times with a 23-gauge needle to remove any clumps.  
The cell pellet was resuspended in OPC media (1.5 brains in 10ml per flask) and plated 
onto T75 vented-top flasks (straight necked to avoid loss of cell culture during shake-off 
step) coated with poly-D-lysine (PDL; 5μg/ml in water; minimum 1 hour coating at 37oC 
I 7.5% CO2).  
Mixed glial cultures were cultured at 37°C and 7.5% CO2 for a period of 10 days and 
replenished with fresh OPC media after 3-5 days and then every 2-3 days. 
Following 10-14 days in culture, the vented cap of the flasks was sealed with parafilm (to 
circumvent the absence of CO2 concentration control functionality on the shaker) and the 
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flasks containing mixed glial cultures were fixed to an orbital shaker using autoclave tape 
and shaken at 240 RPM and 37°C for 1 hour. After 1 hour, the media was replaced in 
order to remove the loosely attached microglia. Fresh media was added and the flasks 
were then reaffixed to the orbital shaker and shaken in the same way for a further 16-18 
hours to isolate OPCs from the basal cell monolayer. 
Following shake-off, flasks were removed from the shaker and media (containing 
shaken-off OPCs) was removed and distributed among 10cm plastic petri dishes and 
incubated at 37°C and 7.5% CO2 for a period of 20-25 minutes (this step eliminates any 
remaining microglia which become adhered to the plastic). Media and non-adhered cells 
(OPCs) were transferred to 50ml falcon tube and centrifuged for 5 minutes at 1000 RPM, 
yielding a population of OPCs, 95% of which can be potentially be differentiated into 
adult oligodendrocytes in culture (Milner and Ffrench-Constant, 1994).   
The supernatant was aspirated and discarded, and the cell pellet was resuspended in 5ml 
culture medium, gently triturated 6-10 times through a 21-gauge needle, passed through 
a 70µm cell strainer, counted and incubated in Sato medium (DMEM with 1% pen/strep. 
1% ITS supplement, 16μg/ml putrescine, 400ng/ml L-thyroxine, 400ng/ml Tri-
iodothyroxine, 60ng/ml progesterone, 100μg/ml BSA (fraction V)) at 37oC in 7.5% CO2 
for up to 4 hours until required for other experimental procedures. 
2.2.4 Culture of post shake-off rat OPCs  
2.2.4.1 Culture of post shake-off rat OPCs on glass coverslips 
Post shake-off OPCs in Sato media in 50ml falcon tubes were spun down and 
resuspended at a density of 50,000 OPCs per 20µl droplet of Sato media per PDL coated 
coverslip in a 24 well plate. After 20 minutes at 37oC and 7.5% CO2 (allowing time for 
OPCs to adhere to the coverslips), coverslips were topped up with 500µl Sato media per 
well. OPCs were then cultured for up to 50 hours and the media was not changed during 
this period. 
2.2.4.2 Culture of post shake-off rat OPCs in 324 well plates 
Post shake-off OPCs in Sato media in 50ml falcon tubes were spun down and 
resuspended at a density of 1000 OPCs per 25µl of Sato media. 25µl of OPCs in Sato media 
were then seeded into per PDL coated 384 well plates. After 15-20 minutes at room 
temperature (allowing time for OPCs to adhere to the bottom of the wells), wells were 
topped up with 25µl Sato media per well. OPCs were then cultured for up to 18 hours 
and the media was not changed during this period. 
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2.2.4.3 Culture and assay of post shake-off rat OPCs in X-celligence RTCA CIM plates 
X-celligence plates were separated into their two parts by unclipping and 160µl of PDL 
was added to each well of the lower chamber. Upper chambers were then reattached and 
50µl of PDL was added to each well of the upper chamber. X-celligence plates were 
incubated at 37°C and 7.5% CO2 for 1 hour. All PDL was aspirated from the upper 
chamber of X-celligence plates and plates were separated by unclipping, before all PDL 
was aspirated from lower chamber. 
Following PDL coating, 160µl of Sato media only or Sato media impregnated with the 
factor being tested was added to each lower chamber, and the upper chambers were 
reattached and 50µl of Sato media was added to each upper chamber. X-celligence plates 
were then incubated in the X-celligence machine at 37°C and 7.5% CO2 for 1 hour.  
In the X-celligence RTCA 2.0 software, the experimental notes tab was populated with 
information regarding the experiment name, purpose and unique X-celligence plate 
device part numbers, and the layout tab with cell type, cell number, factor name and 
concentration. The schedule tab was set up with an initial step of sweeps = 1, interval = 
1 and duration = 0, a second step of sweeps = 100, interval = 15 minutes and duration = 
24 hours and 45 minutes (i.e. 1 sweep every 15 minutes well beyond the end point of the 
experiment), and a final step of sweeps = 1, interval = 1 and duration = 0 with the Auto 
box ticked to ensure the machine idles at the end of the experiment. 
After 1 hour of incubation, the X-celligence RTCA software was used to take the baseline 
electrical impedance of the underside of the membrane in the absence of cells. 
Post shake-off rat OPCs (prepared according to the methods in 2.2.1to 2.2.3) were 
resuspended at a concentration of 250,000 OPCs per 100ul Sato media. 100µl of Sato 
media containing (250,000 cells) was then added to each of the upper chambers. X-
celligence plates were incubated in the X-celligence machine at 37°C and 7.5% CO2 for 
30 minutes to acclimatise before beginning software protocol. 
Immediately after 30 minutes, using the X-celligence RTCA software, a second sweep 
measuring the electrical impedance of the underside of the membrane was performed to 
ascertain the nominal level of electrical impedance at the beginning of the experiment 
when cells are first added. Further electrical impedance sweeps of the underside of the 
membrane were performed at 15 minute intervals thereafter as the cells migrate 
through the permeable membrane.  
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2.2.4.3 Arrest of OPC proliferation by treatment with the proliferation inhibitor mitomycin C 
Post shake-off rat OPCs (prepared according to the methods in 2.2.1to 2.2.3), were 
resuspended in Sato media containing mitomycin C at a concentration of 5µg/ml and 
incubated at 37oC and 7.5% CO2. After a period of two hours, OPCs were spun down in a 
centrifuge for 5 minutes at 1,000 RPM, after which the media was aspirated and OPCs 
were resuspended in fresh Sato media, ready for use in further experiments. 
2.2.5 – Fluorescent Immunocytochemistry (ICC)  
2.2.5.1 ICC of OPCs on glass coverslips and 384-well plates 
Cells were fixed for 10 minutes in 4% paraformaldehyde (PFA; diluted in phosphate 
buffered saline (PBS)), then washed with PBS (3 x 5 minutes). Cells were blocked for 1-
1.5 hours at room temperature on a rocker in blocking solution (10% heat inactivated 
horse serum (HIHS), 0.1% triton in PBS) Cells were then incubated with blocking 
solution diluted primary antibodies, for 1-1.5 hour at room temperature on a rocker. 
Cells were then washed in PBS (3 x 2 minutes) before incubation with secondary 
antibodies, diluted in PBS, for 1 hour at room temperature on a rocker. Cells were 
washed with PBS (3 x 2 minutes), stained with Hoechst for 1 minute and washed again 
with PBS (rinse then 2 minutes) before mounting with Fluoromount in the case of OPCs 
on glass coverslips, or the wells were filled with PBS in the case of OPCs grown in 384-
well plates. 
2.2.5.1 ICC of OPCs on X-celligence RTCA CIM plates  
Following the conclusion of an X-celligence RTCA CIM experiment, X-celligence plates 
were unclipped, all media was aspirated and 160µl of 4% PFA was added to each of the 
lower chambers and 100µl of 4% PFA was added to each of the upper chambers. Plates 
were fixed with PFA for a period of 5 minutes, before all PFA was aspirated and upper 
and lower chambers with washed in PBS (3 x 2 minutes), stained with Hoechst for 1 
minute and washed again with PBS (rinse then 2 minutes) Cells were blocked for 1-1.5 
hours at room temperature on a rocker in blocking solution (10% heat inactivated horse 
serum (HIHS), 0.1% triton in PBS) Cells were then incubated with blocking solution 
diluted primary antibodies, for 1-1.5 hour at room temperature on a rocker. Cells were 
then washed in PBS (3 x 2 minutes) before incubation with secondary antibodies, diluted 
in PBS, for 1 hour at room temperature on a rocker. Cells were washed with PBS (3 x 2 
minutes), stained with Hoechst for 1 minute and washed again with PBS (rinse then 2 
minutes).  
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Membranes (including the electrodes and cells) were extracted by running a scalpel 
around the membrane and carefully peeling it off in a single piece for each plate (see 
figure 4.20). Extracted membranes were then cut to size using scissors and mounted 
onto glass slides using Fluoromount.  
2.2.6 Western Blot 
2.2.6.1 Extraction of proteins from cells 
OPC media was aspirated from the wells of a 24 well plate in which OPCs were cultured 
at a density of 50,000 OPCs per well. Approximately 50µl of radioimmunoprecipitation 
assay (RIPA) buffer with   1% protease inhibitor (PI). OPCs were scraped into the buffer 
using a bent pipette tip and the resultant suspension was transferred to a centrifuge tube. 
This was centrifuged at 13,000 RPM for 10 minutes at 4oC and the supernatant collected.  
2.2.6.2 - Quantification of total protein  
Protein levels were quantified using a bicinchoninic acid assay (BCA assay), using 
solutions from a Pierce BCA protein assay kit. BCA working solution was prepared 
according to the manufacturers instructions, and 200μl added to each well of a 96-well 
plate (flat bottomed). 10μl of sample was then added to each relevant well, and 9 wells 
were also used for a BSA standard curve (2000μg/ml, 1500μg/ml, 1000μg/ml, 
750μg/ml, 500μg/ml, 250μg/ml, 125μg/ml, 25μg/ml, and 0μg/ml in RIPA). The plate 
was incubated at 37oC for 30 minutes and then allowed to cool to RT. The absorbance 
was measured using an Omega Plate Reader for each well at 562nm. The protein 
concentration of each sample was then computed by comparison to the standard curve 
plotted for BSA samples. 
2.2.6.3 Western Blotting  
Protein lysates from OPC samples were diluted in RIPA and 4 x Laemmli buffer (8% 
sodium dodecyl sulphate (SDS), 40% glycerol, 20% β-mercaptoethanol, 0.4% 
bromophenol blue, 0.25M Trizma hydrochloride) at 5μg of protein in 20μl in 1x Laemmli 
buffer. Then, protein lysates from samples were boiled at 95oC for a period of 10 minutes 
and loaded into a Pierce ready-cast 4-20% Tris-HEPES gels, in a gel tank containing 
HEPES running buffer (Pierce). These samples were then run with a protein ladder (Bio-
Rad) for 1.5 hours at 100 Volts. The gel was then extracted and placed into a transfer 
cassette with a polyvinylidene fluoride (PVDF) membrane (activated in methanol). Gels 
were transferred in transfer buffer (20mM Trizma base, 150mM glycine, 20% methanol 
in water) for a period of 2 hours at 400 Amps. Following transfer, the membrane was 
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extracted from the cassette, washed in TBST (tris buffered saline (TBS; 20mM Trizma 
base, 150mM sodium chloride, 2.7mM potassium chloride in water) + 0.1% tween; PBST 
(PBS + 0.05% tween)) before blocking with 4% BSA in TBST for 1 hour on a rocker at 
room temperature. The membrane was then probed with primary antibodies diluted in 
blocking solution on a rocker at 4oC overnight. The membrane was washed with TBST (3 
x 10 minute washes) before incubation with secondary antibodies in blocking solution 
for 1 hour at RT on a rocker. Following secondary antibody administration, the 
membrane was washed in TBST and treated with ECL substrate for a period of 5 minutes. 
The excess was then dabbed off and the membrane was then imaged using a LiCor 
scanner. 
2.2.7 TUNEL Assay 
OPCs were grown overnight on glass coverslips as detailed in chapter 2.2.4.1, and 
TUNEL assay was carried out according to the manufacturers’ Protocol for Cells on 
Coverslips included in the manual for the Click-iT TUNEL Alexa Fluor 647 Imaging Assay 
(Thermo Fischer Scientific). 
2.2.8 Imaging, analysis and statistics for wet laboratory procedures 
2.2.8.1 Imaging 
Fluorescent images were captured using Leica SPE confocal microscope system, Leica 
SP8 confocal microscope system, the Zeiss Axio Observer inverted fluorescent 
microscope system and the Operetta High-Content Imaging System (PerkinElmer).  
2.2.8.2 - Image analysis  
Immunostained images generated using the Leica SPE, Leica SP8 or Zeiss Axio Observer 
microscopy systems were quantified using ImageJ FIJI software (open source). Cells 
were counted using the Cell Counter plugin. ICC images were blinded before 
quantification.  
Immunostained images generated using the Operetta High-Content Imaging System 
(PerkinElmer) were captured using Harmony High-Content Analysis software 
(PerkinElmer) and quantified using Columbus Image Data Storing and Analysis System 
software (PerkinElmer).  
2.2.8.3 - Statistics  
In vitro data was visualised as graphs produced and with statistics calculated using 
GraphPad Prism software. All data is presented as mean +/- standard error of the mean 
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(SEM), comparing at least three biological repeats (data from OPCs from at least 3 
different litters of rat pups) each time. Numbers of technical and/or biological repeats 
are stated in the results sections and in each graphical figure. Due to the fact that all the 
comparisons made were between two groups, significance was computed using a 
Students t-test, either paired (where the control and experimental conditions were run 
in parallel for each biological replicate) or unpaired. 
2.2.9 Materials 
2.2.9.1 Culture dishes and plastics 






24-well plates  Costar (Corning)  3524  
70μm cell strainer  Fisher Scientific  11597522  
Vented T75 flasks 
(OPCs)  
Falcon (Corning)  353110  
384-well plates   
X-celligence RTCA 
CIM plates 
ACEA Biosciences 05665825001 








2.2.9.2 Cell culture solutions 
Name  Company  Product code  
Dnase I type IV  Sigma-Aldrich  D5025  
Dulbecco's modified Eagle 
medium  




buffered saline  
Sigma-Aldrich  D8537  
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Fetal bovine serum  Gibco (now Thermo Fisher 
Scientific)  
10270106  
Heat inactivated horse 
serum  
Gibco (now Thermo Fisher 
Scientific)  
26050  
HEPES  Gibco (now Thermo Fisher 
Scientific)  
15630-049  
ITS  Sigma-Aldrich  I3146  
L-cysteine  Sigma-Aldrich  C7477  
Minimum Essential 
Medium  
Gibco (now Thermo Fisher 
Scientific)  
32360  
Papain, suspension  Worthington Biochemical 
Corporation  
LS003127  
Penicillin/streptomycin  Gibco (now Thermo Fisher 
Scientific)  
15140  





Sigma-Aldrich M4287-5X2MG  
 
2.2.9.2 Recombinant Proteins 
Name Species Company Product Code 
CX3CL1 Rat R&D Systems 537-FT-025/CF 
CXCL12 Rat Source BioScience ABC2919 
Lipocalin-2 (LCN2) Rat R&D Systems 3508-LC-050 




Human PeproTech EC Ltd 100-13A-100ug 
Semaphorin-3A 
(Sema3A) 
Mouse R&D Systems 5926-S3-025/CF 
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2.2.9.2 Primary Antibody dilutions 
Name Species Dilution Company Catalogue 
24p3r Rabbit 1:500 Sigma-Aldrich SAB3500306-
100UG 




CXCR4 Rabbit 1:100 Abcam ab2074 
CXCR7 Mouse 1:500 Abcam ab72100 
Ki67  Rabbit  1:200  Abcam  ab9160  
Ki67  Rabbit  1:200  Abcam  ab16667  














Olig2 Goat 1:20 R&D Systems AF2418 
PCNA  Mouse  1:200  Dako  M0879  
 
2.2.9.3 Secondary Antibody dilutions 
Species  Host  Type  Dilution  Company  Category 
number  
Goat  Donkey  Alexa Fluor 
555  
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Mouse  Donkey  Alexa Fluor 
488  






Mouse  Donkey  Alexa Fluor 
647  






Rabbit  Donkey  Alexa Fluor 
488  






Rabbit  Donkey  Alexa Fluor 
568  






Rabbit  Donkey  Alexa Fluor 
647  






Rat  Donkey  DyLight 
549  




Rat  Donkey  DyLight 
650  
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2.2.9.4 List of kits and other chemicals used 
Reagent  Company  Product code  
10x Phosphate buffered 
saline  
Gibco (now Thermo 
Fisher Scientific)  
70011-036  
4-20% Tris-HEPES gels  Thermo Fisher 
Scientific  
25224  
BCA protein assay kit  Pierce (now Thermo 
Fisher Scientific)  
23228 + 23224  
Click-iT® TUNEL Alexa 





ECL femto kit  Thermo Fisher 
Scientific  
34094  
ECL substrate  Thermo Fisher 
Scientific  
80196  
Ethanol  VWR International  20821.33  
Euthatal  Merial  
Fluoromount  Southern Biotech  0100-01  
HEPES running buffer  Pierce (now Thermo 
Fisher Scientific)  
10230064  
Hoechst  VWR International  BTIU40045  
Kaleidoscope protein 
ladder  
Bio-Rad  1610375  
Methanol  Fisher Scientific  M/3900/17  
Paraformaldehyde  Sigma-Aldrich  P6148  
Potassium chloride  Fisher Scientific  P/4280/53  
Protease inhibitor  Calbiochem  539134  
SDS  Sigma-Aldrich  5030  











Bioinformatic Analysis of Gene 
Expression Array Data from in vivo 
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3.1 Introduction 
The aim of the PhD project described in this thesis, was to identify novel migration 
factors for OPCs in demyelinating injury. Two well characterized models of 
demyelinating injury, are focal demyelinating injury using lysophosphatidylcholine, 
(LPC) and cuprizone induced global demyelination.  
 
In their 2011 study, Huang, Jarjour et al. induced focal demyelinating lesions in the 
caudal cerebellar peduncle of rats by injection of LPC, as a model of focal plaques of 
demyelination found in the CNS of human MS patients. RNA from the entire injury site 
was extracted 5, 14 and 28 days after injury, and analysed using whole genome gene 
expression microarrays. The authors hypothesized that factors driving OPC 
differentiation were likely to be most highly expressed at 14 days post lesion, and 
identified RXR-γ as being highly expressed at 14 days post lesion, compared to 5 days 
post lesion. Further experimentation showed that RXR-γ was expressed by 
oligodendroglial lineage cells and that loss of RXR-γ resulted in impaired OPC 
differentiation in LPC induced lesions. In this way, the gene expression array data set 
generated for focal demyelinating lesions was used to identify a novel regulator of OPC 
biology, the differentiation factor RXR-γ. 
 
Hypothesising that modulators of OPC migration should be secreted at the lesion site 
following injury, I reanalysed this data set and searched for possible OPC migratory 
factors. From the whole genome data, I selected only the secreted factors, before 
narrowing this list down to only the secreted factors which correlated with PDGFα, a 
known chemoattractant for OPCs (Zhang et al., 2004). However, the number of PDGFα 
correlating secreted factors far exceeded the number which could be comfortably be 
tested for their effects on OPCs in vitro. 
 
In order to discover information which would allow me to cut down my list of factors, I 
searched the bioinformatic gene expression data repositories the Gene Expression 
Omnibus (GEO, https://www.ncbi.nlm.nih.gov/geo/) and the Sequence Read Archive 
(SRA, https://www.ncbi.nlm.nih.gov/sra), for further genome wide expression data 
relating to demyelinating injury. 
 
Although a number of transcriptomic data sets relating to OPCs have been published, I 
narrowed my search to include only transcriptomic data sets from OPCs in 
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demyelinating injury models. For this reason I did not reanalyse some well-known OPC 
transcriptome data sets.  
 
In their 2006 study, Golman et al., used Affymetrix microarrays to compare the 
transciptome of immunomagnetically sorted human OPCs to the transcriptome of the 
unsorted white matter from which they were derived (Sim et al., 2006). Although this 
study established the pathways regulating the biology of OPCs in human white matter, 
the study did not investigate the unique transcriptomic environment of demyelinating 
injury. In a further study, the Goldman lab transplanted human OPCs into the non-
myelinated brains of neonatal shiverer (MBP knock-out) mice (Readhead and Hood, 
1990), and for the first time showed that human OPCs were highly migratory (Sim et al., 
2011). While this study again utilised Affymetrix microarrays to  classify the subtype of 
OPCs used for transplantation, no transcriptomic data relating to demyelinating injury 
was produced.  
 
Other well known OPC transcriptomic data sets include the Barres RNA-Seq databases. 
These databases make available the results of RNA-Seq analyses of both mouse (Zhang 
et al., 2014) and human (Zhang et al., 2016) brain cells, isolated by cell type. As with the 
studies from the Goldman lab above, although the Barres databases represent and 
ground-breaking resource for the analysis of gene expression in OPCs and other cell 
types, the data relates only to uninjured tissue. Thus, the data in these studies was not 
suitable for investigating the behaviour of OPCs in demyelinating injury.  
  
In this way, I discovered the data from Moyon et al., 2015, which was uploaded to GEO 
prior to the publication of the article in the Journal of Neuroscience. In this study, gene 
expression arrays were generated using RNA from neonatal OPCs, adult OPCs (from 2 
month old mice), and adult oligodendrocytes isolated from healthy mouse brains. In 
addition the authors also included data from OPCs from mouse brains globally 
demyelinated using cuprizone (known as Activated OPCs).  
 
The authors used their gene expression array data, to show that OPCs from demyelinated 
brains had a more similar gene expression profile to neonatal OPCs than either adult 
OPCs from healthy brains or adult oligodendrocytes. These Activated OPCs were also 
shown to have a higher propensity for migration and differentiation than OPCs from 
uninjured brains.    
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Reasoning that genes highly expressed in both Activated OPCs and during remyelination 
were likely to be important for remyelination, the authors identified genes which were 
highly expressed in both Activated OPCs as compared to OPCs from uninjured brains, 
and at 5 days post lesion (when OPC recruitment is likely to occur) as compared to 14 
days post lesion. Amongst the genes they identified using this method, were interleukin-
1β (IL1β) and chemokine (C-C motif) ligand 2 (CCL2), both of which are associated with 
innate immune system signalling. The authors then went on to show that both IL1β and 
CCL2 increase the directional migration of OPCs in vitro, and that migration in OPC like 
cells transplanted into neonatal mouse brains, could be increased by overexpression of 
CCL2. These results demonstrated that the combination of the two data sets could be 
used to identify new chemomigratory factors for OPCs.   
 
From the outset, I had hypothesized that factors attracting OPCs into the heart of MS 
lesions would be secreted at the lesion site, before diffusing into the CNS parenchyma, 
forming a gradient of the factor, which would contact distal OPCs by binding to cell 
surface receptors expressed by the OPCs. I therefore reanalysed the data from Moyon et 
al., 2015, and selected cell surface receptors which were significantly upregulated in 
Activated OPCs as compared to OPCs from healthy tissue. I then checked this list of cell 
surface receptors against the list of secreted factors I had generated from the Huang, 
Jarjour et al., 2011 data, to identify known ligand-receptor pairs.  
 
In the following chapter I will describe the computation methods with which I carried 
out my analysis of the two data sets. I will also report the results of these bioinformatic 
analyses and finally explain how I created an online resource to make the data accessible 
for other researchers.   
 
All data was analysed using the statistical computing software R version 3.3.2 “Sincere 
Pumpkin Patch” (R Core Team, 2016), with the aid of the microarray specific packages 
downloaded from Bioconductor (Gentleman et al., 2004), Limma (Ritchie et al., 2015) 
and Affy (Gautier et al., 2004). The Illumina specific Beadarray (Dunning et al., 2007) was 
used to parse the Illumina beadchip array data from Huang, Jarjour et al., 2011, and 
Ggplot2 (Wickham, 2009) was used to generate the Principal Component Analysis plots. 
See Appendix 3 for full R code. 
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3.2 Illumina Data -  Expression of Secreted Factors in a rat in vivo Model of Focal 
Demyelination  
3.2.1 Illumina Bead Chip Array Design and Data Parsing  
The data from Huang, Jarjour et al., 2011, was reported as having been generated using 
the Illumina ratRef-12 v1.0 expression beadchip. However, on inspection of the Illumina 
IDs for the probe sequences used on the array, I found that the Illumina IDs used in this 
experiment did not match any of the IDs on the Illumina ratRef-12 v1.0 chip and instead 
matched the IDs on the Illumina ratRef-12 v1.5.0.34 expression bead chip (GEO 
Accession: GPL8031). It can therefore be safely assumed that the data was in fact run on 
this newer version of the beadchip, rather than the older version reported in Huang, 
Jarjour et al., 2011.  
 
As shown in Table 3.1, the data set consisted of three time-points after the induction of 
focal demyelinating injury using LPC, 5 days post lesion, 14 days post lesion and 28 days 
post lesion, and replicates from three separate rats were used for each condition.  
 
 
Data Type GEO Numbers of Replicates 
 
5 Days Post Lesion, Focal demyelination 
induction in the rat cerebellar peduncle  







14 Days Post Lesion, Focal demyelination 








28 Days Post Lesion, Focal demyelination 







Table 3.1. Data sets from Huang Jarjour et al., 2011 (GEO Accession Number GSE24821) 
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An important difference between Illumina bead arrays and other popular gene 
expression microarray technologies, is that while in other array types probes are fixed 
to the 2 dimensional array surface, Illumina beadArrays are made up of 3-micron silica 
beads, each coated with hundreds of thousands of copies of a specific oligonucleotide 
corresponding to a particular genomic sequence (Dunning et al., 2007).  In other array 
platforms, transcript probes are identified by their physical location on the array surface 
(Fodor et al., 1991; Holloway et al., 2002; Schena et al., 1995).  In contrast, in the case of 
Illumina beadchips, the oligonucleotide coated beads self-assemble at random into wells 
on the array platform (Michael et al., 1998) and therefore cannot be identified by their 
physical position on the array. A consequence of this approach is that the randomly 
distributed oligonucleotide beads must be identified and matched to their associated 
transcript sequence before any analysis can take place. This decoding step is achieved 
using sequential hybridisation of fluorescently labelled oligonucleotide sequences to 
unique identifying sequences present on each bead (Gunderson et al., 2004).  
 
To investigate the data sets from Huang, Jarjour et al., 2015, I retrieved the pre-analysed 
data from the Gene Expression Omnibus (GEO, accession number GSE24821). The 
available files included raw bead intensities from each of the 3 replicates for the 3 
conditions (see Table 3.1). The data available for this experiment was in the bead 
summary level format, indicating that background correction, as well as the calculation 
of mean intensities for beads for the same transcript sequence, had already taken place.   
 
Having retrieved the data from GEO, I parsed the mean intensity for each set of beads 
with the same probe sequence (bead group) into an R object using the Illumina beadchip 
specific beadarray package (Dunning et al., 2007). 
 
3.2.2 Primary data inspection, Quality Control and Normalisation 
Having parsed the data into R, I inspected the quality of data by generating quality 
control plots. As shown in Figure 3.1, the mean bead group intensities for each probe 
were extremely similarly distributed across all nine arrays making up this data set.  
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Figure 3.1 Pre-normalisation quality control plots for Illumina data. 5dpl samples are 
represented in red, 14dpl samples in orange and 28dpl samples in yellow a) Density and b) 
box plots showing an extremely similar pattern of raw log intensity across all the arrays in 
the data, without normalisation. 
 
I then used MA plots to explore the distribution of log intensities in more depth. In an MA 
plot, the difference in expression for each transcript between two arrays (M) is plotted 
against the average expression of each transcript on the two arrays (A). Each transcript 
is represented with a single dot on the plot, and the distribution of points on the plot is 
used to visualise the variation between the two arrays. 
 
 As shown in Figure 3.2 a), when an MA plot is generated for two replicate arrays for the 
same condition, in this case 28dpl replicate 1 and 28 dpl replicate 3, the vast majority of 
points are evenly distributed around M≈0 with the loess line at M≈0 across the range of 
average intensities and few outlying points. In Figure 3.2 b), an MA plot for the arrays 
for 28 dpl replicate 3 and 5 dpl replicate 1 was generated, points are similarly evenly 
distributed around M≈0 with the loess line nearly horizontal across M≈0. In this plot, 
more outlying points are evident, but this is to be expected within a normal distribution 
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Figure 3.2 Example MA plots: The log ratio (M) of the pixel intensities for two microarray samples 
is plotted against the average pixel intensity (A) of each probe pre-normalisation. IQR=Interquartile 
Range, Local Regression line denoted in red. The difference in expression for each transcript 
between two arrays (M) is plotted against the average expression of each transcript on 
the two arrays (A) a) 28 dpl replicate 1 vs 28 dpl replicate 3, two replicate arrays for the 
same time-point show high correlation between the arrays with the majority of bead group 
intensities grouped around M≈0, the loess line at M≈0 across the whole range of intensities 
and few outliers. b) 28 dpl replicate 1 vs 5 dp replicate 2, arrays representing two different 
time-points showing an expected level of correlation with the majority of bead group 
intensities grouped around M≈0, the loess line at M≈0 across the whole range of intensities. 
A greater proportion of outliers are evident, representative of the biological differences 
between the two time-points.  
 
Consistent with the plots in figure 3.1, this shows that the data is similarly distributed 
with no significant discrepancies to be mediated, although normalisation is still 
necessary to more evenly align the array distributions. 
 
Having established that the data was of high quality and suitable for analysis, I 
normalised the data using an Illumina bead array specific method from the beadarray R 
package. This method featured quantile normalisation alone, because, as previous 
mentioned, the background correction step was carried out by the original authors 
before I accessed the data.  
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3.2.3 Hierarchical Clustering and Principal Component Analysis 
To visualise how similar the 9 arrays in the data set were to one another, I used 
hierarchical clustering by Pearson’s correlation coefficient to establish the relationships 
between the different arrays. As shown in figure 3.3, hierarchical clustering of the arrays 
using Pearson’s correlation coefficient separates the samples by time-point, as would be 
expected. It also shows that there is higher correlation between the two later post-lesion 
time-points at 14 dpl and 28 dpl, and the earlier time-point at 5 dpl.  
 
 
Figure 3.3 Hierarchical clustering using Pearson’s correlation coefficient groups arrays from 
Huang, Jarjour et al 2011 dataset by post-lesion time-point, with the 14 dpl and 28 dpl more 
closely correlated with one another than with 5dpl 
 
Another technique which can be used to visualise the relationship between the arrays is 
Principal component analysis (PCA). This technique emphasises variation and can be 
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used to identify strong patterns in the data. In the case of gene expression array data, the 
covariance of each transcript in each array against every other transcript in every other 
array is constructed into a multi-dimensional covariance matrix. PCA then identifies the 
directions (known as principal components) in this matrix in which the data varies most 
strongly. The variation between the arrays which can be accounted for by each principal 
component, can then be visualised on a 3-dimensional plot.  
 
As shown in figure 3.4, PCA of the Huang, Jarjour et al., 2011 dataset groups the 
replicates for each time point together, although there is close association between the 
14 dpl and 28 dpl time-points with the 5 dpl time-point more distantly correlated. The 
contributions of the individual principal components can be found in appendix 1, along 
with the genes whose variation is captured most by each principal component.  
 
 
Figure 3.4 3-D Scatterplot of Principal Component Analysis of Huang, Jarjour et al., 2011 
Data Orange dots=5dpl, red dots=14dpl, yellow dots=28dpl, numbers refer to the individual 
replicates (see table 3.1). Principal Component Analysis groups arrays from Huang, Jarjour et 
al 2011 dataset by post-lesion time-point, with the 14 dpl and 28 dpl more closely correlated 
with one another than with 5dpl less closely associated. 
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The differences in the groupings of the arrays by hierarchical clustering versus principal 
component analysis are a function of the difference between the two approaches. In 
essentials, the hierarchical clustering algorithm, groups data sets by similarity, while 
principal component analysis takes the opposite approach of separating data sets by 
their variation. Principal component analysis is designed to capture as much of the 
variation between the data sets as possible, however it also reduces the dimensionality 
of the data, in doing so, some of the weaker effects in the data are filtered out, leaving 
only the components with the strongest separating effects on the data set. A caveat of 
hierarchical clustering is that this method will find groupings in the data, even if no 
strong separating effect is present.  
 
Thus, as shown in the hierarchical clustering dendrogram in figure 3.3, ranking of the 
arrays in the Huang, Jarjour et al., 2011 data by similarity, results in the grouping of the 
arrays by experimental condition. In contrast, in the principal component analysis in 
figure 3.4, the strongest diverging effect in the data set (principal component 1), 
separates the 5 days post lesion arrays from the 14 and 28 days post lesion arrays, more 
strongly than from one another. The principal component analysis suggests that there is 
more similarity in the 14 and 28 days post lesion, which is also reflected in the 
hierarchical clustering. This is a biological possibility given that by these later 
timepoints, the inflammatory infiltration characteristic of early injury has subsided, 
giving way to regeneration. 
 
These results show that post-normalisation, the arrays separate into a pattern that could 
have been predicted based on the experimental design. This shows that normalisation 
was successful and the data is of high quality and suitable for differential expression 
analysis. 
 
3.2.4 Differential Expression Analysis of Huang/Jarjour Data 
Having produced arrays of quantile normalised expression values for the whole dataset, 
the next step in my analysis was to discover which genes were differentially expressed 
at the different time-points. I performed differential analysis and the statistical analyses 
required to accompany it using the limma package available for R.   
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I applied limma in two stages: firstly I created a model matrix specifying which arrays 
represent replicates for the same timepoint and applied it to the data thus allowing mean 
expression values for every probe for each timepoint to be calculated.  
 
The second phase of the limma analysis was the application of the contrast matrix 
designating which conditions were to be compared to one another. Since there were only 
three timepoints available, I compared each timepoint to every other timepoint. 
Contrasts between conditions were calculated as log2 fold changes and the statistical 
tests were carried out to give the outputs listed in table 3.2. Briefly, for each gene in each 
contrast a moderated t-statistic was calculated which measured the difference between 
the two time-points by units of standard deviation, the resulting t-value was moderated 
across all the genes using a Bayesian model. The p-value for each gene was then adjusted 
for multiple testing to give the false discovery rate (Benjamini and Hochberg, 1995).  
 
 
Statistical Analysis Outputs Description 
Log2 fold change 
Difference in mean expression values between the two 
groups 
Moderated t-statistic 
Difference between the two groups by units of standard 
deviation, higher values indicate bigger differences 
between the two groups, the ratio of the Log2 fold change 
to its standard error.  
p-value 
t-value moderated across all genes using a Bayesian 
model, the probability that the observed difference 
between groups is real, does not account for multiple-
testing 
Adjusted p-value 
p-value adjusted for multiple testing using the false 
discovery rate developed by Benjamini and Hochberg 
(Benjamini and Hochberg, 1995) 
Log odds score 
Log odds of differential expression for this gene (Smyth, 
2004) adjusted for multiple testing assuming that 1% of 
genes are differentially expressed 
Table 3.2 Statistical outputs from differential expression analysis using Limma 
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To eliminate genes with no significant variance in any of the contrasts between 
timepoints, I excluded features without an adjusted p-value of ≤0.05 for at least one 
contrast from further analysis. In this way, from the 22,226 features on the array I found 
only 4,814 (21.66%) which were differentially expressed between at least two 
timepoints.  
 
3.2.5 Selection of Secreted Factors Using Ensembl Biomart 
My overall aim in analysing this dataset was to search for factors emanating from sites 
of demyelinating injury, which might modulate OPC behaviour. For this reason, having 
identified the significantly differentially expressed genes, I utilised the Ensembl Biomart 
tool (Herrero et al., 2016, Ensembl release 84, 
http://www.ensembl.org/biomart/martview/84ae73fe2c935c797186934eba30f2e9) 
to obtain a list of all the genes on the Illumina ratRef-12 v1.5.0.34 expression bead chip 
whose proteins were known to be secreted. 
In the Ensembl Biomart web interface, I selected Ensembl Genes 84 database and the Rat 
Genes (Rnor_6.0) dataset. On the Attributes tab, I selected Gene ID, Transcript ID and 
Associated Gene Name as outputs from the GENE dropdown list and signal peptide from 
the list of Transmembrane and Signal domains as an output from the PROTEIN DOMAINS 
AND FAMILIES dropdown list. This produced a list of all 3891 rat genes listed as having 
a protein signal domain indicative of extracellular secretion.  
 
 I then matched my differentially upregulated gene list to this signal peptide list and 
identified 3614 significantly differentially upregulated genes with a signal peptide in 
their corresponding proteins.   
 
3.2.6 Selection of Factors by Expression Pattern Using Correlation Analysis 
With so many secreted factors identified, an approach curtailing this list to only those 
factors most likely to impact OPC biology was necessary. I reasoned that secreted factors 
which augment OPC migration were likely to be similarly expressed in a similar pattern 
to PDGFα, which is a known chemoattractant for OPCs (Zhang et al., 2004).  
 
As illustrated in figure 3.5a), PDGFα expression steadily rises in expression intensity 
from the 5 days post lesion time point to the 28 days post lesion time point. Reasoning 
that other novel regulators of OPC biology might follow a similar pattern of expression, I 
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next performed a correlation analysis to discover factors whose expression pattern 
correlated with both PDGFα. Figure 3.5b), plots the Log2 fold changes in PDGFα 
expression for all the possible contrasts for the 3 time-points. 
 
Figure 3.5 Experssion of PDGFα in Huang, Jarjour et al., 2011 data a) Normalised expression of PDGFα 
across the 3 time-points, there is a significant increase in expression of PDGFα between 14 dpl and 
5dpl, and a further more significant increase in expression between 28 dpl and 5 dpl (both by unpaired 
t-Test) b) Pattern of Log2 fold change in PDGFα between the 6 possible contrasts for the 3 time-points, 
all Log2 fold changes have an adjusted pvalue ≤0.05. 
 
To give the maximum number of data points for the correlation analysis, I analysed the 
log2 fold change between the means of each time-point for contrasts between all 
conditions (28 days post lesion vs 5 days post lesion, 28 days post lesion vs 14 days post 
lesion, 14 days post lesion vs 5 days post lesion, 14 days post lesion vs 28 days post 
lesion, 5 days post lesion vs 14 days post lesion and 5 days post lesion vs 28 days post 
lesion).   
 
In order to identify other factors which followed a similar pattern of expression, I 
calculated the Pearson’s correlation coefficient for each secreted factor compared with 
PDGFα. From the secreted factors, I selected only those which had a correlation 
coefficient of >0.85 with PDGFα. Using this method, I identified 410 factors with 
correlating expression patterns, as demonstrated in figure 3.6. Interestingly, among the 
secreted factors identified was Lingo-1, reported to be a negative regulator of OPC 
differentiation (Mi et al., 2005) and CXCL12 which has been shown to act as a 
proliferation and differentiation factor for OPCs (Patel et al., 2012). This supports my 
hypothesis that other modulators of OPC biology would be expressed in a similar post 
injury temporal pattern to known PDGFα.   
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Figure 3.6 Expression Pattern of Secreted Factors with a Correlation with PDGFα of >0.85. Expression 
patterns of all 288 features from the Huang/Jarjour et al.,  2011 study with an adjusted p-value of 
<0.05 in at least 1 contrast, and Pearson’s Correlation of >0.85 with PDGFα. Interestingly, another 
known OPC modulators LINGO-1 which is a negative regulator of OPC differentiation (Mi et al., 2005) 
and CXCL12(Patel et al., 2012) a proliferation and differentiation factor for OPCs are also expressed in 
a correlating pattern. 
 
A full list of the 410 correlating factors and their statistics can be found in appendix 2. 
 
In summary, of the 22,226 probes represented on the complete array, I found only 4,814 
with statistically significant differences in expression between two or more timepoints 
(with a p-value of ≤0.05). Of these 4,814, I found only 3,614 with a known signal domain 
according to the Ensembl Biomart database, of which only 410 correlated with the 
temporal expression pattern of PDGFα. Since this was a reasonably small number of 
potential targets, I did not reduce the list further based on absolute expression value or 
fold change between timepoints, at this stage. Further reduction of this list of potential 
targets was achieved using the data from the Moyon et al., 2015 data, which will be 
described in Chapter 3.3. 
 
With 410 correlating secreted factors identified, I next set out to reduce this number by 
identifying only those secreted factors which had receptors which were expressed by 
migratory OPCs. In the next section, I will explain how I analysed the data from Moyon 
et al., 2015 and used it to identify cell surface receptors expressed by migratory OPCs.  
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3.3 Identification of Upregulated Cell Surface Receptors in Regeneratively Activated OPCs 
3.3.1 Moyon et al., 2015 Experimental Design 
As summarised in Table 3.2, in their 2015 paper, Moyon et al. ran samples of purified 
mouse activated OPCs, non-activated OPCs, neonatal OPCs, adult OPCs and adult 
oligodendrocytes on Agilent 026655 Whole Mouse Genome Microarrays (GPL11202 
GEO). These arrays have 39,430 biological features derived from Entrez Gene RNAs and 
10 replicate probes for each biological feature along with 12 x10 ERC control probes and 
32x10 E1A spike in control probes. All probes are 60mer in length and arrays were 
prepared using Agilent sureprint technology. 
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Sample Type Preparation Animal Line 






Isolation from P1 – P5 mouse 
brain by Fluorescence-activated 



















Isolation from 2month old 
mouse brain by Fluorescence-



















Isolation from 2month old 
mouse brain by Fluorescence-
activated cell sorting (FACS) 
 
PLP-GFP mice 













Isolation from 2 month old 
mouse brain precedently 
treated with 0.2% cuprizone for 
5 weeks  by Fluorescence-
activated cell sorting (FACS)  

















Isolation from 2 month old 
mouse brain by Fluorescence-
activated cell sorting (FACS)  
(Piaton et al., 2011) 
PDGFαR:GFP 
hemizygous mice 







Table 3.2. Data sets from Moyon et al., 2015 (GEO Accession Number GSE48872) 
 
Page 58 Catriona Ford s1059067 
3.3.2 Primary Data Inspection, Quality Control and Difference in Intensity Distribution 
Between Arrays Issue 
To visualise the data sets from Moyon  et al., 2015, I retrieved the pre-analysed data from 
the Gene Expression Omnibus (GEO, accession number GSE48872) and read the mean 
foreground and background pixel intensities for all probe spots into the statistical 
analysis environment R.  
Having read the mean pixel intensities for the Agilent microarrays into an R data frame, 
I visualised the distribution of pixel intensities using density plots and box plots (Figure 
3.7).  The density plots (Figure 3.7a)) and boxplots (Figure 3.7d)) for the foreground 
features reveal that the data sets can be divided into two distinct groups based on their 
distributions of pixel intensities.  
 
The first pixel intensity group with higher median log pixel intensities of around 10 
comprising all the replicates for activated OPCs and non-activated OPCs will henceforth 
be described as Intensity Group A (figure 3.7 b), e)), and the second with lower median 
log pixel intensities of around 8 comprising all the replicates for neonatal OPCs, adult 
OPCs and adult oligodendrocytes, will henceforth be described as Intensity Group B 
(figure 3.7 c), f)). Such a discrepancy in the distributions of log intensities between 
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Figure 3.7 Distribution of pre-normalisation mean pixel intensity values for all arrays representing 
the different oligodendroglial cell types in the Moyon  et al., 2015 data set show that the arrays fall 
into two distinct groups. For boxplots, the coloured boxes extend from quartile 1 to quartile 3 
intersected by the median, which is represented by a line, the minimum to maximum extent of the 
data is signified by the dashed line and outliers denoted as circles. In all plots arrays of the same cell 
type are coloured as follows: Neonatal OPCs-Blue, Adult OPCs-Orange, Adult Oligodendrocytes-Red, 
Activated OPCs-Light Green, Non-activated OPCs-Dark Green. a) Pre-normalisation box plot and d) 
pre-normalisation density plots show that the data groups into two separate sets based on the mean 
and ranges of log2 intensity for each array and that arrays from the same cell type have broadly similar 
intensity distribution. b) Box plots and e) density plots for Intensity Group A, with higher median log 
pixel intensities of around 10 comprising all the replicates for activated OPCs and non-activated OPCs. 
c) Boxplots and f) density plots for Intensity Group B, with lower median log pixel intensities of around 
8 comprising all the replicates for neonatal OPCs, adult OPCs and adult oligodendrocytes. 
 
To visualise the distribution of probe intensities across the arrays in more detail, I 
employed MA plots (Figure 3.3). As shown in figure 3.8a) when an MA plot is generated 
for the arrays of two replicate samples for the same condition, a widespread distribution 
in average intensity of probes can be observed along the x-axis, while the log ratio M 
between the two arrays is around zero for the majority of probes. By fitting a local 
regression line (red), the variation in the log ratio as average intensity increases can be 
represented using a smooth curve.  As expected, the close proximity of features 
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represented by spots to M=0 across the increasing values of average intensity indicates 
significant similarity between the two arrays for the same condition. 
 
In figure 3.8b) when an MA plot is generated for two samples from different conditions 
with a reasonably similar expression profile (see figure 3.7) M~0 for the majority of 
probes consistent with a lack of differential expression between the two arrays for these 
genes. As compared to figure 3.8a) there is a higher proportion of outlying probes 
indicative of increased differential expression between the two conditions.  
 
As mentioned earlier and indicated by the boxplots and density plots in figure 3.7, the 
arrays in this experiment can be separated into two distinct groups based on the 
distribution of their probe intensities as in figures 3.7 b), e) and c), f).  In figure 3.8c) 
arrays from the two groups have been combined. As compared to the previous examples 
in figures 3.8a) and 3.8b), M=0 for very few of the probes and the whole data set is 
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Figure 3.8. Example MA plots: The log ratio (M) of the pixel intensities for two microarray samples 
is plotted against the average pixel intensity (A) of each probe pre-normalisation. IQR=Interquartile 
Range, Local Regression line denoted in red. a)  M=log2(Activated adult OPC replicate 2) – 
log2(Activated adult OPC replicate 3) pre-normalisation, an example of two replicates of the same 
condition between which little variation should be expected with the vast majority of genes evenly 
distributed around an M of 0. Deviation of the local regression line from M=0 indicates that 
normalisation steps will be required for this data b) M=log2(Activated adult OPC replicate 2) – 
log2(Non-activated OPC replicate 1), an example of arrays from two different sample conditions with 
similar raw pixel intensity distributions (both Intesity Group A) pre-normalisation. The vast majority of 
genes are distributed around M=0, variation in the magnitude of M is as expected for two samples 
from different conditions. Deviation of the local regression line from M=0 indicates that normalisation 
steps will be required for this data. c) M= log2(Activated adult OPC replicate 2) – (Neontal OPC replicate 
1), an example of replicates from two different samples with extremely divergent raw pixel intensity 
distributions (from different intensity groups), pre-normalisation. Universally increased expression 
values on the Activated adult OPC replicate 2 chip as compared to the Neonatal OPC replicate 1 chip 
results in a skewed plot with the majority of probes > M=0. Robust deviation of the local regression 
line from M=0 indicates that there may be technical issues with the data. 
 
From the box-plots, density plots and MA plots above, I concluded that the quality of the 
data had been compromised. A possible explanation for this could be a high background 
to foreground ratio on the arrays. 
3.3.3 Background Signal Issue 
To find out if high background signal was an issue in this dataset, I looked at the 
background reading for each array in the data set. On the Agilent array platform, along 
with the foreground readings representing the biological signal, for each spot on the 
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array a background signal representing the ambient signal is generated from the average 
pixel intensity surrounding each probe spot.  
As shown in figure 3.9, I generated boxplots for the background signal of each array. On 
comparison of the foreground signal (figure 3.9a)) with the background signal (figure 
3.9b)), it became obvious that the background signal for all the arrays was extremely 
high, averaging at around 70-90% of the mean foreground signal. As shown in figure 
3.9c), due to the high background signal, background correction has a deleterious effect 
on the data, leaving almost no data for further analysis.  
 
 
Figure 3.9 Background correction has a deleterious effect on Moyon et al., 2015 data. Box plots 
showing distribution of log2 raw pixel intensity data for all arrays with replicates of the same cell type 
and condition represented by colour. Arrays of the same cell type are coloured as follows: Neonatal 
OPCs-Blue, Adult OPCs-Orange, Adult Oligodendrocytes-Red, Activated OPCs-Light Green, Non-
activated OPCs-Dark Green. a) Foreground measurements b) Background measurements reveal that 
background intensities for Intensity Group A and Intensity Group B have similar median values to their 
corresponding foreground probes, indicative of high signal:background noise ratio c) Foreground 
measurements after background correction (subtraction of background from foreground, offset with 
the addition of the biggest difference between foreground and background to keep all background 
corrected intensities > 0). The background values represent such a large portion of the foreground 
values that subtraction of the background leaves very little data to be analysed.              
                                            
Background readings can generally be attributed to experimental error such as optical 
noise from the scanner or errors in treatment of the microarray chip such as deposits 
remaining post wash stage or user DNA or RNA contamination (reviewed Ritchie et al., 
2007). In principle, subtraction of the background from the foreground should eliminate 
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non-specific signal, however in this case background correction is too disruptive to be 
appropriate. For this reason, I skipped any background correction step for this data-set.  
 
Due to the high background signal, small differences in gene expression in this data-set 
are difficult to detect, because their signal is obscured by the background noise. 
However, changes in gene expression of higher magnitude will still be detectable, the net 
effect is that fewer significantly varying genes are likely to be detected.  
 
As a result of the difference in the distribution of both background and foreground 
intensities between the two groups of samples (Neonatal OPCs, Adult OPCs and Adult 
Oligodendrocytes vs Activated OPCs and Nonactivated OPCs), without batch correction, 
direct comparison of gene expression cannot be made between the two groups. Taking 
this into account, along with the focus of this thesis being the biology of adult OPCs, I 
decided to eliminate the lower intensity samples (Neonatal OPCs, Adult OPCs and Adult 
Oligodendrocytes) from further analysis and focus solely on the comparison between 
Activated OPCs and Nonactivated OPCs. 
 
3.3.4 Normalisation 
My next step was to counteract non-biological variation between arrays using a modified 
version of Robust Multichip Averaging (RMA) normalisation developed by Irizarry et al., 
2003. RMA normalisation is usually performed in three stages: background correction, 
scaling and aggregation of signals pertaining to the same gene.  
 
As detailed in the exploratory analysis above, I determined background correction to be 
deleterious to this data set. I thus applied only the scaling and aggregation steps. The 
data was scaled by quantile normalisation between arrays and the signal was aggregated 
by averaging replicate probes for the same gene.  
 
3.3.5 Hierarchical Clustering and Principal Component Analysis 
Having normalised the data, I next wanted to find out how closely the arrays correlated 
with one another,  firstly, to ascertain whether replicate arrays for the same sample were 
highly correlated, and secondly to investigate the relationship between the different 
samples. 
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I used Pearson’s correlation coefficient to measure the similarity in overall gene 
expression between each of the arrays. The Pearson’s correlation coefficients for each 
possible pair of samples in the two groups were then ranked, allowing the hierarchical 
clustering dendrograms in figure 3.10 to be constructed. 
 
As shown in the dendrogram in figure 3.10, the two sets of replicates for Activated and 
Non-activated OPCs separate to form the two major branches of the dendrogram with 
replicates of the same cell type grouping together, this shows that replicate samples for 
the same cell type are more strongly correlated with one another than with samples for 
the opposing cell type.  
 
 
Figure 3.10 Hierarchical clustering of normalised intensity values using Pearson’s correlation 
coefficient shows degree of correlation between arrays. Activated OPCs - Light Green, Non-activated 
OPCs - Dark Green, replicates cluster by cell type. Replicate arrays for Activated OPCs group separately 
from the replicate arrays for Nonactivated OPCs indicating higher correlation between arrays for the 
same cell type than for arrays for different cell types. 
Page 65 Catriona Ford s1059067 
 
While hierarchical clustering using Pearson’s correlation coefficient may give some 
indication of the relationships between samples and the averages of pooled samples, it 
relies heavily on cumulative variance of all the probe-sets on the array and assumes that 
features and therefore the genes they represent vary independently.  Following any 
change in cellular conditions, the subsequent conformational change in gene 
transcription is not the sum of independently functioning individual genes, but a complex 
network of co- and interdependent regulatory elements resulting in the co-expression of 
interrelated sets of genes.  
3.3.5 Principal Component Analysis of Normalised Data 
As with the Huang, Jarjour et al., 2011 data, a technique better equipped to deal with this 
phenomenon is principal component analysis, a statistical paradigm used to simplify 
complex data sets by  multidimensional matrix reduction (reviewed, Raychaudhuri et al., 
2000).   
 
As shown in figure 3.11, PCA of the Moyon et al., 2015 dataset groups the replicates for 
each time point together, although there is close association between the 14 dpl and 28 
dpl time-points with the 5 dpl time-point more distantly correlated. The contributions of 
the individual principal components can be found in appendix 1, along with the genes 
whose variation is captured most by each principal component.  
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Figure 3.11 Scatterplot of Principal Component Analysis of Moyon et al., 2015 Data  
 Activated OPCs - Light Green spots, Non-activated OPCs - Dark Green spots, spot numbers represent 
the name of the replicate number. Replicate arrays for Activated OPCs group separately from the 
replicate arrays for Nonactivated OPCs indicating higher correlation between arrays for the same cell 
type than for arrays for different cell types 
 
Satisfied that by both hierarchical clustering and PCA, the arrays for Activated and Non-
activated OPCs grouped by sample type, I next performed differential expression 
analysis to determine which gene were more highly expressed in Activated OPCs.  
 
3.3.6 Differential Expression Analysis of Moyon et al., 2015 Data 
Having produced arrays of quantile normalised expression values for Activated and Non-
activated OPCs, the next step in my analysis was to discover which genes were 
differentially expressed between the two cell types. I performed differential analysis and 
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the statistical analyses required to accompany it using the limma package available for 
R.   
 
As before, I applied limma in two stages: firstly, I created a model matrix specifying which 
arrays represent replicates for the same timepoint and applied it to the data thus 
allowing mean expression values for every probe for each timepoint to be calculated.  
 
The second phase of the limma analysis was the application of the contrast matrix 
designating that the means of the replicates for Activated and Non-activated OPCs were 
to be compared to one another. This contrast was calculated as log2 fold changes and the 
statistical tests were carried out to give the outputs listed in table 3.2.  
 
To eliminate genes with no significant variance between Activated and Non-activated 
OPCs, I excluded features without an adjusted p-value of ≤0.05 from further analysis. In 
this way, from the 45,181 features on the array I found only 2,447 (5.42%) which were 
differentially expressed between Activated and Non-activated OPCs. The low number of 
features identified at this stage reflects the high background data issue discussed in 
chapter 3.3.3, expression of low expression features was lost in the background noise, 
leaving only the highly expressed features. I then selected only those which were more 
highly expressed in activated OPCs by excluding any gene with a negative log2 fold 
change, discovering 1,329 (2.94% of genes on the array) genes upregulated in activated 
OPCs. 
3.3.7 Selection of Secreted Factors Using Ensembl Biomart 
The aim of analysing this dataset, was to identify cell surface receptors expressed by 
Activated (migrating) OPCs. For this reason, having identified the significantly 
differentially expressed genes I utilised the Ensembl Biomart tool (Herrero et al., 2016, 
Ensembl release 84, 
http://www.ensembl.org/biomart/martview/84ae73fe2c935c797186934eba30f2e9) 
to obtain a list of all the genes on the Agilent 026655 Whole Mouse Genome Microarray 
whose proteins were known to be cell surface bound. 
 
In the Ensembl Biomart web interface, I selected Ensembl Genes 84 database and the 
Mouse genes (GRCm38.p5) dataset. On the Attributes tab, I selected Gene ID, Transcript 
ID and Associated Gene Name as outputs from the GENE dropdown list and 
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Transmembrane domain (tmhmm) from the list of Transmembrane and Signal Domains 
as an output from the PROTEIN DOMAINS AND FAMILIES dropdown list. This produced 
a list of all of the mouse genes listed as having a transmembrane domain indicative of 
cell membrane localisation in their corresponding proteins.  
 
I then matched my differentially upregulated gene list to this transmembrane domain 
list and identified 266 significantly differentially upregulated genes with a 
transmembrane domain in their corresponding proteins. 
3.4 Selection of CX3CR1/CX3CL1 for Further Investigation Based on Data from Both Studies 
 
By filtering by adjusted p-value, protein domain and correlation analysis, I produced a 
list of 266 putative cell surface receptors from the Moyon et al., 2015 activated OPC 
dataset and a list of 410 correlating secreted factors from the Huang/Jarjour et al., 2011 
whole lesion site dataset. The next stage was to identify receptor ligand pairs which 
appeared on both lists.  
 
To achieve this, I used the International Union of Basic and Clinical 
Pharmacology(IUPHAR)/British Pharmacological Society(BPS) Guide to Pharmacology 
database (http://www.guidetopharmacology.org/), to annotate the list of cell surface 
receptors from the Moyon et al., 2015 paper with their known ligands. Of the 266 factors, 
only 35 were found to have known ligand published in the literature. Of these 33 factors, 
8 (Grm5, Srebf1, Axl, Darc, Fgfr1, Ltbr, Fzd1 and Ntrk3) were immediately eliminated 
because they each had five or more known ligands, making them unattractively complex 
to study using in vitro and in vivo models.  
 
Having identified these ligands, I then searched the list of secreted factors from the 
Huang/Jarjour et al., 2011 paper to find out if they also appeared there.  Of the remaining 
25 putative receptors on activated OPCs, only 2 had known ligands which appeared in 
the list of secreted factors. Receptor Tyrosine Phosphatase Z1 (PTPRZ1) with its ligand 
Contactin-1 (CNTN1) and CX3C Chemokine Receptor 1 (CX3CR1) and its singular known 
ligand CX3C Chemokine 1 (CX3CL1), otherwise known as Fractalkine.  
 
Studies in the published literature have found PTPRZ1 to negatively impact OPC 
differentiation as well as myelination by oligodendrocytes (Kuboyama et al., 2012; 
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Pendleton et al., 2013), an observation confirmed in a more recent study which showed 
that inactivation of PTPTZ1 actively promoted OPC differentiation and remyelination 
(Kuboyama et al., 2015). The focus of this PhD project was to find factors that might 
improve remyelination through the modulation of OPC biology. Since the published 
literature suggested PTPRZ1 had exactly the opposite effect, it was not adopted for 
further investigation. 
 
This left a singular receptor ligand pair: CX3CL1/Fractalkine and CX3CR1. Existing 
literature had little explored the effect of CX3CL1 on OPC biology making it an attractive 
candidate. I therefore took the CX3CR1/CX3CL1 receptor ligand pair forward for in vitro 
studies, as described in Chapter 5: CX3CL1 is a Master Regulator of OPC Mediated 
Regeneration. 
3.5 Development and Implementation of an Interactive Data Display Tool for Microarray 
Data 
On completion of my analysis of the two microarray data sets, I set out to create an 
interactive database allowing researchers without bioinformatics experience easy 
access to pre-analysed gene expression data.  
3.5.1 Rationale and Functionality of Online Tool 
An existing example of such a tool is the brain RNA-seq database developed for mouse 
and data and published by the Barres group in 2014 
(http://www.stanford.edu/group/barres_lab/brain_rnaseq.html, Zhang et al., 2014), 
now expanded with human datasets 
(http://web.stanford.edu/group/barres_lab/brainseqMariko/brainseq2.html, Zhang et 
al., 2016). 
 
The group created online search tools which allow users to view a bar plot graphing the 
expression levels (in Fragments Per Kilobase of transcript per Million mapped reads 
(FPKM)) of a single named gene, with the intention of facilitating easier identification of 
receptor-ligand pairs specific to the individual cell types (Zhang et al., 2014). However, 
while the Barres database has proved to be an incredibly useful tool, the website design 
limits the user to viewing only one gene at a time and accesses the existing data sets.  
In order to make the data I have analysed accessible, I designed and implemented a web 
based tool – CatVis, in which users may compare the expression of multiple genes from 
multiple data sets.  Website access is available at https://stembio.github.io/williams 
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(University of Edinburgh VPN required). As demonstrated in figure 3.12, on accessing 
the tool’s landing page, the graphical user interphase (GUI) presents the user with a drop 
down list of the available data sets. Data sets are selected by clicking the “Add DataSet” 
button and multiple data sets may be displayed at the same time.  
Figure 3.12 Screenshot illustrating the range of data sets available on CatVis  Graphical User Interface 
(GUI) for CatVis utilises a drop down menu from which data sets to be visualised can be selected 
(multiple data sets may be selected at once), the name of a gene to be added to the graph(s) can be 
typed into the Add Gene field which provides a list of suggestions based on the letters typed and the 
name of a gene to be removed from the graph(s) can be typed into the Remove Gene field which 
provides a list of suggestions limited to the genes which are already visible. 
 
Genes of interest are selected by typing the gene symbol into the “Add Gene” field which 
makes suggestions based on the letters typed and the gene names available in the 
selected datasets. Genes can also be deselected by typing the gene symbol into the 
“Remove Gene” field, which also provides suggestions, this time based on the letters 
typed and the genes plotted on the graph. 
 
As the screenshot in figure 3.13 shows, the expression patterns of selected genes can be 
displayed simultaneously, allowing genes to be compared and contrasted.  
Page 71 Catriona Ford s1059067 
 
Figure 3.13 Screenshot of CatVis in action. Visualisation of patterns of gene expression across two 
data sets GSE48872 Moyon et al., 2015 OPC to Oligodendrocyte and GSE24821 Huang, Jarjour et al., 
2011. Multiple genes are being compared at once: MBP, PDGFα, CX3CR1 and CXCL12. 
 
3.5.2 Development of Online Tool Using Java and JavaScript/jQuery 
In the design of this tool, the flexibility to simultaneously access multiple datasets and 
genes necessitated a different computational approach from that used in the Barres 
database.   
 
In the development of the Barres database, a single static Portable Network Graphic 
(PNG) image was generated for the expression pattern of each gene in the RNA-seq data 
set using an R script. Typing the gene symbol for a gene of interest into the “Enter Gene” 
field results in the return of the static image associated with that gene name which is 
displayed to the user in the Common Gateway Interface (CGI)/Python/HyperText 
Markup Language (HTML) coded web page.  
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While the Barres database design allows for easy access to the expression pattern of an 
individual gene in a single dataset, the use of pre-made images limits the display options 
available to the user and lacks the flexibility to display multiple genes or incorporate new 
datasets. In my tool, in contrast to displaying pre-prepared images, the bar plots 
displayed to the user are generated after the datasets and first gene have been selected. 
Bar plots can then be modified with the addition or removal of additional genes.  
 
To achieve this flexibility, I utilised the Stembio visualisation server system developed 
by Duncan Godwin (PhD student and software developer in the Tomlinson lab), which 
uses the Java and JavaScript/jQuery programming languages.  
3.5.3 Gene Expression Data for CatVis is stored in an Online GitHub Repository 
As illustrated in figure 3.14, the CatVis tool can be broadly split into three components 
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Figure 3.14 Flow diagram of computational approach used for the development of CatVis. a) Pre-
analysed microarray data in .csv format is stored in an online GitHub repository. b) Through the 
visualisation Framework Server, Java is used to access the GitHub repository in which the data is stored 
and parse the data into a new searchable data object manipulated into the JSON format necessary for 
the graph. c) Genes selected using the GUI are searched for using JavaScript and selected from the 
JSON using the gene symbol as a key to access the row of data associated with that gene.  d3/jQuery 
(a JavaScript library) is used to convert the rows of data into a bar plot which is displayed in a web 
page. The framework for the webpage including the positions of the bar plot and other elements such 
as buttons and images is defined in HTML and the aesthetic appearance (colour, font etc) of the page 
elements are defined in the accompanying CSS file. The interactive functionality of page elements such 
as buttons and drop down menus is implemented using a combination of HTML and jQuery. 
 
As shown in figure 3.14 a), the data for the tool is stored in an online GitHub repository. 
GitHub is a code hosting platform which allows multiple users to access and edit 
communal files (https://guides.github.com/activities/hello-world/). In this case, pre-
processed microarray data expression tables in the Comma Separated Values (.csv) 
format with the column header ‘Gene’ in the top, left cell, were uploaded to a communal 
GitHub (See figure 3.15). 
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Figure 3.25 Example of .csv data format required for CatVis. First four rows of the .csv file for the 
Huang/Jarour et al., 2011 dataset. With the required column header ‘Gene’ in the top left most cell, 
the other column headers are the experimental conditions. All other rows begin with a gene symbol 
which will be used to identify the rows after parsing by Java.  The data is the averaged, normalised and 
intensity values analysed using the methods in chapters 3.2 and 3.3. 
 
3.5.4 Server Side Java Parses Gene Expression Data from the GitHub Repository into a JSON 
The second integral component is the server side Java which prepares the data for bar 
plot display (see figure 3.14 b)) and is hosted on the Stembio visualisation server. The 
visualisation server framework developed by the Tomlinson lab, provides a system for 
the development of data visualisation tools which packages up server side Java and web 
based JavaScript in a format, which can be easily incorporated into an HTML web page.  
Following dataset selection by the user, commands in the Java parse the data retrieved 
from the GitHub repository into a new data object in lookup-table format in which each 
row from the original data can be identified using the gene symbols from the left most 
column of the .CSV file as keys. This new data object is known as a JavaScript Object 
Notation (JSON), which can be read using JavaScript.   
3.5.5 Data for Genes to be Displayed on the Graph is Selected Using jQuery 
Once the data has been converted into a JSON, it is ready to be used by the jQuery 
commands which define the functionality and appearance of the graph.  jQuery is a 
versatile library of JavaScript commands which simplify the development of functional 
elements for web pages (https://jquery.com/). When a user types gene symbols into the 
“Add Gene” box, the jQuery searches through the JSON and selects rows with a key 
matching the symbol entered. The jQuery then reformats the data into the correct tabular 
format for the graph. 
3.5.6 Displayed Bar Plots are Built Using d3.js  
A useful subset of jQuery is the d3.js library which can be used to allow data to be 
manipulated via a website interface (https://d3js.org/). The specific bar plot displayed 
on the CatVis website was based on the open source d3.js code for the Grouped Bar Chart 
developed by d3.js user Mike Bostock (http://bl.ocks.org/mbostock/3887051), adapted 
for the microarray data to be displayed. 
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 The d3.js code is hosted along with the Java on the Stembio visualisation server, through 
which the bar plot can be trialled and populated with data, ready to be embedded in the 
CatVis webpage. Everything which appears within the graph area in which the bar plot 
is displayed is built using the d3.js hosted on the Stembio visualisation server and was 
added to the webpage by adding the lines of code automatically generated by the Stembio 
visualisation manager to the header of the HTML file.   
3.5.7 Structure and Function for the CatVis Webpage was Developed in jQuery and HTML 
with Aesthetics in CSS 
 
As shown in figure 3.14 c), I built the CatVis website using a combination of HTML, 
Cascading Style Sheets (CSS) and jQuery. The HTML was used to design the framework 
for the website and defines the elements such as buttons, drop down menus and the 
graph areas which appear on the webpage. The functionality for the elements on the 
webpage was coded into the header of the HTML using jQuery and the aesthetic 
appearance for page elements including colour, font and size was written in CSS in a 
separate .css file.  
 
While the Java and d3.js components are hosted on the Stembio visualisation server, the 
.html and .css files are stored in a second GitHub repository. Opening the CatVis webpage 
at https://stembio.github.io/williams accesses the .html file store on GitHub. Scripts in 
the header portion of this .html file point to the .css file also in the GitHub repository and 
the Java and jQuery hosted on the Stembio visualisation server.  
 
3.5.8 New Datasets Uploaded to the Linked GitHub Repository are Instantly Available to 
Users 
A major advantage written into CatVis is the easy addition of new datasets. The linked 
GitHub repository currently includes the data I have analysed from the Moyon et al., 2015 
and Huang/Jarjour et al., 2011 studies along with the data from the Barres database. Any 
additional datasets uploaded to the GitHub repository in the correct format, will 
instantly be added to the CatVis website ready to be visualised. 
As new datasets are added to GitHub, the available datasets on the web tool are updated 
in real time, allowing users to instantly access the newly available data sets by refreshing 
the web page. 
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This instant access is available because when the webpage initiates, the jQuery and 
HTML based website communicates with the Java server which sends back the names of 
all the datasets in the GitHub repository to which it is linked. Dataset names returned 
from the server are then used to populate the “Add DataSet” dropdown list (see figures 
3.12 and 3.13) with options for all the datasets, which are present in the GitHub 
repository. 
 
Together, the GitHub, visualisation server and webpage components combine to build a 
functional user friendly website which allows non-bioinformaticians easy access to the 
expression data for multiple genes in multiple studies. This endows users with the ability 
to simultaneously visualise the expression of related genes (e.g. gene families, receptor-
ligand pairs) in diverse models and conditions.  
 
By providing quick and easy access to gene expression data, it is hoped that CatVis will 
aid researchers in generating the inferences which inform project driving hypotheses, 
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3.6 Discussion 
 
The aim of this thesis chapter was to identify secreted factors and cell surface receptors 
by bioinformatic analysis of gene expression array data from published studies. By 
utilising online data repositories, I selected datasets from two published microarray 
studies.: the first, on the Illumina rat microarray platform detailing gene expression in 
whole lesion sites after demyelinating injury (Huang, Jarjour et al., 2011)., the second, on 
the Agilent mouse microarray platform detailing the gene expression in Activated and 
Non-activated adult OPCs (Moyon et al., 2015).  
 
It should be noted that the two microarray studies from which the data for this thesis 
chapter were drawn, were from two different chips, from two different species. Of the 
total 39,487 genes represented on the Agilent mouse chip used in Moyon et al., 2015, 
19,583 (49.59%) also appear on the Illumina rat chip used in Huang, Jarjour et al 2011. 
In the case of the rat chip used in Huang, Jarjour et al., 2011, of the 22,227 genes 
represented on the array, 19,617(88.26%) also appeared on the on the Agilent mouse 
chip used in Moyon et al., 2015. That such a large proportion of the genes on the 2015 
mouse array do not appear on the 2011 rat array, can be explained by the later 
production of the array chip, and by the generally better annotation available for 
transcripts in the mouse genome compared to transcripts in the rat genome. 
 
Using microarray packages for the statistical analysis software R, I normalised and 
investigated the data and performed differential gene expression analysis.  As illustrated 
in figure 3.21, using a combination of gene ontological information from Ensembl and 
correlation analysis, I reduced the Moyon et al., 2015 data down to 266 putative 
receptors expressed by activated OPCs and the Huang/Jarjour et al., 2011 dataset down 
to 286 putative secreted factors with an expression pattern correlating with PDGFα and 
CXCL12.  
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Figure 3.15 Venn Diagram Illustrating Methods for Target Selection.  
 
By matching these lists of putative receptors and secreted factors, I identified only two 
receptor-ligand pairs, one of which was eliminated based on unfavourable reports in the 
literature.  
 
In this way, gene expression array analysis lead me to a single receptor ligand pair: 
CX3CR1 which is upregulated in activated OPCs and CX3CL1/Fractalkine which is 
expressed at the lesion site following demyelinating injury and has an expression pattern 
correlating with known modulators of OPC biology. 
 
In addition, I have created an online resource CatVis, making the data accessible to other 
biologists. This online resource includes the written in flexibility to compare multiple 
genes in multiple datasets and add data from new studies.   
 
In the context of my PhD project, the purpose of investigating the Huang, Jarjour et al., 
2011 dataset was to identify extracellular secreted factors which might regulate OPC 
biology during remyelination. On my first analysis of the data, I hypothesised that 
mediators of OPC migration might be most highly expressed before and during the 
period in which OPCs are migrating. However, to this end my analysis was somewhat 
confounded by the omission of an uninjured control from the Huang, Jarjour et al., 2011 
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data set.  It would be useful to know whether the expression of factors at 5dpl is elevated, 
reduced or unchanged in comparison to uninjured controls. Had I been able to perform 
contrasts between the earliest time-point (5dpl, by which time OPC migration would be 
expected) and an uninjured control I would likely have gleaned a more realistic 
impression of gene expression in early injury.  
 
The purpose of this PhD project, was to identify regulators of OPC biology active during 
the regenerative process of remyelination. To this end, it was necessary to analyse data 
sets from experiments which use models of injured and regenerated tissue, rather than 
data sets from normal uninjured tissue, such as the Barres Databases (Zhang et al., 2014, 
2016) and human OPC data from the Goldman lab (Sim et al., 2006, 2011). 
  
In conclusion, I successfully identified a target by bioinformatic analysis of relevant data 
and developed a database to make the data accessible. In the following chapters, I will 
illustrate how I optimised a migration assay system and used it and other cell biology 
techniques to show that the target I identified in my bioinformatic screen, 
CXCL1/Fractalkine is a master regulator of OPC biology.   
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4.1 Introduction 
In the regenerative biology of the CNS, OPCs are guided toward injury sites by a 
chemotactic gradient in which the concentration of chemokinetically active factor 
increases from the location of distally scattered OPCs to the site of demyelinating insult. 
Having identified candidate regeneratively active modulators of OPC migration in my 
bioinformatic screen, the next step was to discover if any of these factors had a 
chemomigratory effect on OPCs in vitro.   
 
As previously iterated, the objective of this thesis was to identify and validate genes or 
proteins which increase OPC migration, thus facilitating OPC led regeneration. To 
validate any targets identified in my bioinformatics screen, it was therefore of utmost 
importance that I found a way to quantify OPC migration in vitro. 
 
I thus, began this phase of the project by evaluating and testing different in vitro cell 
migration assays. 
 
In the following chapter I will detail the shortcomings which lead me to reject a number 
of existing migration assays. I will then outline the advantages of the X-celligence Real 
Time Cell Analysis (RTCA) Cell Invasion and Migration (CIM) system, as well as how I 
adapted this system to measure proliferation and differentiation, and how I used these 
adaptions to discover one novel proliferation factor and one novel migration factor for 
OPCs in vitro.  
4.2 Disadvantages of existing migration assays 
4.2.1 Live Cell Imaging 
One of the most straightforward ways to analyse cell migration, is to simply seed cells 
into flat bottomed multi-well plates and image them periodically. Cell tracking software 
can then be used to follow individual cells, computing metrics such as velocity of 
migration and distance travelled.  
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While this technique can be effective in capturing some of the migration of OPCs, much 
useful data can be lost in the imaging and tracking process. Based on cell morphology, 
software (such as Harmony) identifies only a small fraction of the cells which can be 
identified by eye due to the complex morphology of actively migrating cells. This 
difficulty in cell identification applies to all the images making it extremely difficult to 
follow individual cells over long time periods. As a result, very few cells can be tracked, 
and only over a brief period of time.  
A further limitation is related to the difference between the experimental set-up and the 
conditions experienced by OPCs migrating in the adult brain. Without modifications, it is 
only possible to expose OPCs seeded in multi-well plates to a solid concentration of any 
factors added to their media. In contrast, migrating OPCs in the adult CNS are exposed to 
gradients of factors, allowing the cell to sense the difference in the amount of ligand-
receptor binding between the front and back of the cell. It is this gradient sensing ability 
which stimulates cells to actively directionally migrate, a process also known as 
chemotaxis.  
4.2.2 Oris cell invasion assay 
The Oris cell migration/invasion assay also utilises a flat multi-well plate format, in this 
case 96 wells. As shown in figure 4.1, this format is modified by the addition of a stopper 
which eliminates cell growth from the centre of the well. Cells are seeded with the 
stopper in place and after the cells are settled the stopper is removed, leaving a cell free 
area into which cells may migrate.  
 
Figure 4.1 Oris migration and invasion assay a) Cells are seeded into the Oris assay well with a physical 
stopper barrier in place b) After the cells have settled, the stoppers are removed c) The cells migrate 
into the area left by the stopper d) The cells are fixed and imaged with the help of the microplate 
reader mask, which covers the periphery of the wells, leaving only the central region where the 
stopper was for imaging (Image from http://www.arunabiomedical.com/index.php?id=52) 
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To test this assay, I seeded OPCs at a density of 10,000 cells per Oris assay well with the 
stopper in place, incubated overnight at 37oC and 7.5% CO2 until the cells were well 
adhered, and removed the stopper. Cells were incubated at 37oC and 7.5% CO2 over a 30 
hour period before fixing with 4% paraformaldehyde and staining the cell nuclei with 
Hoechst. I then imaged the wells by fluorescent microscopy and counted the number of 
OPCs which had migrated into the centre of the well.  
As shown in figure 4.2, on analysis of my images, I found a significant increase in the 
number of cells that had migrated into the stopper region in OPCs exposed to PDGFα, a 
known OPC chemoattractant and proliferative factor. However, it was impossible to 
discern whether PDGFα stimulated the directional chemotaxis of OPCs, or simply 
increased their background motility, or even just increased their proliferation.  
 
Figure 4.2 Preliminary results from Oris migration and invasion assay Post shake-off rat OPCs were 
seeded at a cell density of 10,000 OPCs per Oris assay well and cultured for a period of 30 hours in 
either Sato media with the stoppers left in or Sato media or human recombinant PDGFα at a 
concentration of 10ng per ml Sato media with the stoppers removed. A significant difference between 
OPCs in PDGFα and the controls could be detected. 
 
OPCs are motile cells, which exhibit random migratory behaviour even in the absence of 
any stimulating factor. To identify factors for directional OPC migration, or chemotaxis, 
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it is therefore imperative to include Sato media only controls which account for 
background motility. Proliferation could also be eliminated by adding an anti-mitotic 
agent such as mitomycin C. 
While the cells in the Oris assay have the ability to create their own local gradient by 
removing the closest chemokinetic particles by ligand receptor binding (Tweedy et al., 
2016), as with live imaging, the assay only really exposes OPCs to a single solid 
concentration of the factor being tested (in this case PDGFα) and does not recapitulate 
the gradients of chemokines experienced by chemotaxing OPCs in vivo. 
Concluding that while the Oris assay might expose some of the OPCs to a local gradient, 
this experimental set-up was ineffective in recapitulating the extracellular ligand 
gradient experienced by migrating OPCs in the CNS, I turned my attention to other assays 
which engineer a ligand gradient. 
 
4.2.3 Cline Nanogradient Assay 
I also had the opportunity to trial the newly developed Cline Nanogradient Technology 
as a suitable migration assay for OPCs (http://www.clinescientific.com/?page=162).  As 
shown in figure 4.3, the Cline Nanogradient consists of a glass slide onto which gold 
nanoparticles are affixed. Molecules of ligand are attached to the gold nanoparticles by 
biotinylation and the gradient is created by the positioning of the ligand coated 
nanoparticles on the glass slide.  
 
Figure 4.3 Cline Nanogradient a) Cline nanogradient showing chemokine coated 10nm gold 
nanoparticles interspersed to form a gradient on transparent glass covered with cell media b) 
18x18mm Cline nanogradient with nanoparticle gradient visible (images modified from 
http://www.clinescientific.com/?page=162) 
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While the concept of a gradient of chemokine immobilised on a glass slide seems ideal, 
the Cline Nanogradients proved extremely difficult to use. Cells seeded at the low end of 
the gradient would be expected to migrate in the direction of the increasing gradient, 
however, the glass slide tended to move around and it was difficult to monitor the axes 
of the gradient for analysis of directional migration.  
I was also somewhat dubious of how well the fixed flat gradient truly captured the 
conditions experienced by OPCs in the CNS. While some chemokines are known to be 
bound to the cell surface, many others are soluble and are secreted into the extracellular 
milieu forming a liquid gradient (de Castro and Bribián, 2005).  
On consideration of the technical difficulties and absence of a liquid gradient with the 
Cline Nanogradient, I continued my search for a more directional assay. 
 
4.2.4 Boyden Chamber transwell chemotaxis assay 
A well established method for the quantification of directional cell migration is the 
Boyden chamber. As shown in figure 4.4a), in this set-up, two media-filled chambers are 
separated only by a permeable membrane; the lower chamber contains the factor to be 
tested, and the upper chamber the migratory cells. Pores in the membrane allow the test 
factor-impregnated media from the lower chamber to diffuse into the media from the 
upper chamber, resulting in the formation of a gradient of test factor particles within the 
pores. This more closely approximates the chemokinetic gradient experienced by OPCs 
in vivo because it is an OPC independent liquid gradient. 
However, my initial trials of the Boyden chamber assay gave inconsistent results and as 
shown in the example experiment in figure 4.4b), I was unable to detect  statistically 
significant differences in migration between OPCs exposed to known chemoattractant 
Semaphorin 3F (Spassky et al., 2002), known chemorepellant Sema3a (Spassky et al., 
2002; Sugimoto et al., 2001). While other researchers have produced results with the 
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Figure 4.4 The Boyden chamber directional chemotaxis assay a) The Boyden chamber is composed 
of two media filled chambers separated by a polyethylene terephthalate membrane with pores 8µm 
in diameter, cells are seeded in media in the upper chamber and the lower chamber is filled with media 
containing a chemoattractant, thus creating a steep gradient of the chemoattractant in the pores. 
Over time, cells migrate through the pores and adhere to the underside of the membrane. Cells 
attached to the membrane can then be fixed, imaged by fluorescent microscopy and quantified by 
manual counting b) Result of my initial Boyden chamber experiments; no difference in cell count is 
apparent between OPCs cultured with Sato media in both chambers, OPCs cultured with the 
chemorepellant Semaphorin 3A in the lower chamber or OPCs cultured with the chemoattractant 
Semaphorin 3F in their lower compartment 
The inconsistency in results can perhaps be attributed to the inherent limitations of the 
Boyden chamber assay. Following initial set up, Boyden chamber experiments were run 
for a period of 16.5 hours after which membranes were fixed in 4% PFA and the cells 
stained with Hoechst and counted via fluorescent microscopy.  For the experiment to 
work, it is assumed that all OPCs migrate through the permeable membrane and become 
adhered to its underside, where they can be quantified at the conclusion of the 
experiment.  However, it is possible that some OPCs might migrate through the 
membrane, adhere to the underside of the membrane and later become detached, 
possibly by displacement by other OPCs, and thus not be counted upon quantification. 
Another issue is that as an end point assay (in this case at 16.5 hours), Boyden chamber 
results cannot be mined for information regarding fluctuations in chemokinetics over 
the period of cell migration. This is important because of the possibility that some 
chemoattractants might affect migration more quickly than others. The gradient may 
also dissipate at different rates with different chemotactic molecules. In the absence of 
real-time data, it is difficult to evaluate the effectiveness of one chemokine as compared 
to another.  
Page 87 Catriona Ford s1059067 
 
4.3  Description of the X-celligence RTCA CIM system and its advantages as a 
migration assay 
An assay system which collects real time data, as well as preserving the cell independent 
gradient system of the Boyden chamber assay, is the X-celligence Real Time Cell Analysis 
(RTCA) Cell Invasion and Migration (CIM) system developed by ACEA biosciences. The 
X-celligence RTCA CIM system may be viewed as an improved version of the Boyden 
chamber. As shown in figure 4.5, the X-celligence RTCA CIM system similarly generates 
its cell independent gradient using two media-filled chambers separated by a porous 
membrane.  
The innovative aspect of the X-celligence RTCA CIM plate is the incorporation of an array 
of gold microelectrodes covering 70-80% of the underside of the porous membrane. At 
defined intervals over the course of the experiment, an electronic potential is passed 
through the electrodes. In the absence of cells, the stream of electrons making up the 
electrical potential passes between the electrodes via the electrically conductive media. 
In the presence of cells, the efficiency of the passage of the electrical potential is hindered, 
a metric which can be measured as electrical impedance.    
Electrical impedance readings are taken at three critical points in an X-celligence RTCA 
CIM plate experiment. A base reading is taken before the cells are added, after both the 
normal media in the upper chambers and the chemoattractant-impregnated media in the 
lower chambers have acclimatised in the incubator for 1 hour, allowing the gradient to 
become established. A second nominal impedance value is taken 30 minutes after the 
cells are added (30 minutes is required to give the cells time to settle into a monolayer). 
From this point onward, the X-celligence RTCA system takes electrical impedance 
readings at intervals defined by the user, throughout the remaining course of the 
experiment.  
As illustrated in figure 4.5, electrical impedance readings are instantly transferred to the 
X-celligence RTCA software, which computes electrical impedance readings into unitless 
Cell Index values which are calculated using the following equation: 
 




Figure 4.5 The X-celligence Real Time Cell Analysis Cell Invasion and Migration System 
Similar to the Boyden chamber assay, the X-celligence RTCA CIM system creates a gradient of 
chemoattractant in the 8µm pores of a polyethylene terephthalate membrane separating two media 
filled chambers, the upper chamber containing the cells and the lower chamber containing media 
impregnated with the chemoattractant. In an improvement to the Boyden chamber, the X-celligence 
RTCA CIM system features an array or microelectrodes on the underside of the porous membrane  
 
CI values from throughout the experiment can be visualised as plots on the X-celligence 
RTCA software. As shown in figure 4.6, on the conclusion of the experiment, the CI plot 
for each X-celligence RTCA CIM well must be adjusted up or down to give all the wells a 
CI value of zero at the first measured time-point to eliminate technical variation between 
wells. Thus, the Cell Index is not a raw measure of the cell coverage of the underside of 
the membrane, but a measure of the change in Cell Index compared the initial reading.  
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Figure 4.6 Example X-celligence RTCA Cell Index plots a) Before curve adjustment b) After curve 
adjustment, reducing all initial readings to zero. Each line represents readings from 1 well. 
 
Using periodic Cell Index(CI) measurements, the X-celligence RTCA CIM system allows 
real time measurement of the coverage of the underside of the membrane. Satisfied that 
the X-celligence RTCA CIM system generates real time measurements of the activity of 
OPCs exposed to a liquid gradient of the factor being tested, I next trouble shot the system 
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4.4 Optimisation of the X-celligence RTCA CIM system for OPCs 
4.4.1 Preliminary experiments generated extremely low Cell Index values 
For my preliminary experiments with the X-celligence RTCA CIM system, I compared 
OPCs cultured with media only in both chambers, with OPCs cultured with media only in 
the upper chamber and 10ng human recombinant PDGFα per ml of Sato media in the 
lower chamber. In this way, I was able to control for the non-directional background 
migration of OPCs and investigate their chemotaxis up a gradient of PDGFα.  
 
Briefly, the lower chambers of X-celligence RTCA CIM plates were filled with Sato media 
containing recombinant human PDGFα at a concentration of 10ng per ml Sato media and 
a baseline electrical impedance reading was taken.  50,000 post-shake-off OPCs were 
then seeded into the upper chambers in a volume of 150ul Sato media and a second 
electrical impedance reading was taken. OPCs were cultured in the X-celligence RTCA 
CIM plates for a period of 16.5 hours and further electrical impedance readings were 
taken every 15 minutes.  
 
As shown in figure 4.7, the results obtained from these experiments proved to be 
variable both between different wells for the same condition and between OPCs from 
different litters of rat pups. This result was somewhat unexpected given that I had used 
the cell density from the protocol from ACEA Biosciences provided with the X-celligence 
RTCA CIM system.  
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Figure 4.7 Preliminary X-celligence RCTA CIM experiments Results of X-celligence experiments with 
OPCs from 3 litters of rat pups. OPCs were seeded in the upper wells of X-celligence RTCA CIM plates 
with either standard Sato media or Sato media with 10ng per ml human recombinant PDGFα. a) 
Representative X-celligence machine readout plotting the Cell Index of each well, readings taken every 
15 minutes over a 20 hour period b) Results from 3 replicate experiments, No significant difference in 
Cell Index results for wells containing OPCs vs control wells without OPCs was found by paired T-test. 
To find out if there was some difference between my experiments and those reported by 
other researchers, I reviewed the existing literature from studies published using the X-
celligence RTCA CIM system.  
On my review of the literature, I was immediately struck by difference between the Cell 
Index ranges in the published studies and my experimental Cell Index range. As shown 
in figure 4.8, my cell index range of 0-0.2 was dwarfed by the reported Cell Index ranges 
of 0 to as much as 9 (Zieker et al., 2013).  
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Figure 4.8 Comparison of initial OPC X-celligence RTCA CIM Cell Index range to Cell Index ranges 
from the published literature Boxes extend from the minimum Cell Index value to the minimum cell 
index value reported over the duration of the X-celligence RTCA CIM run with the mean of the 
maximum and minimum represented by a line, Purple box - Post-shake-off rat OPCs were seeded into 
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the upper wells of X-celligence RTCA CIM plates containing either Sato media only, or PDGFα at a 
concentration of 10ng/ml in Sato media in their lower wells, X-celligence experiments were then run 
for a period of 16.5 hours, Blue bars - Cell Index ranges from a range of published X-celligence RTCA 
CIM studies, all published study results show a wider range and higher maximum Cell Index value than 
with OPCs. 
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4.4.2 Cell Index values are improved by increasing the number of cells seeded 
On further review of the literature, I noted that many of the cell types used in other 
experiments were considerably larger than OPCs. As shown in figure 4.9, OPCs are 
typically only 5-20µm in length, markedly smaller than some of the cells included  in the 
published in the published studies such as HUVECs (Niland et al., 2013) at ~80µm and 
A549 - Human Lung cancer cell line (Limame et al., 2012) at ~50µm.  
 
 
I also noticed that although ACEA recommend seeding 50,000 cells per X-celligence 
RTCA CIM well in their standard protocol, as shown in figure 4.8, in some of the 
publications as many as 100,000 or even 500,000 cells were seeded per X-celligence 








Figure 4.9 OPCs are small cells 
at 5-20µm in length OPCs were 
cultured on glass coverslips at a 
cell density of 50,000 OPCs per 
well of a 24 well plate in Sato 
media for a period of 16.5 hours. 
At this pre-differentiation stage 
OPCs have limited NG2+ 
processes, do not express MBP 
and also express the 
proliferative marker Ki67. 
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Putting together the information that OPCs were a much smaller cell type than had been 
typically analysed and that many published studies reported higher Cell Index values and 
a greater number of cells being seeded, I surmised that the published studies reported 
higher Cell Index values because a greater surface area of the underside of the membrane 
was being covered, either by larger cells or by an increased number of cells. As a 
consequence of these observations, I hypothesized that increasing the number of OPCs 
seeded into each X-celligence RTCA CIM well, might lead to an increase in Cell Index 
values. 
 
To find out if increasing the OPC cell count increased Cell Index values, I seeded OPCs at 
densities of 50,000, 100,000, 250,000, 500,000 and 1,000,000 cells per well into the 
upper chamber of X-celligence RCTA CIM wells, with SATO media only in the lower 
chamber. I also ran cell-free control wells with SATO media only in both chambers. As 
shown in figure 4.10, when wells containing OPCs are compared to cell-free control 
wells, a significant difference in Cell Index can only be perceived by the X-celligence 
RTCA CIM system, at 250,00, 500,000 and 1,000,000 OPCs per well. 
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Figure 4.10 X-celligence RTCA CIM system senses OPC migration when at least 250,000 
OPCs are seeded per well Different cell densities of Post-shake-off rat OPCs were seeded into 
the upper wells of X-celligence RTCA CIM plates containing Sato media only in both their upper and 
lower chambers and X-celligence RTCA CIM experiments were run for 16.5 hours. The X-celligence 
RTCA CIM system only perceives a significant difference between wells containing cells and cell-free 
control wells at 250,000, 500,000 and 1,000,000 OPCs seeded per well. 
 
Having established that significant results could be generated by seeding 250,000 OPCs 
per well, I thus altered my standard protocol to reflect this cell count. All further X-
celligence RTCA CIM data reported in this thesis are from experiments run using 250,000 
OPCs per well (excluding cell-free controls). 
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4.4.3 Fluctuations in environmental conditions can impact Cell Index ranges between 
experiments 
Throughout my X-celligence RTCA CIM system, I noticed that there was considerable 
variation between the Cell Index ranges for replicate experiments with OPCs from 
different litters of rat pups.  Bearing in mind that I was simultaneously carrying out other 
experiments with the same cells (immunofluorescent stains, RT-PCR etc.) and finding no 
discernible difference between replicates it seems unlikely that the differences in Cell 
Index observed was the result of true biological differences between litters of rat pups.  
Over the course of my X-celligence experiments I had also noticed that slight differences 
in the way the RTCA CIM plates were treated could impact the Cell Index values. As 
iterated earlier, at the 0 hour time point, a Cell Index reading is taken for the X-celligence 
RTCA CIM wells which contain only the media and migration factors without any cells. 
After the Cell Index reading has been taken, the RTCA CIM plates are removed from the 
incubator to allow the cells to be seeded. Once the cells are in the wells they are incubated 
for 30 minutes to allow the cells to settle. This can either be done by placing the RTCA 
CIM plates on a shelf in the incubator (then transferring them to the X-celligence machine 
after the 30 minutes has elapsed) or replacing them in the cradles of the X-celligence 
machine. As shown in figure 4.11a), when the cell equilibration step is carried out with 
the plates on a shelf in the incubator a peak in Cell Index can be observed between the 0 
and 1 hour timepoints. In contrast, when the equilibration step is carried out with the 
plates in the X-celligence machine the peak in Cell Index does not occur (figure 4.11b)). 
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Figure 4.11 Equilibration of OPCs for the 30 minutes following cell seeding in the cradle of the X-
celligence RTCA CIM system eliminates early peak in Cell Index. a) OPCs were seeded into the upper 
chambers of X-celligence RTCA CIM wells at a density of 50,000 cells per well and were then 
equilibrated on a shelf in the incubator for 30 minutes before transfer to the X-celligence machine. b) 
OPCs were seeded into the upper chambers of X-celligence RTCA CIM wells at a density of 250,000 
cells per well and were then equilibrated in the cradle of the X-celligence machine. The early peak in 
Cell index (arrow) represents confounding technical noise which can be eliminated by equilibrating 
the plates in the X-celligence machine. 
 
The peak in Cell Index observed in figure 4.11a), is likely the result of the fluctuation in 
temperature or CO2 concentration which occurs as a result of opening the incubator 
door, or the mechanical disruption of moving the plates from the incubator shelf to the 
X-celligence machine. This result shows that small changes in temperature, CO2 
concentration or plate movement can have a discernible impact on Cell Index values. 
Consequently, I always equilibrated the cells with the RTCA CIM plates in the X-celligence 
machine, however the differences in Cell Index range between experiments persisted.  
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Based on my observations, I suspect that the difference in Cell Index ranges might reflect 
changes in environment resulting from the hazards of using a communal incubator such 
as the opening and closing of the incubator door and accidental shaking of shelves caused 
by the movement of plates and culture dishes. While further experimentation would be 
required to confirm this suspicion, I found that I could eliminate these batch differences 
from my data by simply calculating the mean fold change between conditions (e.g. Sato 
media only vs PDGFα) for each replicate and combining these values to calculate the final 
experimental results. 
4.4.4 Verification of the X-celligence RTCA CIM system as a suitable directional migration 
assay for OPCs 
Having established that 250,000 OPCs per well were required to generate reliable Cell 
Index values, I next set out to find out whether the system properly functioned as a 
migration assay at this cell density. To this end, I repeated the experiment detailed in 
figure 4.7, using PDGFα as a chemoattractant for OPCs seeded at a density of 250,000 
cells per X-celligence RTCA CIM well. 
As shown in figure 4.12, with 250,000 OPCs seeded per well, there is a significant 
increase in Cell Index when OPCs are stimulated with a gradient of PDGFα, as compared 
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Figure 4.12 When 250,000 OPCs are seeded per well, an increase in Cell Index between PDGFα and 
the Sato media only control was detected by the X-celligence RTCA CIM system OPCs were seeded 
in the upper chamber of X-celligence CIM plates and a gradient between the upper and lower 
chambers was established by the addition of 10ng recombinant PDGFα per ml Sato media. After 16.5 
hours, there was an increase in Cell Index in PDGFα stimulated OPCs compared to unstimulated OPCs. 
a) The experiment was run 4 times, each dot representing the Cell Index for each well, with an increase 
in every replicate, although there was considerable variation between replicates. b) To ameliorate the 
variation between replicates, increases were computed as a fold change in electrical impedance, which 
was highly significant by paired t-Test 
According to the manufacturers of the X-celligence RTCA system, an increase in Cell 
Index such as this one should be interpreted as an increase in directional cell migration. 
However, changes in electrical impedance across the underside of the membrane 
quantified as Cell Index may reflect cellular processes other than migration, including 
proliferation and changes in cell morphology (Limame et al., 2012).   
4.4.5 The X-celligence RTCA CIM system is ineffective as an assay to study chemorepellants 
for OPCs  
Having established that the X-celligence RTCA system was an effective assay to study 
chemoattractants for OPCs, I next evaluated the system as an assay to study 
chemorepellants. As shown in figure 4.13, when I exposed OPCs to the known 
chemorepellant Semaphorin 3A (Sema 3A) (Boyd et al., 2013a; Spassky et al., 2002; 
Sugimoto et al., 2001) at a concentration of 1µg per ml Sato media, I found no significant 
difference in Cell Index between Sema 3A stimulated OPCs and OPCs in Sato media only 
controls. 
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Figure 4.13 When 250,000 OPCs are seeded per well no significant difference in Cell Index between 
Sema 3A and the Sato media only control was detected by the X-celligence RTCA CIM system OPCs 
were seeded in the upper chamber of X-celligence CIM plates and a gradient between the upper and 
lower chambers was established by the addition of 1µg recombinant Sema 3A per ml Sato media. After 
16.5 hours, there was no difference in electrical impedance (Cell Index) in Sema 3A stimulated OPCs 
compared to unstimulated OPCs. a) The experiment was run 3 times, each dot representing the Cell 
Index for each well, with no difference between Sema 3A and Sato media only controls, although there 
was considerable variation between replicates. b) To ameliorate the variation between replicates, fold 
change in electrical impedance in Sema 3A stimulated OPCs compared to Sato media only controls, 
which was no significant difference between the two conditions was found by paired t-test 
 
I had expected that when exposed to a chemorepellant in the lower X-celligence RTCA 
CIM chamber, OPCs would migrate away from the chemorepellant and so fewer OPCs 
would migrate through the membrane resulting in a reduction in Cell Index. In the 
absence of any Cell Index reducing effect, I wondered if the concentration of the gradient 
of chemorepellant experienced by the OPCs through the pores between the two 
chambers might be too weak a signal to induce OPC repulsion. To further investigate the 
chemorepulsive effect, I redesigned the X-celligence RTCA CIM well set up. As shown in 
figure 4.14a), I reversed the media filling the two chambers so that OPCs were seeded 
into the upper chamber which contained the chemorepellant and had the opportunity to 
‘escape’ the chemorepellant through the pores of the X-celligence RTCA CIM chamber. I 
expected that the presence of a chemorepellant in the upper chamber would induce 
directional migration of OPCs through the pores, and away from the chemorepellant 
resulting in an increase in Cell Index.  
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Conversely, I expected that the presence of a chemoattractant in the upper chamber 
would result in a decrease in Cell Index as more OPCs would stay in the upper chamber 
closer to the chemoattractant. I confirmed this reverse chemoattractant effect by seeding 
OPCs into the upper chambers of X-celligence RTCA CIM wells containing the 
chemoattractant PDGFα. As figure 4.14b), shows there is a reduction in Cell Index 
compared to Sato media only controls when PDGFα is in the upper chamber.  
 
To find out if this modification of the system could be used to measure a chemorepellant 
effect, I seeded OPCs into the upper chambers of X-celligence RTCA CIM wells containing 
either Sema 3A at a concentration of 1µg per ml Sato media, or another known OPCs 
chemorepellant Netrin-1 (Jarjour et al., 2003; Tepavčević et al., 2014) at a concentration 
of 100ng per ml Sato media. As shown in figure 4.14 c) and d), I could discern no 
significant difference in Cell Index between either the Sema 3A or Netrin-1 conditions 
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Figure 4.14 The X-celligence RTCA CIM system is not an effective assay with which to study 
chemorepellants for OPCs in vitro a) Modification to the X-celligence RTCA CIM set-up for the study 
of chemorepulsion, OPCs are seeded into the upper chambers of X-celligence RTCA CIM wells which 
contain a chemorepellant, with Sato media only in the lower chamber b) 250,000 Post shake-off rat 
OPCs were seeded into the upper wells of X-celligence RTCA CIM plates containing the 
chemoattractant PDGFα, and X-celligence RTCA CIM experiments were run for 16.5 hours. Seeding of 
OPCs into the upper chambers of X-celligence RTCA CIM wells containing the chemoattractant PDGFα, 
results in a decrease in Cell Index compared to Sato media only controls c)  250,000 Post shake-off rat 
OPCs were seeded into the upper wells of X-celligence RTCA CIM plates containing one of the 
chemorepellants Sema 3A or Netrin-1 and X-celligence RTCA CIM experiments were run for 16.5 hours 
d) For each replicate for the same condition, technical variation has been eliminated by calculating the 
fold change between OPCs exposed to a chemoattractant in their upper X-celligence RTCA CIM well 
and their corresponding OPCs in Sato media only controls. No significant difference in Cell Index can 
be observed between chemorepellant stimulated OPCs and OPCs in Sato media only controls.  
 
The result that the X-celligence RTCA CIM system could not be used to identify 
chemorepellants for OPCs was somewhat disappointing, and brought with it the added 
implication that a lack of significant difference in Cell Index between X-celligence RTCA 
CIM wells containing a factor to be tested and Sato media only controls, could mean that 
either the factor had no impact on OPCs or that it could be a chemorepellant.  
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 I was confident however, that any increase in Cell Index in the presence of a tested factor 
could not be the result of chemorepulsion. I therefore turned my attention to verifying 
whether an increase in Cell Index could truly be attributed to directional 
chemoattraction.  
 
4.4.5 The X-celligence RTCA CIM system is an effective assay to study chemoattractants for 
OPCs  
As illustrated in figure 4.15, while the increase in Cell Index observed in the presence of 
PDGFα (see figure 4.13) may be the result of genuine directional migration as in figure 
4.15a), it is possible that this result may be the result of PDGFα-independent migration 
of a small number of OPCs to the underside of the membrane coupled with proliferation 
of these cells as in figure 4.15b). The teasing apart of these two possibilities in of 
particular significance given that PDGFα has been shown to increase both the migration 
and proliferation of OPCs (Baron et al., 2000; Franklin, 2002; Frost et al., 1996, 2003, 
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Figure 4.15 Cell Index values can be increased by proliferation as well as migration Cell Index is a 
measure of electrical impedance over the electrodes on the surface of the underside of the 
membrane, therefore increasing coverage of the underside of the membrane increases electrical 
impedance. Coverage of the membrane could be increased either by a) continual directional migration 
of OPCs over the course of the experiment or b) background cell motility resulting in a few OPCs 
migrating through the membrane which then proliferate. (Figure modified from Limame et al., 2012) 
 
To eliminate proliferation, I treated OPCs with a range of concentrations of the 
proliferation inhibitor mitomycin C, a DNA crosslinking agent (Li et al., 2015; Werner et 
al., 2013). As shown in figure 4.16a), I used a TUNEL assay (Click-iT TUNEL Alexa Fluor 
647 Imaging Assay, for microscopy HCS, Thermo Fisher Scientific, Catalogue 
Number:C10247) to assess OPC cell death in response to mitomycin C and found that it 
was safe for OPC treatment up to a concentration of 5µg mitomycin C per ml SATO media. 
The proliferation rate of post shake-off OPCs was also assessed using a Click-It EdU kit 
(Life Technologies), and was found to be around 5.3% of all cells in post shake-off OPCs 
cultures grown in culture in the absence of any growth factors (see figure 4.16b)). I also 
used immunoreactivity of antibodies for the proliferation marker Ki67 to determine that 
mitomycin C abolishes OPC proliferation at a concentration of 5µg per ml Sato media (see 
figure 4.16c)). 
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Figure 4.16 Mitomycin C can be used to safely inhibit proliferation a) Post shake-off rat OPCs were 
exposed to various dilutions of the proliferation inhibitor mitomycin C in Sato media, 1:500=1ug/ml, 
1:100=5µg/ml, 1:50=10µg, 1:10=50µg/ml for two hours prior to seeding onto glass coverslips at a 
concentration of 50,000 OPCs per 500µl Sato media and incubated overnight at 37oC and 7.5% CO2, 
staining and TUNEL assay were performed on fixed cells, OPC survival was quantified as the percentage 
of NG2 positive cells with TUNEL positive nuclei b) Post shake-off rat OPCs were cultured in the 
absence of any growth factors. OPCs from 10 separate rat pup litters were EdU labelled using a Click-
It kit. Edu positivity was quantified as the % of total Hoescht stained nuclei. 5.3% of total nuclei in post-
shake-off OPC culture were Edu+ (data courtesy of Gregor Skeldon and Elitsa Peeva) c) Post shake-off 
rat OPCs were exposed to mitomycin C at a concentration of 5µg per ml Sato media for two hours 
prior to seeding onto glass coverslips at a concentration of 50,000 OPCs per 500µl Sato media and 
incubated for 16.5 or 50 hours at 37oC and 7.5% CO2, staining was performed on fixed cells, OPC 
proliferation was quantified as the NG2 positive cells with Ki67 positive nuclei as a %age of NG2 
positive cells with Ki67 positive nuclei at 16.5 hours. At both 16.5 and 50 hours 0% of NG2 positive 
OPCs treated with mitomycin C expressed Ki67. 
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Having verified the effectiveness of proliferation inhibition in OPCs using mitomycin C, I 
next ran X-celligence experiments in which OPCs were first treated with 0.5µg mitomycin 
C per ml Sato media for a period of two hours prior to seeding in the upper chambers of 
X-celligence RTCA CIM wells with Sato media only in both the upper and lower chambers. 
As shown in figure 4.17a), both with and without mitomycin C there is considerable 
variation between replicates for the same condition. To allay this variation, I calculated 
the fold change between the X-celligence RTCA CIM wells containing OPCs and the 
control cell free wells included in the same experimental run. As shown in figure 4.17b), 
using the fold change a significant difference between OPCs with and without mitomycin 
C treatment has been detected by the X-celligence RTCA CIM system which can be 
attributed to the loss of proliferation in mitomycin C treated OPCs.  
 
 
Figure 4.17 The X-celligence RTCA CIM system can be used to detect OPC proliferation 250,000 Post 
shake-off rat OPCs either with or without 2 hours of exposure to the proliferation inhibitor mitomycin 
C at a concentration of 5µg per ml Sato media, were seeded into the upper wells of X-celligence RTCA 
CIM plates containing Sato media only in both their upper and lower chambers and X-celligence RTCA 
CIM experiments were run for 16.5 hours. a) The X-celligence RTCA system detects the presence of 
cells as an increase in Cell Index both with and without mitomycin C treatment although there is 
considerable variation between replicates b) Variation between replicates for the same condition, has 
been eliminated by calculating the fold change between OPCs with and without mitomycin C 
treatment and their corresponding cell free controls. A significant difference was found between OPCs 
with and without mitomycin C treatment, this difference can be attributed to higher OPC proliferation 
in the absence of mitomycin C.  
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 Having shown that the X-celligence RTCA system can be used to quantify OPC 
proliferation as well as migration, I repeated my PDGFα X-celligence RTCA CIM 
experiment, this time treating the OPCs with a concentration of 5µg mitomycin C per ml 
Sato media for two hours prior to cell seeding. As figure 4.18a) reveals, when 
proliferation is inhibited by mitomycin C treatment, there is still an increase in Cell Index 
in the presence of PDGFα. As shown in figure 4.18b), the Cell Index values reported in 
the presence of mitomycin C treatment are lower than in its absence, reflecting the 




Figure 4.18 Inhibition of proliferation results in a larger increases Cell Index in X-celligence RTCA CIM 
wells 250,000 Post shake-off rat OPCs were exposed to the proliferation inhibitor mitomycin C for 2 
hours, were seeded into the upper wells of X-celligence RTCA CIM plates containing recombinant 
PDGFα at a concentration of 10ng per ml Sato media and X-celligence RTCA CIM experiments were 
run for 16.5 hours. a) The experiment was run twice, each dot representing the mean Cell Index for 
each well, with an increase between mitomycin C treated OPCs with Sato media in both chambers and 
mitomycin C treated OPCs exposed to PDGFα in the lower chamber, although there was considerable 
variation between replicates. b) Compared to the Sato media only control, Cell Index is increased for 
OPCs exposed to PDGFα in the lower chambers, both for OPCs without mitomycin C treatment, and 
for OPCs with mitomycin C treatment, although there is more variation between experiments for 
proliferating OPCs  
 
These experiments showed that increased Cell Index as the result of migration or 
proliferation can be separated using the experimental protocol I had developed. Using 
my system, for each new factor tested for its effect on OPCs using the X-celligence RTCA 
system, experiments need to be run both with and without proliferation inhibition using 
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mitomycin C. If the Cell Index is higher when proliferation occurs, then this shows that 
the factor induces proliferation in OPCs. If, in contrast, the Cell Index is the same both 
with and without proliferation then proliferation can be eliminated showing that the 
factor is a chemoattractant for OPCs. 
 
Thus, running experiments both with and without a proliferation inhibitor, the X-
celligence RTCA CIM system can be used to separately quantify both the proliferative and 
migratory effects of factors on OPCs.  
 
4.4.6 The X-celligence RTCA CIM system can be used to study OPC differentiation as well as 
migration 
Another possible source of increased Cell Index, is the differentiation of OPCs into mature 
oligodendrocytes. As shown in figure 4.19, oligodendrocytes (figure 4.19a)) produce 
extensive MBP positive processes giving the cells a much larger surface area than OPCs 
(figure 4.19b)). 
 
As figure 4.19c) illustrates, differentiation of a few compact OPCs into bulky mature 
oligodendrocytes could increase the surface area covered by the cells, thus increasing 
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Figure 4.19 Mature oligodendrocytes cover a larger surface area than immature OPCS a) Post-shake-
off rat OPCs were seeded at a cell density of 50,000 OPCs per 500µl Sato media on glass coverslips, 
cultured for 16.5 hours in Sato media at 37oC and 7.5% CO2 before fixing and staining with antibodies 
for NG2 (OPC marker), Ki67 (proliferation marker) and MBP (mature oligodendrocyte marker). After 
16.5 hours in culture OPCs are small cells at around 5-10µm in diameter and express NG2 and Ki67 but 
not MBP b) Post-shake-off rat OPCs were cultured as before but the culture period was extended to 
50 hours by which point they were differentiating into oligodendrocytes. After 50 hours 
oligodendrocytes express the mature oligodendrocyte marker MBP as well as OPC marker NG2 but 
not proliferation marker Ki67, oligodendrocytes are much larger than OPCs with networks of bulky 
MBP positive processes c) In X-celligence RTCA CIM experiments, Cell Index can be thought of as a 
measure of coverage of the underside of the X-celligence RTCA CIM well membrane. i) The continual 
directional migration of OPCs through and adherence to the underside of the membrane could give 
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similar Cell Index readings as ii) migration of a few OPCs through and adherence to the underside of 
the membrane, followed by differentiation of OPCs into large oligodendrocytes with extensive 
processes which increase the surface area covered by the cells, giving a similar Cell Index reading. 
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To find out if OPC maturation was reflected in an increase in Cell Index, I developed 
methods which would allow staining of the underside of the X-celligence RTCA CIM 
plates. As shown in figure 4.20a) and 4.20b), X-celligence RTCA CIM plates are 
composed of two separate pieces which can be clipped together, the upper part 
incorporating the upper chambers and the permeable membranes and electrodes, and 
the lower part incorporating only the lower chambers. 
  
To access the cells on the permeable membranes, I fixed the cells by filling both the upper 
and lower chambers with 4% PFA and clipping the two parts of the plate back together 
for 10 minutes, before separating and washing with PBS. Cells were also 
immunofluorescently stained using antibodies for markers of OPCs and mature 
oligodendrocytes by flooding both the upper and lower chambers with antibodies and 
clipping the plate back together. In order to excise the electrodes and membrane from 
the underside of the lower chambers, I then ran a scalpel around the edge of the plastic 
sheet with the electrodes and membranes on it and then carefully peeled the plastic away 
taking the membranes and electrodes with it (see figure 4.20c)). With the fixed 
membranes/electrodes extracted, I then mounted them on glass slides with 
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Figure 4.20 Development of methods to excise OPC bound X-celligence RTCA CIM plate membranes 
and electrodes for imaging a) X-celligence RTCA CIM plates are made up of three parts, the upper and 
lower chambers and lid which must be clipped together during culture to bring the electrode covered 
membranes into contact with the media in the lower chambers b) Schematic of a single X-celligence 
RTCA CIM well and its correspondence to the structure of the X-celligence RTCA CIM plate c) At the 
end of an X-celligence RTCA CIM experiment, the membrane and electrodes can be accessed by 
unclipping, aspirating the fluid from the plate, and flipping the upper chamber section over. Excision 
can be achieved by running a scalpel around the underside of the membrane and electrodes and 
carefully peeling them away in a single piece d) and e) Membranes can then be mounted on glass 
slides using Fluoromount and imaged by conventional fluorescent microscopy.  
 
Having accessed, immunofluorescently stained and mounted the membranes, the cells 
were then imaged by confocal microscopy (Leica SP8). Figure 4.21, shows the result of 
an experiment in which OPCs were seeded into the upper chambers of X-celligence RTCA 
CIM wells with Sato media only in both the upper and lower chambers. In this 
experiment, OPCs were cultured in the X-celligence RTCA CIM plates for a period of 
either 16.5 hours (figure 4.21a)) or 3 days by which point they would be expected to be 
maturing into oligodendrocytes (figure 4.21b)). 
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Figure 4.22 Differentiation of OPCs on X-celligence RTCA CIM plates can be detected as an increase 
in Cell Index 250,000 Post shake-off rat OPCs were seeded into the upper wells of X-celligence RTCA 
CIM plates containing Sato media only in both their upper and lower chambers and X-celligence RTCA 
CIM experiments were run for 16.5 or 50 hours. a) After 16.5 hours, X-celligence experiment was 
stopped and the membranes, electrodes and cells were fixed, stained and imaged by fluorescent 
confocal microscopy, OPCs are small and round in morphology and express NG2 and Ki67 but not MBP 
b) After 50 hours, X-celligence experiment was stopped and the membranes, electrodes and cells were 
fixed, stained and imaged by fluorescent confocal microscopy, OPCs have begun to differentiate into 
oligodendrocytes with extensive MBP positive processes c) – e) Inserts from b) showing colocalization 
between NG2 (green) and MBP (red) f) Results of corresponding X-celligence experiments, show an 
increase in Cell Index between 16.5 hours and 50 hours g) Variation between replicates for X-celligence 
experiments was eliminated by calculation of the fold change between X-celligence RTCA CIM wells 
containing OPCs/oligodendrocytes and corresponding cell free control wells, matched to the same 
time point. 
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As figure 4.22b) – e) shows, large MBP positive oligodendrocytes can be observed after 
50 hours which results in higher coverage of the membrane/electrodes than by the NG2 
positive OPCs at 16.5 hours (see figure 4.22f), g)). This shows that in the absence of any 
stimulant some OPCs still migrate through the membrane before adhering to the 
underside and differentiating into mature oligodendrocytes.  Bearing in mind the 
possibility that a pro differentiation factor might accelerate OPC differentiation resulting 
in mature oligodendrocytes within 16.5 hours increasing the Cell Index value, this 
technique can be used to determine whether an increase in Cell Index at 16.5 hours is 
the result of migration or accelerated differentiation.  
 
4.5 Lipocalin-2 is a proliferation factor for OPCs in vitro 
Having verified the X-celligence RTCA CIM system as an effective assay for directional 
OPC migration and developed methods to use the system to assay both proliferation and 
differentiation, I then used the system to study the effects of candidate factors on OPC 
biology.  
Lipocalin-2(LCN2) is a small intracellular protein which has been reported to be highly 
expressed in astrocytes and the cerebral spinal fluid in EAE mouse models of MS 
(Marques et al., 2012; Nam et al., 2014) and in demyelinating human optic neuritis (Chun 
et al., 2015). While it has been shown that injured neurons secrete LCN2 as a way of 
signalling to astrocytes and microglia which express its receptor 24p3r  (Xing et al., 
2014), the effect of these signals on OPCs has never previously been characterised.  
Hypothesizing that the LCN2 neuronal distress signal might also elicit a response in 
OPCs, I first determined whether or not the LCN2 receptor 24p3r was also expressed by 
OPCs. 
As shown in figure 4.23, I referred to the gene expression array dataset from Moyon et 
al., 2015 (see Chapter 3) and found that there was a small but significant decrease in 
24p3r in Activated OPCs as compared to Non-activated OPCs.  
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As shown in figure 4.24a), I looked at the expression of LCN2 in the Huang, Jarjour et al., 
2011 dataset (see Chapter 3), and found that expression of LCN2 was apparently highest 
at 28 days post lesion when remyelination should be well underway, although there was 
high variation between the three replicates. This small difference might suggest a role 
for LCN2 in remyelination, however the result is not statistically robust due to the 
variation and consequently high SEM between the replicates for the 28dpl time point. 
This variation could be due to genuine biological variation in gene expression between 
the replicates, but this is not reflected in the expression patterns of other genes in the 
data set. It is also possible that the variation may be due to some technical disparity such 
as RNA degradation during storage or inexpert manual handling of the microarray 
during processing resulting in damage to the reactive surface. In any case further 
experiments analysing the expression of LCN2 in in vivo LPC induced demyelination 
would be necessary to verify this result. 
Interestingly, as shown in figure 4.24b), when I analysed the expression of 24p3r in this 
data set, I found a significant increase in expression, both between 14 days post lesion 
and 5 days post lesion and between 28 days post lesion and 5 days post lesion. Even more 
interestingly, I found that the expression pattern of 24p3r had a Pearson’s correlation 
with PDGFα of 0.93.  
Figure 4.23 Expression of the LCN2 
receptor 24p3r in the cuprizone 
injury data set from Moyon et al., 
2015 There is a small but significant 
decrease in the expression of 24p3r 
in Activated OPCs as compared to 
Non-activated OPCs 
Page 117 Catriona Ford s1059067 
 
Figure 4.24 Expression of LCN2 and 24p3r in the focal demyelination injury set from Huang, Jarjour 
et al., 2011 a) LCN2 appears to be most highly expressed at 28 days post lesion, but there is high 
variation between the replicates b) Expression of 24p3r significantly increases between 14 and 5 days 
post lesion and 28 and 5 days post lesion, in a similar expression pattern to PDGFα. 
In addition, I also looked at the expression of 24p3r in my processed data from the 
developmental series in Moyon et al., 2015. Interestingly, as shown in figure 4.25 below, 
24p3r is significantly more highly expressed in neonatal OPCs than in either adult OPCs 
or adult oligondedrocytes. While this result suggests that the expression of 24p3r may 
be linked to less developed, and therefore more proliferative OPCs, further experiments 
would be necessary to verify this result in vitro or in vivo. 
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Figure 4.25 Expression of 24p3r in the OPC development set from Moyon et al., 2015  24p3r appears 
to be most highly expressed in Neonatal OPCs, and is significantly more highly expressed in Neonatal 
OPCs than in either Adult OPCs or Adult Oligodendrocytes. 
 
To find out if 24p3r was expressed by post shake-off rat OPCs, as shown in figure 4.26, 
I used immunofluorescent staining of OPCs cultured overnight on glass coverslips at a 
cell density of 50,000 OPCs per 500µl Sato media to show, for the first time, that 24p3r 
is expressed by OPCs in vitro. 
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Figure 4.26 OPCs express 24p3r the receptor for LCN2 in vitro Post shake-off OPCs were seeded onto 
glass coverslips at a cell density of 50,000 OPCs per ml Sato media and cultured overnight in Sato 
media at 37oC and 7.5% CO2. OPCs on glass coverslips were then fixed and stained before imaging by 
immunofluorescent confocal microscopy. NG2 positive OPCs also express 24p3r.  
 
Having shown for the first time that OPCs also expressed the receptor for LCN2 I next 
performed X-celligence RTCA CIM experiments to determine the effect of LCN2 
administration to OPCs. As shown in figure 4.27a) and b), when OPCs seeded in the 
upper chambers of X-celligence RTCA CIM wells are exposed to rat recombinant LCN2 
(Recombinant Rat Lipocalin-2/NGAL, CF, R&D Systems, catalogue number: 3508-LC-
050) at a concentration of 0.5µg per ml Sato media in the lower chambers, a highly 
significant increase in Cell Index value can be observed as compared to Sato media only 
controls.  
 
To find out if this result could be attributed to proliferation, I repeated the experiment, 
this time inhibiting proliferation by treatment of the OPCs with mitomycin C. As shown 
in figure 4.27c) and d), the increase in Cell Index when OPCs are exposed to LCN2 as 
compared to SATO media only, is completely abolished when proliferation is inhibited.  
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Figure 4.27 LCN2 is a proliferation factor for OPCs in vitro a) 250,000 Post shake-off rat OPCs were 
seeded into the upper wells of X-celligence RTCA CIM plates containing recombinant rat LCN2 at a 
concentration of 25µg per ml Sato media only in their lower chambers or Sato media only in both their 
upper and lower chambers and X-celligence RTCA CIM experiments were run for 16.5 hours b) 
Variation between replicates for the same condition, has been eliminated by calculating the fold 
change between OPCs exposed to LCN2 and OPCs in Sato media only controls. There is a highly 
significant increase in OPCs exposed to LCN2 as compared to Sato media only controls c) 250,000 Post 
shake-off rat OPCs, either with or without proliferation inhibition using mitomycin C, were seeded into 
the upper wells of X-celligence RTCA CIM plates containing recombinant rat LCN2 at a concentration 
of 25µg per ml Sato media only in their lower chambers or Sato media only in both their upper and 
lower chambers and X-celligence RTCA CIM experiments were run for 16.5 hours d) Variation between 
replicates for the same condition, has been eliminated by calculating the fold change between OPCs 
exposed to LCN2 with proliferation inhibited using mitomycin C and proliferation inhibited OPCs in 
Sato media only controls, no significant difference was found.  
 
To make sure that the observed increase in cell index in the presence of LCN2 was not 
the result of the differentiation of OPCs into oligodendrocytes, I visualised the OPCs on 
the underside of the membrane using the methods described in chapter 4.4.6. As shown 
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in figure 4.28a), OPCs populate the underside of the X-celligence RTCA CIM membrane 
by both proliferation and migration. In the presence of LCN2, more proliferating OPCs 
colonise the underside of the membrane by background migration and increased 
proliferation (see figure 4.28b)) and there is no evidence of increased differentiation. 
These results revealed that the increase in Cell Index in response to LCN2 could not be 
the result of differentiation confirming the result that LCN2 is a proliferation factor for 
OPCs in vitro. 
 
Figure 4.28 Increased X-celligence Cell Index when OPCs are exposed to LCN2 is not the result of OPC 
differentiation 250,000 Post shake-off rat OPCs either with or without proliferation inhibited using 
mitomycin C were seeded into the upper wells of X-celligence RTCA CIM plates containing either LCN2 
at a concentration of 25µg per ml of Sato media in their lower chambers or Sato media only in both 
their upper and lower chambers. X-celligence RTCA CIM experiments were run for 16.5. After 16.5 
hours, X-celligence RTCA CIM experiment was stopped and the membranes, electrodes and cells were 
fixed, stained and imaged by fluorescent confocal microscopy a) OPCs exposed to Sato media only, 
populate the underside of the X-celligence RTCA CIM membrane by background migration and 
proliferation and express NG2 and the proliferation marker PCNA with some expressing MBP b) 
Proliferating OPCs exposed to LCN2, populate the underside of the X-celligence RTCA membrane by 
increased proliferation and express NG2, PCNA and very limited MBP.  
 
Taken together, these results show for the first time, that the LCN2 receptor 24p3r is 
expressed by OPCs and that the LCN2 is a proliferation factor for OPCs in vitro. 
4.6.7 CXCl12 is a chemoattractant for OPCs in vitro 
Another factor for which I found interesting results using the X-celligence system was C-
X-C motif chemokine 12 (CXCL12).  CXCL12 (also known as stromal-cell derived factor 1 
(SDF-1)), has been documented as both a proliferation and differentiation factor for 
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OPCs during remyelination (Patel et al., 2012; Williams et al., 2014) and has been found 
to promote developmental OPC migration (Dziembowska et al., 2005).  
 
As shown in Appendix 2, in my bioinformatic analysis of the data in Huang, Jarjour et al., 
2011, of the 410 secreted factors correlating with PDGFα expression I identified in 
Chapter 3, I identified only two which belonged to the chemokine family: CX3CL1 (which 
will be discussed at length in Chapter 5), and CXCL12. As shown in figure 4.29, CXCL12 
expression rises over the course of LPC induced demyelinating injury and is most highly 
expressed at 28 days post lesion when remyelination should be well under way.  
 
Figure 4.29 Expression of CXCL12 rises over the course of LPC induced demyelinating injury 
from Huang, Jarjour et al., 2011, peaking when remyelination should be well under way 
 
I also checked the expression of the two receptors for CXCL12, CXCR4 and CXCR7, in the 
data I analysed from Moyon et al., 2015, but as shown in figure 4.30, there was very little 
difference in the expression of either receptor between Activated and Non-activated 
OPCs. However, I hypothesized that this could reflect high receptor expression in both 
Activated and Non-activated OPCs.  
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Figure 4.30 Expression of a) CXCR4 and b) CXCR7, the receptors for CXCL12 in the Cuprizone injury 
data from Moyon et al., 2015 
 
To find out if the receptors for CXCL12 were strongly expressed on post shake-off rat 
OPCs, I performed immunofluorescent antibody staining on OPCs cultured overnight at 
37oC and 7.5% CO2. As shown in figure 4.31, NG2 positive OPCs also expressed both 
receptors for CXCL12, CXCR4 (see figure 4.31 a)) and CXCR7 (see figure 4.31 b)).  
 
 
Figure 4.31 OPCs express CXCR4 and CXCR7 the receptors for CXCL12 in vitro Post shake-off OPCs 
were seeded onto glass coverslips at a cell density of 50,000 OPCs per 500µl Sato media and cultured 
overnight in Sato media at 37oC and 7.5% CO2. OPCs on glass coverslips were then fixed and stained 
before imaging by immunofluorescent confocal microscopy. NG2 positive OPCs also express a) CXCR4 
and b) CXCR7.  
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To find out if recombinant CXCL12 acts as a chemoattractant for OPCs in vitro, I ran X-
celligence RTCA CIM experiments in which OPCs were seeded in the upper chambers and 
exposed to recombinant rat CXCL12 at a concentration of 1µg per ml Sato media in the 
lower chambers. As shown in figure 4.32 a) and b), there was a significant increase in 
Cell Index when OPCs were exposed to CXCL12.  
 
To eliminate proliferation as the source of increased Cell Index in the presence of 
CXCL12, I repeated the experiments with OPCs which had first been treated with 
mitomycin C to inhibit proliferation. As shown in figure 4.32 c) and d), the increase in 
Cell Index observed in CXCL12 stimulated OPCs was reduced by not entirely abolished 
in the absence of proliferation. These results show that while a proliferative effect of 
CXCL12 cannot be ruled out, proliferation alone is not responsible for the increase in Cell 











Page 125 Catriona Ford s1059067 
 
Figure 4.32 CXCL12 is a chemoattractant for OPCs in vitro a) 250,000 Post shake-off rat OPCs were 
seeded into the upper wells of X-celligence RTCA CIM plates containing recombinant rat CXCL12 at a 
concentration of 1µg per ml Sato media only in their lower chambers or Sato media only in both their 
upper and lower chambers and X-celligence RTCA CIM experiments were run for 16.5 hours b) 
Variation between replicates for the same condition, has been eliminated by calculating the fold 
change between OPCs exposed to CXCL12 and OPCs in Sato media only controls. There is a significant 
increase in OPCs exposed to LCN2 as compared to Sato media only controls c) 250,000 Post shake-off 
rat OPCs, either with or without proliferation inhibition using mitomycin C, were seeded into the upper 
wells of X-celligence RTCA CIM plates containing recombinant rat CXCL12 at a concentration of 1µg 
per ml Sato media only in their lower chambers or Sato media only in both their upper and lower 
chambers and X-celligence RTCA CIM experiments were run for 16.5 hours d) Variation between 
replicates for the same condition, has been eliminated by calculating the fold change between OPCs 
exposed to CXCL12 with proliferation inhibited using mitomycin C and proliferation inhibited OPCs in 
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The increase in CXCL12 exposed OPCs compared to OPCs in Sato media only controls is 
not lost when proliferation is inhibited using mitomycin C. 
To establish whether the increases in Cell Index observed could be the result of OPC 
differentiation, I imaged the underside of the X-celligence plates and as shown in figure 
4.33, no discernible difference in MBP expression or process formation could be seen 
between OPCs exposed to CXCL12(figure 4.33 b)) and OPC in Sato media only controls 
either with (figure 4.33 a)).  
 
 
Figure 4.33 Increased X-celligence Cell Index when OPCs are exposed to CXCL12 is not the result of 
OPC differentiation 250,000 Post shake-off rat OPCs either with or without proliferation inhibited 
using mitomycin C were seeded into the upper wells of X-celligence RTCA CIM plates containing either 
CXCL12 at a concentration of 1µg per ml of Sato media in their lower chambers or Sato media only in 
both their upper and lower chambers. X-celligence RTCA CIM experiments were run for 16.5. After 
16.5 hours, X-celligence RTCA CIM experiment was stopped and the membranes, electrodes and cells 
were fixed, stained and imaged by fluorescent confocal microscopy a) OPCs exposed to Sato media 
only, populate the underside of the X-celligence RTCA CIM membrane by background migration and 
proliferation and express NG2 and the proliferation marker PCNA with and some MBP b) OPCs exposed 
to CXCL12, populate the underside of the X-celligence RTCA membrane by directional chemotaxis 
toward CXCL12 and express NG2, PCNA and very limited MBP  
Thus, results for my experiments with CXCL12 show that in addition to proliferation, 
CXCL12 is also a chemoattractant for post shake-off rat OPCs in vitro.  
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4.7 Discussion 
4.7.1 Results Summary 
At the outset of this phase of the project, I set out to identify and optimise a suitable assay 
with which to study the chemotaxis of OPCs in response to novel factors in vitro. On 
review of current commercially available assays designed for this purpose, I identified 
both the formation of a liquid gradient and analysis of cell migration in real time as 
essential components for a suitable chemotaxis assay.  
The X-celligence RTCA CIM system developed by ACEA Biosciences, incorporates both 
these features in its design. The system consists of two media filled chambers separated 
by a porous membrane, the upper chamber containing the cells and the lower chamber 
containing the factor to be tested. A gradient of the factor tested forms in the pores of the 
membrane, and cells migrate through the pores in response to this gradient, before 
adhering to the underside of the membrane. Cell Index values reflecting the change 
electrical impedance across the underside of the membrane are measured by 
microelectrodes, arrayed on the underside of the membrane.  
My preliminary experiments indicated that optimisation of the system for the specific 
requirements of OPCs was necessary. Firstly, I increased the number of cells seeded into 
each well to 250,000 OPCs per well. Next I used the proliferation inhibitor mitomycin C 
to control for proliferation, allowing the system to be used to monitor proliferation in 
addition to migration. I then developed a system to extract membranes from the X-
celligence RTCA CIM plates at the conclusion of the experiment, and stain them to reveal 
the differentiation stage of the cells bound to its underside.  In this way, differentiation 
could both, be eliminated as a cause of increased Cell Index in response to migration, and 
also studied using the X-celligence RTCA CIM system.  
Having optimised the X-celligence RTCA CIM system for the analysis of the directional 
migration, proliferation and differentiation of OPCs in vitro, I then used the system to 
make novel inferences regarding the effect of the factors LCN2 and CXCL12 on OPC 
biology.  
The addition of LCN2 to OPCs in X-celligence RTCA CIM experiments, resulting in a 
statistically significant increase in Cell Index, but only when proliferation was not 
inhibited. I found no evidence of increased OPC differentiation in response to LCN2. In 
this way, my results show, for the first time, both that OPCs express the LCN2 receptor 
24p3r, and that LCN2 is a proliferation factor for OPCs in vitro. 
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Conversely, the addition of CXCL12 to OPCs in X-celligence RTCA CIM experiments, 
resulted in an increase in Cell Index which remained robust in the absence of 
proliferation. Staining of the underside of X-celligence RTCA CIM membranes revealed 
no increase in OPC differentiation in response to CXCL12. These results show, for the 
first time, that CXCL12 is a chemoattractant for OPCs in vitro.  
4.7.2. Evidence from LCN2 suggests OPC proliferation may occur late during focal 
demyelinating injury 
As iterated above, this thesis includes the novel finding that 24p3r is expressed by post 
shake-off OPCs and LCN2 functions as a proliferation factor for OPCs in vitro. The results 
from the Moyon et al., 2015 cuprizone data set, that 24p3r is more highly expressed in 
Non-activated than Activated OPCs, and the results from the Huang, Jarjour et al., 2011 
dataset show increasing expression of 24p3r over the course of demyelinating injury, 
similar to the expression pattern of PDGFα. Taken together, these results may indicate 
that the proliferation of OPCs occurs late in demyelinating injury, after OPC migration. 
Further experimentation classifying the expression of 24p3r and LCN2 in both human 
MS lesions and throughout LPC induced demyelination in mice. 
4.7.3 CXCL12 as a migration, proliferation and differentiation factor for OPCs 
In their 2012 study, Patel et al., showed that CXCL12 functions as both a proliferation 
and differentiation factor for OPCs in cuprizone induced global demyelination. In a 
further study they also showed that CNS remyelination could be improved by 
antagonism of CXCR7 (Williams et al., 2014) (CXCR7 sequesters CXCL12 for degradation, 
reducing the number of CXCL12 molecules available to bond CXCR4, thus muting the 
cellular response to CXCL12 stimulation (Boldajipour et al., 2008; Cruz-Orengo et al., 
2011; Naumann et al., 2010)). No migratory effect on OPCs was reported in either study. 
In contrast to the published data, using the X-celligence RTCA CIM system, I have shown 
that CXCL12 functions as a chemoattractant for OPCs in vitro. This was not a hugely 
surprising result, given that CXCL12 has been found to augment migration in a wide 
variety of cell types (reviewed in Puchert and Engele, 2014).  
Cuprizone is a model of global demyelination, because of this, it is possible that the lack 
of OPC migration reported could be explained by the lack of formation of a directional 
gradient of CXCL12 in this model. It would therefore be interesting to study the effect of 
CXCL12 in LPC induced focal demyelinating injury.  As my results from the gene 
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expression array data from Huang, Jarjour et al., 2011 shows, the concentration of 
CXCL12 at the lesion site rises over the course of LPC induced focal demyelination. This 
rising expression pattern which correlates with PDGFα, could represent the 
accumulation of CXCL12 at the lesion site, which forms a gradient up which OPCs 
migrate.  
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5.1 Introduction 
5.1.1 Selection of the CX3CR1/CX3CL1 Receptor Ligand Pair for in vitro Analysis 
On my review of the existing literature pertaining to the biology of Oligodendrocyte 
Precursor Cells (OPCs) at the beginning of my project, I was struck by the lack of high 
throughput data analysis applied to understanding the role of OPCs in CNS regeneration. 
Many previous studies investigating OPC migration had used a candidate gene approach, 
selecting a single target based on existing literature concerning OPCs in CNS 
development, or other known migration pathways such as axon guidance.  With my 
particular interest in bioinformatics, I reasoned that a less biased genome wide approach 
might reveal new previously unconsidered targets with important roles in regeneration.   
 
As detailed in Chapter 3, having discovered relevant data sets, I took a two pronged 
approach mining gene expression array data from isolated OPCs (Moyon et al., 2015) for 
cell surface receptors as well as gene expression array data from whole demyelinating 
lesion sites (Huang et al., 2011) for extracellularly secreted factors. On my combined 
analysis of the two data sets, I discovered that of all the cell surface receptors identified 
as being upregulated in activated OPCs (fold change of at least 2 as compared to non-
activated OPCs), only two had known ligands which were significantly differentially 
expressed in at least one post-injury time-point and expressed in a pattern correlating 
with both PDGFα and CXCL12 (Pearson’s correlation coefficient of >0.85). 
 
As explained in Chapter 3.5, of the two ligand-receptor pairs identified, one, PTPRZ1, 
could be eliminated as a candidate for further experimentation because previously 
published studies had found it to be a negative regulator of OPC differentiation and 
remyelination (Kuboyama et al., 2012, 2015; Pendleton et al., 2013). This left only the 
CX3CR1/CX3CL1 receptor ligand pair. 
 
5.1.2 Structure and Activity of CX3CL1 and CX3CR1 
CX3CR1 is a G-protein coupled receptor which features 7 hydrophobic transmembrane 
domains within its 355 amino acid polypeptide sequence. It was first reported under the 
name V28, as an orphan receptor identified in human DNA because of its sequence 
similarity to known chemokine receptors (Raport et al., 1995). CX3CR1 was later shown 
to be a high affinity receptor for CX3CL1, binding of which induced calcium flux and 
Page 132 Catriona Ford s1059067 
migration in leukocytes (Imai et al., 1997). CX3CR1 is as yet the only documented 
receptor for CX3CL1 (Liu et al., 2016; Poniatowski et al., 2016). 
Like other chemokines, CX3CL1 derives its name from the number of amino acids 
between the first two cysteine residues of its amino acid sequence. Thus, in CX3C the two 
cysteine residues (C) are separated by 3 other non-conserved amino acids (X3) (Luster, 
1998). In contrast with the other main families of human chemokines, C, CC and CXC, all 
of which include multiple ligands, CX3CL1 is the only known member of the CX3C family.  
CX3CL1 (fractalkine) is composed of 373 amino acids and is expressed in a range of 
organs including the lung, heart, kidney, small intestine and brain. As illustrated in figure 
5.1a), the amino acid sequence of the CX3CL1 protein can be divided into 5 regions. The 
first is a 25 amino acid N-terminal signal peptide sequence, indicative of the secretory or 
membrane associated character of the newly synthesized polypeptide.  This is followed 
by a 76 amino acid chemokine domain, a 241 amino acid mucin-like stalk region, a 19 
amino acid transmembrane domain and terminates with a 37 amino acid intracellular 
domain(Bazan et al., 1997).  
CX3CL1 is unique amongst chemokines, in that is it has both a membrane bound form 
and a soluble form which can be secreted from the cell surface following proteolysis 
(Bazan et al., 1997; Imai et al., 1997). The unusual structure of CX3CL1 in which the 
chemokine domain is anchored to the transmembrane and intracellular domains by a 
mucin like stalk (see figure 5.1b)), facilitates two modes of interaction with CX3CR1.  
Firstly, the chemokine domain can be released into the extracellular milieu by cleavage 
of the stalk (see figure 5.1c)). The untethered chemokine domain may then travel 
through the CNS parenchyma and activate distal CX3CR1 expressing cells, triggering 
downstream intracellular signalling cascades resulting in the expression of migration 
associated genes (see figure 5.1d)). In contrast, CX3CL1 acting as a single membrane 
tethered protein, has the ability to adhere CX3CL1 and CX3CR1 expressing cells through 
the interaction of the chemokine domain and CX3CR1 (see figure 5.1e)).   
5.1.3 The Role of CX3CR1/CX3CL1 in Microglia in the CNS 
While the CX3CR1/CX3CL1 has been found to play a role in a variety of human diseases 
(reviewed in Liu et al., 2016), it is of particular importance in CNS pathology. CX3CL1 is 
highly expressed in the brain, particularly in neuron rich regions, while CX3CR1 is 
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expressed by microglia, for which the chemokine domain of CX3CL1 acts as a 
chemoattractant (Harrison et al., 1998).  
 
 
Figure 5.1 Structure and Function of CX3CL1 Protein. a) Schematic representation of the CX3CL1 
protein, scaled by number of amino acids and coloured by protein region function b) – e) Functional 
activity of CX3CL1 through interaction with CX3CR1 b) On the surface of CX3CL1 expressing cells, the 
chemokine domain of CX3CL1 is attached to its transmembrane and intracellular domains by an 
extended mucin like stalk c) Cleavage of the stalk results in the release of the chemokine domain into 
the extracellular environment d) The free floating chemokine domain of CX3CL1 binds to CX3CR1 
triggering an intracellular signalling cascade in the CX3CR1 expressing cell e) Alternatively, CX3CL1 as 
a single, un-cleaved molecule binds to the CX3CR1 receptor of a neighbouring cell, forming a cell to 
cell adhesion. 




In the CNS, the process of inflammation is chiefly modulated by the microglia. Microglia 
are the resident macrophages of the CNS and make up 5-12% of the overall cell 
population (Lawson et al., 1990; Miron and Franklin, 2014). In the very earliest stages of 
CNS injury, microglia become activated, before performing neuroregenerative functions 
including phagocytosis of debris, orchestration of monocyte derived macrophages and 
the secretion of pro-regenerative factors (Kreutzberg, 1996; Miron and Franklin, 2014; 
Miron et al., 2013).  
However, other factors secreted by microglia have been found to negatively impact CNS 
biology, a process which is implicated in the inappropriate inflammatory response in 
pathologies such as MS (Miron and Franklin, 2014).  
The CX3CR1/CX3CL1 axis however, is reported to positively impact neuroregeneration. 
Administration of CX3CL1 has been found to increase microglial survival by blocking 
apoptosis in vitro (Boehme et al., 2000), while the loss of the CX3CR1/CX3CL1 axis 
through the knock-out or antagonism of CX3CR1 has been shown to disrupt regenerative 
microglial activities and increase neurotoxicity in a variety of CNS injury models 
(Bellavance et al., 2015; Cardona et al., 2006; Harrison et al., 1998; Lampron et al., 2015; 
Rivest, 2015). 
In summary, the view of CX3CR1/CX3CL1 CNS function established in the literature is 
that CX3CL1 is primarily secreted by neurons as a way of signalling to microglia, the only 
CNS cells to express CX3CR1.  
5.1.4 Polymorphisms in CX3CR1 are Associated With MS 
It has been postulated that polymorphisms modulating the binding affinity of CX3CL1 for 
its receptor CX3CR1 may be implicated in the rapidity of MS disease course. In MS 
patients, heterozygosity for the V249I polymorphism, located in the transmembrane 
region of CX3CR1, has been associated with protracted initial relapsing and remitting 
(RR) phase and slower transition into the secondary progressive (SP) phase(Arli et al., 
2013; Stojković et al., 2012). CX3CR1 expressing cells with this polymorphism have been 
shown to bind CX3CL1 more slowly, resulting in deficient calcium flux and ultimately 
reduced migration in response to a CX3CL1 gradient (McDermott et al., 2003).  
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In their 2012 study, Broux and colleagues investigated the expression of CX3CL1 and 
CX3CR1 in the brains of MS patients. A cytokine antibody array found upregulation of 
CX3CL1 in the cerebrospinal fluid of MS patients at their first clinical manifestation of 
the disease, and immunofluorescent staining revealed increased expression of CX3CL1 
in inflammatory MS lesions compared to non-lesioned tissue. Immunofluorescent 
staining was also used to reveal CX3CR1 expression in the NAWM of MS patients, as well 
as in the perivascular cuff of active MS lesions. In addition, the same study documented 
the migration of pro-inflammatory CX3CR1 expressing CD4(+) CD28(-) T-cells up an 
increasing gradient of CX3CL1 in vitro. Taken together, these data suggest that the 
CX3CL1/CX3CR1 interaction orchestrates the recruitment of CD4(+) CD28(-) T-cells to 
inflammatory MS lesions.  
Interestingly, the same study also found expression of CX3CR1 in CD4(+) T-cells, 
microglia and oligodendrocytes in MS lesions, indicative of a broader role for the 
CX3CL1/CX3CR1 interaction in demyelinating injury. 
5.1.5 CX3CR1 Expression in the CNS May Not be Limited to Microglia 
The pervasive notion that CX3CR1 is exclusively expressed by microglia in the CNS 
appears to stem from Harrison et al., 1998. However, while this study clearly documents 
the expression of CX3CR1 on microglia, it does not record the analysis of other brain cell 
types for the expression of CX3CR1.  
In addition, it has been reported that in the brain lesions of EAE rats, while the majority 
of CX3CR1 expressing cells can be identified as phagocytic macrophages or microglia, a 
subset of CX3CR1 expressing cells lacking immunoreactivity for antibodies for 
macrophages, microglia, astrocytes or neurons can also be detected (Sunnemark et al., 
2005).  
Having found the expression of CX3CR1 in activated OPCs in my microarray screen, I 
wondered if the unidentified CX3CR1 expressing cells might be OPCs and accordingly, 
searched the literature for any known effects of the CX3CR1/CX3CL1 axis on OPCs. 
5.1.5 Migration of OPCs in Response to Demyelination is Impaired in CX3CR1 Knock-out 
Mice 
I discovered almost no pre-existing data on the effect of the CX3CL1 ligand on OPC 
biology although a recent paper predominantly investigating the effects of CX3CR1 
knock out on the functionality of microglia in cuprizone induced demyelination in the 
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mouse CNS (Lampron et al., 2015) found that CX3CR1 knock-out impeded the 
regenerative process. The authors attributed this obstruction of remyelination purely to 
inefficient clearance of myelin debris by microglia, however, they also included a single 
figure showing a reduction in the presence of PDGFRα+ OPCs in the demyelinated corpus 
callosum. This failure of OPC recruitment may be secondary to failure of microglia entry 
and clearance of debris, but may also be a primary failure of OPC recruitment. 
5.1.6 Expression of CX3CR1 and CX3CL1 in Uninjured Brain Tissue 
To garner more information about the CX3CR1/CX3CL1 interaction I referred to the 
Barres Brain RNA-seq Database for isolated CNS cell types from uninjured tissue in mice 
(Zhang et al., 2014) and in humans (Zhang et al., 2016). I began by looking at the mouse 
data and found that while CX3CL1 had some low expression in astrocytes, newly formed 
oligodendrocytes, myelinating oligodendrocytes, microglia and endothelial cells, CX3CL1 
is by far most highly expressed by neurons, but is also significantly expressed by OPCs 
(see Figure 5.2a)).  
 
The mouse data for CX3CR1 showed that in uninjured brain tissue CX3CR1 is 
predominantly expressed in microglia while there is some expression in OPCs, although 
the authors include a caveat that the OPC isolate was contaminated with around 5% 
microglia (see Figure 5.2b)).  
 
In humans, the data from the Barres Brain RNA-seq Database shows that CX3CL1 is 
expressed by foetal astrocytes, mature astrocytes and neurons, but more significantly by 
endothelial cells (see figure 5.2d)). Similar to the mouse data, CX3CR1 is highly 
expressed by microglia/macrophages, but also by oligodendrocytes (figure 5.2e)).,  
 
Interestingly, while OPCs are not included in the human dataset, the cell surface receptor 
PDGFRα which is highly expressed by mouse OPCs (figure 5.2c)), is also expressed by 
human oligodendrocytes (figure 5.2f)), suggesting that other cell surface receptors 
expressed by mouse OPCs might be detected in this human oligodendrocyte isolate, 
either from contaminating OPCs or a biological similarity between OPCs and 
oligodendrocytes in humans. This might explain why CX3CR1 expression could be 
detected in the human (figure 5.2e)) but not the mouse (figure 5.2b)) oligodendrocyte 
isolates. 
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Figure 5.2  Expression of CX3CL1, CX3CR1 and CD68 in uninjured brain tissue according to the Barres 
Brain RNA-seq. Data from RNA-seq for isolated CNS cell types from uninjured tissue, noting that the 
OPC isolate has 5% microglial contamination (Zhang et al., 2014). Expression for each cell type 
calculated as Fragments Per Kilobase of exon per Million fragments mapped (FPKM). a)-c) Mouse, d)-
f) Human. In mice, CX3CL1 a) is expressed by all cell types but is most highly expressed in neurons and 
OPCs. In agreement with previously published literature, CX3CR1 b) is very highly expressed by 
microglia but also has some expression in OPCs. (Although there is 5% contamination of the OPC 
isolate by microglia) c) PDGFRα is included as an example of a cell surface receptor which is highly 
expressed on OPCs. In humans, d) While CX3CL1 is expressed by neurons, it is also highly expressed by 
endothelial cells. e) CX3CR1 is expressed by microglia and oligodendrocytes. While OPCs are not 
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included separately in the human data, f) PDGFRα, an OPC marker, is expressed by oligodendrocytes, 
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These observations suggested to me a strong case for further investigation of whether or 
not CX3CR1 was expressed in OPCs as well as microglia. 
 
In this chapter, I will describe how I indisputably show that CX3CR1 is expressed by OPCs 
in vitro, before going on to describe the dynamic effects of different concentrations of 
CX3CL1 on the migration, proliferation and maturation of OPCs and how control of these 
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5.2 CX3CR1 is Expressed by Oligodendrocyte Precursor Cells 
5.2.1 CX3CR1 is expressed in ‘activated’ OPCs in gene array expression analysis data 
As discussed earlier, the first of the bioinformatics data sets I analysed was run on an 
Agilent microarray platform and I used it to compare gene expression between OPCs 
activated in response to cuprizone induced demyelination and non-activated OPCs from 
uninjured tissue (Moyon et al., 2015).  As shown in figure 5.3, the result from my analysis 
of this comparison was that the G-protein coupled receptor CX3CR1 was differentially 
expressed 3-fold higher in activated OPCs as compared to non-activated OPCs (Linear 
fold change=2.99915894372415, Log2 fold change=1.61064724969289).  
 
 
Figure 5.3 Expression of CX3CR1 expression triples between Non-Activated and Activated OPCs. 
Results of gene expression array analysis of the data from Moyon et al., 2015. Normalised expression 
is 3 times higher in Activated OPCs from cuprizone injured brain tissue than in Non-Activated OPCs 
from uninjured brain tissue (mean of 4 replicates for Activated OPCs and 3 replicates for Non-Activated 
OPCs +/- SEM, p=0.02077755 by differential expression analysis using Limma). 
 
As explained in Chapter 3, the expression levels for all the features in the Moyon et al., 
2015 dataset were elevated by significant background noise, such that fold changes 
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background. Thus, the 3-fold increase between non-activated and activated OPCs is likely 
to reflect an even larger increase in expression than could be detected in this dataset. 
 
I thus began my in vitro experiments with the verification of the result from the 
bioinformatics data, that CX3CR1 protein is expressed on OPCs.  
 
5.2.2 CX3CR1 expression can be detected in OPC cultures by western Blot 
To achieve this aim, with the assistance of visiting PhD student Misuzu Hashimoto, 
expression of CX3CR1 in OPCs was confirmed by western blot (see methods chapter 
2.2.6.3). As the bioinformatics data showed upregulated expression of CX3CR1 in 
“activated” OPCs, lysates were prepared from rat OPCs cultured either normally 
(unstimulated) or in the presence of 0.03µg/ml recombinant rat CX3CL1 for 16 hours 
(stimulated) and probed for the expression of CX3CR1, using GAPDH as a loading control.  
A single band at ~50kDa for CX3CR1 was detected in both CX3CL1 stimulated and non-
stimulated OPCs again suggesting the presence of the CX3CR1 protein in OPCs (see 
Figure 5.4).  
 
 
Figure 5.4 Confirmation of CX3CR1 expression in OPCs by western blot. Specific bands for 
CX3CR1 are detected with the polyclonal antibody at ~50kDa in post-shake-off rat OPCs both 
normally (unstimulated) or in the presence of 0.03µg/ml recombinant rat CX3CL1 for 16 
hours (stimulated), using the housekeeping gene GAPDH as a loading control. 
 
Page 142 Catriona Ford s1059067 
However, when rat OPCs are prepared using the shake-off method(see McCarthy and de 
Vellis, 1980 and methods chapter 2.2.3), microglia are only removed from the culture 
by virtue of their weaker adhesion, and there is a risk that the final cultures are 
contaminated by residual microglia that are inefficiently removed in this manner. With 
the overwhelming evidence in the literature that CX3CR1 is expressed by microglia 
(Bellavance et al., 2015; Broux et al., 2012; Cardona et al., 2006; Harrison et al., 1998; 
Lampron et al., 2015; Paolicelli et al., 2014; Rivest, 2015), and no literature suggesting it 
is expressed in OPCs, it was imperative to eliminate the possibility that the 
immunoreactivity of CX3CR1 seen by western blot was due to the presence of CX3CR1 
expression in contaminating microglia rather than in OPCs.  
5.2.3 CX3CR1 is expressed by Olig2+/MBP- OPCs 
Verification of the purity of post shake-off OPCs, was carried out by Hui Zhang, a previous 
student in the Williams lab. As shown in figure 5.5 below, rat OPC cultures were 
immunostained for lineage specific markers for the oligodendroglial lineage(Olig2), 
astrocytes (GFAP) and microglia (CD68). Around 85% of the cultures were found to be 
expressing Olig2, while around 14% of the cell were found to be contaminating 
astrocytes. Although there is some evidence of microglial contamination, CD68 
expressing microglia made up less than 1% of the total cells.  
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Figure 5.5 Purity of Post Shake-Off Rat OPC Culture Cultures from 3 separate litters of rat pups 
prepared according to methods section 2.2.3 Preparation of primary rat OPCs from neonatal brain 
tissue. Following shake-off, mixed glial cultures were immuostained for markers of glial cell types. 0.85 
Marker +ve cells/Total Cells With Hoechst +ve Nuclei were found to express the Olig2 marker of 
oligodendroglia, 0.145 Marker +ve cells/Total Cells With Hoechst +ve Nuclei were found to express the 
GFAP marker of astrocytes, and 0.00995 Marker +ve cells/Total Cells With Hoechst +ve Nuclei were 
found to express the CD68 marker of microglia, verifiying that microglia make up only a very small 
fraction of the post shake-off OPC culture.  
 
To establish the expression of CX3CR1 specifically in OPCs, I immunostained rat OPC 
cultures using antibodies for oligodendroglial-specific markers and CX3CR1 (see 
chapter 2.2.9.2 for full antibody list). Post shake-off rat OPCs were either normally 
cultured or stimulated with recombinant rat CX3CL1 at increasing concentrations: 
0.01µg/ml, 0.03µg/ml, 0.1µg/ml, 0.3µg/ml, 0.9µg/ml, 2.7µg/ml overnight. 
 
Visual examination of images generated by confocal microscopy revealed expression of 
CX3CR1 in Olig2+/MBP- OPCs (Figure 5.6 a)-g)) in all conditions as well as increased 
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abundance of Olig2+/MBP- oligodendrocyte at the highest concentrations of CX3CL1 
stimulation (Figure 5.6 f) and g)). 
 
To verify this result, I repeated the same experimental set-up using the Operetta high 
content fluorescent microscopy system (PerkinElmer) and quantified CX3CR1 
expression in Olig2+/MBP- OPCs in these images using Columbus analysis software. As 
shown in Figure 5.6.h), without CX3CL1 stimulation, on average 93.98% of 
Olig2+/MBP- cells are also CX3CR1 positive. When cells were stimulated with CX3CL1, 
CX3CR1 expression can be detected in over 90% of Olig2+/MBP- cells across all 
concentrations (0.01µg/ml = 95.41%, 0.03µg/ml = 93.95%, 0.1µg/ml = 92.78%, 
0.3µg/ml = 95.27%, 0.9µg/ml = 95.86%, 2.7µg/ml = 95.88% (means plus s.e.m. plotted 
in figure)). 
As Olig2+/MBP- cells are by definition immature oligodendroglial lineage cells or OPCs, 
this result eliminates the possibility that detection of CX3CR1 immunoreactivity is the 
product of microglial contamination and verifies that CX3CR1 is expressed by OPCs.  
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Figure 5.6 Verification of CX3CR1 expression in Olig2+/MBP- OPCs by immunofluorescence. a)-g) 
CX3CR1 is expressed in Olig2+/MBP- OPCs cultured overnight either normally or stimulated with 
increasing concentrations of recombinant CX3CL1. In addition, abundance of Olig2+/MBP+ 
oligodendrocytes is increased at higher CX3CL1 concentrations.  
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5.3 CX3CL1 modulates OPC biology in vitro 
5.3.1 CX3CL1 expression increases over the course of CNS regeneration 
With the expression of CX3CR1 in OPCs initially identified by gene expression array 
analysis confirmed by my in vitro immunofluorescence experiments I then leveraged the 
data from the Huang, Jarjour et al., 2011 dataset to investigate the expression pattern of 
CX3CL1, the ligand for CX3CR1, in CNS demyelination.   
 
In their 2011 paper, Huang, Jarjour et al., induced demyelination in the caudal cerebral 
peduncle of rats by injection of the detergent lysophosphatidylcholine and extracted 
RNA from the regenerating whole lesion site at 5, 14 and 28 days after demyelination. 
The expression levels of CX3CL1 rose steadily over this time course, (see Figure 5.7)) 
with a 1.3-fold increase between day 5 and day 14 and a further 1.38-fold increase 
between day 14 and day 28.   
 
Figure 5.7 Expression of CX3CL1 in gene expression array data from whole regenerating lesion sites. 
In lysophosphatidylcholine induced demyelinated lesions (data reanalysed from Huang et al., 2011), 
CX3CL1 expression increases steadily from 5 to 28 days post lesion (mean of 3 replicates for each 
condition +/- SEM). There is a significant increase in expression between 5 days post lesion and 28 
days post lesion. 
 
Page 148 Catriona Ford s1059067 
While this result suggests that CX3CL1 might be an important pro-regenerative factor, 
there is no data prior to 5 days post lesion, by which point OPC migration is well 
underway. Therefore, we cannot yet speculate whether CX3CL1 is involved in early 
regenerative processes such as the activation or directional migration of OPCs.  
 
5.3.2 OPCs migrate in response to stimulation by a low concentration gradient of CX3CL1 
Having established that CX3CR1 is expressed by OPCs as well as microglia in vitro and 
that CX3CL1 increases in expression at the RNA level over the course of remyelination in 
both spinal cord injury and lysophosphatidylcholine induced demyelination, I then set 
out to discover if CX3CL1 has migratory effects on OPCs. To achieve this aim (with the 
assistance of Misuzu Hashimoto), I utilised the X-celligence migration plate system, 
previously described in chapter 4. 
 
OPCs, seeded in the upper X-celligence chamber, were exposed to a gradient of 
recombinant CX3CL1 from a concentration of 0.1µg/ml Sato media in the lower X-
celligence chamber. As shown in figure 5.8, after a period of 16.5 hours a significant 
increase in Cell Index was detected. As discussed earlier, although the X-celligence CIM 
system is designed to detect migration, an increase in impedance (cell index) may also 
be secondary to an increase in either cell proliferation or maturation into a bulkier adult 
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Figure 5.8 Administration of a low concentration of CX3CL1 (0.01µg/ml) to OPCs increases Cell Index 
on X-celligence migration plates. OPCs were seeded in the upper chamber of X-celligence CIM plates 
and a gradient between the upper and lower chambers was established by the addition of 0.01µg 
recombinant CX3CL1 per ml Sato media. After 16.5 hours there was a significant increase in Cell Index 
in CX3CL1 stimulated OPCs compared to unstimulated OPCs. a) The experiment was run 9 times, each 
dot representing the mean Cell Index for each well, with an increase in every replicate, although there 
was considerable variation between replicates. b) To ameliorate the variation between replicates, 
increases were computed as a fold change between OPCs exposed to 0.01µg CX3CL1 per ml Sato media 
and OPCs in Sato media only controls for each experiment, there was a significant increase between 
the two conditions by paired t-Test 
 
To eliminate OPC proliferation as the cause of the increased Cell Index in my X-celligence 
results, I repeated the experiment, this time treating the OPCs with proliferation 
inhibitor mitomycin-C for two hours prior to the initiation of the X-celligence 
experiment. As illustrated in figure 5.8, the observed increase in Cell Index remains 
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Figure 5.9 Increased Cell Index on X-celligence migration plates in response to administration of 
0.01ng/ml CX3CL1 to OPCs is robust in the absence of proliferation. OPCs were treated with the 
proliferation inhibitor mitomycin-C and seeded in the upper chamber of X-celligence CIM plates. A 
gradient between the upper and lower chambers was established by the addition of 0.01µg 
recombinant CX3CL1 per ml SATO media. After 16 hours, there was a significant increase in Cell Index 
in CX3CL1 stimulated OPCs compared to unstimulated OPCs. a) The experiment was run 3 times, with 
an increase in every replicate, although there was considerable variation between replicates. b) To 
ameliorate the variation between replicates, increases were computed as a fold change between 
proliferation inhibited OPCs exposed to 0.01µg CX3CL1 per ml Sato media and proliferation inhibited 
OPCs in Sato media only controls for each experiment, there was a significant increase between the 
two conditions by paired t-Test  
 
To eliminate maturation of OPCs as being responsible for the increased Cell Index, I 
imaged the underside of the membrane of the X-celligence plates (as described in 
chapter 4.4.6) from the proliferating OPC s. As shown in figure 5.10, in the Sato media 
only controls (figure 5.10a)), many NG2/Ki67 positive OPCs have migrated through the 
pores and adhered to the underside of the membrane. NG2/Ki67 OPCs exposed to 0.01 
µg CX3CL1 per ml Sato media appear to have colonised the underside of the membrane 
in greater numbers, however there is no evidence of the increased NG2 positive process 
formation or MBP expression which would be associated with OPC differentiation.  
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Figure 5.10 Increased Cell Index at 0.01µg CX3CL1 per ml Sato media as compared to Sato media 
controls is not the result of OPCs maturation The underside of the membranes of X-celligence RTCA 
CIM plates were extracted, stained and imaged by fluorescent microscopy a) OPCs in Sato media only 
controls have migrated through the membrane by background motility, the express NG2, Ki67 and 
limited MBP b) OPCs exposed to 0.01µg recombinant CX3CL1 per ml Sato media in the lower chambers 
of X-celligence RTCA CIM wells appear to have migrated through the membrane in greater numbers 
than in the Sato only controls, they express NG2, Ki67 and limited MBP. No increase in the formation 
of NG2 positive processes or MBP expression is immediately obvious as compared to Sato only controls 
 
To confirm this result, I grew OPCs overnight in SATO media impregnated with 
recombinant CX3CL1 at the same concentration as in the X-celligence experiment 
(0.01µg/ml SATO media). As figure 5.11, demonstrates, no significant difference in the 
number of MBP positive mature oligodendrocytes could be discerned between CX3CL1 
stimulated and unstimulated OPCs.  
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With the elimination of both proliferation and maturation, it can be assumed that CX3CL1 
stimulates OPC migration along a low concentration gradient peaking at a concentration 
of 0.01µg/ml.  
 
5.3.3 OPC maturation is accelerated in the presence of a high concentration of CX3CL1  
In addition to the low CX3CL1 concentration, I also ran X-celligence experiments 
exposing OPCs to a gradient of CX3CL1 peaking with the much higher concentration of 
2.7µg CX3CL1 per ml SATO media. As shown in figure 5.12, I found a small increase in 
Cell Index in all three replicates of the experiment, although this was not statistically 
significant by paired t-Test. 
 
Figure 5.11 Increased Cell Index on X-
celligence migration plates in response to 
administration of 0.01ng/ml CX3CL1 to OPCs 
is not the result of OPC maturation  
OPCs were cultured overnight in a) SATO 
media and b) 0.01ug CX3CL1 per ml SATO 
media. c) No significant change in %age of 
Olig2+/MBP+ oligodendrocytes was observed 
between the two conditions 
Page 153 Catriona Ford s1059067 
 
Figure 5.12 Administration of a high concentration of CX3CL1 (2.7µg/ml) to OPCs slightly increases 
Cell Index on X-celligence migration plates. OPCs were seeded in the upper chamber of X-celligence 
CIM plates and a gradient between the upper and lower chambers was established by the addition of 
2.7µg recombinant CX3CL1 per ml SATO media. After 16 hours, there was a slight increase in Cell Index 
in CX3CL1 stimulated OPCs compared to unstimulated OPCs. a) The experiment was run 5 times, with 
an increase in every replicate, although there was considerable variation between replicates. b) To 
ameliorate the variation between replicates, increases were computed as a fold change between OPCs 
exposed to 2.7µg CX3CL1 per ml Sato media and OPCs in Sato media only controls for each experiment, 
there was a significant increase between the two conditions by paired t-Test 
 
To establish whether this small increase could be attributed to OPC proliferation, as 
before, I ran the X-celligence experiments again, this time treating the OPCs with the 
proliferation inhibitor mitomycin-C prior to seeding. As figure 5.13 demonstrates, 
inhibition of proliferation results in the abolition of the increase in Cell Index and 
appears to reduce Cell Index.   
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Figure 5.13 The small increase in Cell Index on X-celligence migration plates in response to 
administration of 2.7ng/ml CX3CL1 to OPCs is reversed in the absence of proliferation. OPCs were 
treated with the proliferation inhibitor mitomycin-C and seeded in the upper chamber of X-celligence 
CIM plates. A gradient between the upper and lower chambers was established by the addition of 
2.7µg recombinant CX3CL1 per ml SATO media. After 16 hours, there was a decrease in Cell Index in 
CX3CL1 stimulated OPCs compared to unstimulated OPCs. 
 
While this result suggested that the increase in Cell Index at 2.7µg CX3CL1 per ml Sato 
media might be due to proliferation, I also stained the underside of the X-celligence 
plates to find out if maturation of OPCs might also contribute to the increased Cell index. 
As shown in figure 5.14, after 16.5 hours, OPCs exposed to 2.7µg CX3CL1 per ml Sato in 
the lower chamber of the X-celligence RTCA CIM wells produce extensive MBP positive 
processes, covering a large proportion of the underside of the X-celligence RTCA CIM 
plate membrane.  
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Figure 5.14 Exposure to 2.7µg CX3CL1 per ml Sato media through the X-celligence RTCA CIM plate 
membrane induces OPCs to differentiate into mature oligodendrocytes a) Post-shake-off rat OPCs 
were cultured in X-celligence RTCA CIM wells containing Sato media only in both their upper and lower 
chambers for a period of 16.5 hours. Membranes were excised, stained and imaged revealing that 
many OPCs have migrated through the membrane, OPCs express the OPC marker NG2 and 
proliferative marker Ki67 with limited expression of the mature oligodendrocyte marker MBP b) Post-
shake-off rat OPCs were cultured in X-celligence RTCA CIM wells containing 2.7µg recombinant CX3CL1 
per ml Sato media in their lower chambers for a period of 16.5 hours. Membranes were excised, 
stained and imaged revealing that the majority of OPCs on the underside of the membrane have 
differentiated into oligodendrocytes with large MBP positive processes and limited expression of NG2 
and Ki67. 
 
To find out if this increased maturation effect held true in the absence of a gradient, I 
used standard OPC cultures.  OPCs were cultured overnight in 2.7µg recombinant 
CX3CL1 per ml SATO media. As figure 5.15 reveals, exposure to this higher 
concentration resulted in a significant increase in the percentage of Olig2 positive cells 
expressing MBP, a marker of mature oligodendrocytes.  
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As exemplified in figure 5.15b), it can also be observed that in high CX3CL1 
concentration cultures, the maturing oligodendroglia produce lots of complex MBP 
positive processes within only 18 hours, a process which normally takes as much as 2-3 
days in unstimulated cultures.  
 
Together, these results suggest low concentrations of 0.01µg/ml CX3CL1 induces 
increased migration, while at 2.7µg/ml CX3CL1 there is increased OPC maturation into 







Figure 5.15 OPC maturation is accelerated 
in response to high dose CX3CL1 
OPCs were cultured overnight in a) SATO 
media and b) 2.7ug CX3CL1 per ml SATO 
media. c) The %age of Olig2+/MBP+ 
oligodendrocytes was significantly increased 
when OPCs were stimulated with high dose 
CX3CL1 
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5.4 Discussion 
5.4.1 Results summary 
As iterated above, the bioinformatic screen identified CX3CR1 as a cell surface receptor 
expressed significantly more by activated OPCs in demyelinated tissue than non-
activated OPCs in healthy tissue. This result was matched with the discovery of CX3CL1 
as a secreted factor with rising expressing over the course of focal demyelinating injury. 
In this chapter, I verified the expression of CX3CR1 on the surface of OPCs. I then used a 
combination of the protocols I developed for the X-celligence CIM plate system to show 
that a gradient of CX3CL1 peaking at a low concentration induces directional OPC 
migration and that exposure to high dose CX3CL1 accelerates OPC maturation.  
 
While these data are in vitro only, these results show for the first time, both that CX3CR1 
is expressed by OPCs and that CX3CL1 modulates OPC biology. Based on my results and 
information in the literature, it is possible to envisage a model in which CX3CL1 is the 
master regulator of remyelination, which I discuss further below.  
 
5.4.2 Model for the mode of action of CX3CL1 in regeneration after demyelinating injury 
CX3CR1 has long been known to be expressed by microglia(Bellavance et al., 2015; 
Boehme et al., 2000; Cardona et al., 2006; Harrison et al., 1998), and CX3CR1 knock-out 
has been shown to impact remyelination trough inefficient clearance of myelin debris by 
microglia (Lampron et al., 2015), which is a necessary part of early stage infiltration of 
microglia into demyelinating injuries (Miron and Franklin, 2014).  
 
While no difference has been found in the expression of the CX3CL1 gene between 
uninjured and globally demyelinated brains (Lampron et al., 2015), there is evidence that 
cleavage of the fractalkine chemokine domain is increased during (Chapman et al., 2000). 
In contrast, in the Huang, Jarjour et al., 2011 data set from focal demyelinating injury, I 
found steady rising expression of CX3CL1 over the entire injury time course (see figure 
5.6). 
 
The crosstalk between neurons and microglia via the CX3CR1/CX3CL1 axis reported in 
the published data, combined with my OPC results, leads me to hypothesize a model 
where differing concentrations of CX3CL1 emanating from a demyelinating lesion, 
control the regenerative response of OPCs (and microglia) to this lesion.  
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CX3CL1 secreted by neurons, diffuses outward from the site of demyelination, leading to 
ever-decreasing concentrations contacting distal OPCs distant to the lesion. The neuron-
derived CX3CL1 chemokine domain may bind to distal CX3CR1 expressed by OPCs, 
perhaps releasing OPCs hitherto adhered to neighbouring cells via CX3CR1/CX3CL1 cell-
to-cell interactions. OPCs then may migrate up the gradient of CX3CL1 towards the lesion 
site.  
 
On arrival at the lesion site, the CX3CL1 concentration is higher, stimulating OPC 
differentiation. It may be that all the CX3CR1 receptors on the OPCs become saturated 
with CX3CL1, rendering OPCs unable to sense the chemokinetic gradient. This halts OPC 
migration, allowing differentiation into myelinating oligodendrocytes.  These mature 
oligodendrocytes then are able to remyelinate the injured axons, regenerating the lesion 
site.  
 
This model suggests that increased expression of CX3CL1 dissipating from the lesion site 
might improve the entire process of regeneration, from microglial debris clearance to 
OPC recruitment and remyelination. 
 
5.4.3 Additional experiments to test this model 
The response of microglia to CX3CL1 after demyelinating injury (Lampron et al., 2015) 
and my in vitro OPC results suggest that CX3CL1 expression by neurons/axons might be 
expected to increase following injury. My bioinformatic result showing increased 
expression of CX3CL1 throughout focal demyelinating injury (see figure 5.6) supports 
this view. However, Lampron et al., 2015 found no increase in CX3CL1 mRNA expression 
between globally demyelinated and healthy brain tissue. The extraordinary structure of 
CX3CL1, with its membrane bound and freely released forms could explain this result. It 
is possible that while mRNA expression of CX3CL1 does not increase initially, release of 
CX3CL1 by neurons occurs at the protein level by cleavage of the mucin stalk freeing the 
chemokine domain.  
To test whether release of the CX3CL1 chemokine domain is increased at sites of focal 
demyelination, tissue from our focally demyelinated model (demyelination of the mouse 
corpus callosum by injection of lysophosphatidylcholine), could be stained for 
immunoreactivity with antibodies for the CX3CL1 chemokine domain. Tissue sections 
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could be generated for a wide range of time-points throughout the process of focal 
demyelination and remyelination and could be co-stained with markers of myelin to 
visualise the location of CX3CL1 within the geography of the lesion site and surrounding 
white matter.  
Sections of tissue from both the lesion epicentre and corresponding tissue from 
uninjured controls, could also be excised, the RNA extracted and then run as a qPCR to 
determine whether the lack of increased CX3CL1 mRNA observed in a model of global 
demyelination (cuprizone-induced) also holds true for focal demyelination (LPC-
induced). 
Staining of focally demyelinated mouse tissue could also be used to confirm the 
expression of CX3CR1 on the surface of OPCs, by co-staining with OPC markers such as 
PDGFRα, NG2 or Olig2.  
To find out whether remyelination in focally demyelinated lesions is impaired in the 
absence of CX3CR1, focal demyelinating lesions could be induced in the corpus callosum 
of both WT and CX3CR1 knock-out mice. Tissue sections could be taken at a range of 
time-points throughout regeneration and immunostaining for OPCs and adult 
oligodendrocyte markers used to confirm that both OPC infiltration into the lesion site 
and remyelination are impaired in CX3CR1 knock-out mice.  
To discover whether the predicted impairment of OPC-led regeneration in CX3CR1 
knock-out mice can be rescued by the presence of CX3CR1 positive OPCs, CX3CR1 
positive OPCs from WT mice could then be injected adjacent to the lesion site in the 
CX3CR1 knock-out mice. Tissue sections could again be taken at a range of time-points 
throughout regeneration and immunostaining for OPC and oligodendrocyte markers 
used to determine if OPC infiltration and remyelination is restored. 
A caveat with the previous experiment is that addition of OPCs will not improve 
inefficient clearance of myelin debris by microglia which could still impact 
remyelination. To find out if stimulation of both microglia and OPCs by CX3CL1 is 
necessary for improved remyelination, a further in vivo experiment could be carried out. 
In WT mice, lesion induction could be followed by the addition of recombinant CX3CL1 
chemokine domain into the lesion epicentre at a time-point prior to the expected 
induction of OPC migration. Immunofluorescence of microglia and myelin debris 
markers should be used in tissue sections from within hours of lesion induction to find 
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out whether phagocytosis of myelin debris is improved. Sections could also be taken 3-5 
days after lesion induction and stained for OPC markers to determine if the abundance 
of OPCs within the lesion site has increased. Finally, tissue sections taken prior to and 
during the expected time-course of remyelination could be stained for mature 
oligodendrocyte markers, to determine whether the abundance of mature 
oligodendrocytes and myelin is either increased at earlier time points or increased 
overall.   
In addition to the data shown here, I have also carried out preliminary experiments 
which suggest that at a medium concentration of 0.1µg CX3CL1 per ml SATO media may 
induce OPC proliferation. Repetition of X-celligence experiments testing this CX3CL1 
concentration both with and without inhibition of proliferation using mitomycin-C, with 
the addition of testing OPCs cultured overnight in media at this CX3CL1 concentration 
for markers of proliferation (e.g. Ki67, PCNA), are necessary experiments to confirm this 
result. Proliferation of OPCs at this medium concentration, could also fit with the 
hypothesis. It can be postulated that following migration, OPCs meeting this CX3CL1 
concentration when they first infiltrate the lesion site, first proliferate before the 
accumulation of CX3CL1 resulting from increasing mRNA expression (see figure 5.6) 
induces OPC differentiation.  
Testing of this proliferation hypothesis could be easily added to the above in vivo 
experiments, by staining tissue sections from for proliferative markers and looking for 
co-localisation with OPC markers.  
5.4.4 Conclusion 
In this chapter, I used in vitro methods to verify the expression of CX3CR1 in cultured 
OPCs and used the X-celligence system and antibody immunoreactivity for markers of 
OPCs and adult oligodendrocytes to show that OPCs migrate up a low concentration 
gradient of CX3CL1 and accelerate maturation into adult oligodendrocytes when 
stimulated by a high concentration of CX3CL1. 
Taken in the context of existing literature and the model I have proposed, and with the 
addition of the in vivo experiments outlined above, this research represent a significant 
contribution to our knowledge of OPC led regeneration in the CNS.  
In the following discussion chapter, I will discuss the impact of these results in the wider 
context of MS research.  












Page 162 Catriona Ford s1059067 
There are thought to be 2.5 million MS patients worldwide (Pugliatti et al., 2002), with 
some populations affected more than others. A single cause for the onset of MS pathology 
has never been identified, MS may therefore be considered as a multifactorial disorder, 
the result of a combination environmental and genetic factors. 
Geography 
The incidence and prevalence of MS are not equal across all global populations. Rather, 
there is a strong association to geography in which generally, in which MS cases 
increase in frequency with increasing distance from the equator (Compston and Coles, 
2008; Kurtzke, 1975, 1993). However, while this geographical rule can be used to 
generalise the world population, there are exceptions which appear to be linked to the 
geographical origins of the populations involved. 
In general, MS is more pervasive in populations of northern European origin, however, 
there is evidence that the geographical region in which individuals reside during early 
life also contributes to their MS risk (Compston and Coles, 2008; Goodin, 2016b). Studies 
of immigration to regions of varying MS prevalence including the UK (Elian et al., 1990), 
South Africa (Dean and Kurtzke, 1971), Hawaii (Detels et al., 1977), Israel (Alter et al., 
1962), and Australia (Hammond et al., 2000) have found the geographical region of an 
individual’s formative years (up to the age of around 15 (Hammond et al., 2000)), to be 
a stronger predictor of MS risk than the geographical region to which an individual 
migrates as an adult.    
Viral Infection 
It has been postulated that the initiation of the biological dysregulation which leads to 
MS pathology may be the result of viral infiltration. There is evidence that this correlation 
may be exacerbated by a lack of microbial and/or viral infection during early life. The 
‘hygiene hypothesis’ proposes that individuals raised in a fastidiously clean 
environment, thus less exposed to minor infections in early life, are more likely to 
contract autoimmune disorders including MS (Compston and Coles, 2008). A range of 
infections regularly contracted in early childhood including the Epstein-Barr virus and 
measles, mumps and rubella have been reported to be first contracted later in MS 
patients than in HLA-DR2 matched controls (Martyn et al., 1993).  
A molecular basis for the association between MS and these early life infections has been 
found in the case of the Epstein-Barr virus. A 2003 study demonstrated that the T-cell 
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receptor (TCR) of an MS patient, recognized both myelin basic protein (MBP) and an 
Epstein-Barr virus peptide (Lang et al., 2002). On Epstein-Barr infection, T-cells reacting 
to the presence of viral particles may potentially attack MBP within the myelin sheath, 
resulting in demyelination.  
Further evidence of the role of Epstein-Barr infection in the triggering of MS has also 
been found in a 2007 study of post mortem tissue samples from secondary progressive 
MS patients (Serafini et al., 2007). In 95% of cases studied, a high proportion of brain 
infiltrating B cells were found to be enriched with Epstein-Barr Virus encoded small 
nuclear mRNAs. In addition, metanalyses found that patients with a history of infectious 
mononucleosis, a common complication of Epstein-Barr virus  infection, had an 
increased risk of developing MS (Handel et al., 2010; Sundqvist et al., 2012).  
Nearly 100% of MS patients have been found to test positive for Epstein-Barr virus 
infection (Burnard et al., 2017), with one study reporting 100% seroconversion prior to 
MS diagnosis (Levin et al., 2010). However, no study has as yet established whether 
Epstein-Barr infection directly causes MS, or if Epstein-Barr susceptibility is simply a 
side effect of the alterations in the immune system which ultimately lead to MS (Burnard 
et al., 2017).   
A major caveat of the association of Epstein-Barr infection with MS, is that as many as 
90% of the human population are infected with the virus (Gao et al., 2006), but only a 
very small proportion develop MS. It has been suggested that the random integration of 
viral genetic material into the host cell genome (Santpere et al., 2014; Takakuwa et al., 
2004), could result in the disruption of protein coding genes, or epigenetic alterations to 
MS associated loci which are yet to be identified, although this hypothesis has not yet 
been tested (Burnard et al., 2017).   
Other pathogenic infections implicated in triggering MS pathology include typhoid, 
smallpox, herpes virus(HHP)-6, chickenpox and chlamydia. Although no single infecting 
agent solely responsible for MS has been identified thus far (Compston and Coles, 2008). 
Regardless of the pathogen implicated, not all infected individuals go on to develop MS, 
suggesting any pathogenic trigger must be coupled with additional enivironmental 
and/or genetic factors.  
 
Genetic 
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As previously mentioned, the genetic relatives of MS patients, have a greater risk of 
developing the disorder than the general population. With brothers or sisters of MS 
probands with a 20-30 fold increase in risk and more than a 200 fold increase for 
monozygotic twins (Goodin, 2016b). In addition, the association of MS with populations 
of northern European origin (as iterated above), suggests that genetic factors may also 
be involved. 
In recent years, advances in high throughput sequencing and bioinformatics have 
facilitated the identification of MS associated loci through genome-wide association 
studies. In this way a strong link between the MS susceptibility and polymorphisms in 
the Major Histocompatibility Complex gene set in addition to 103 other MS associated 
loci, however, identified genetic risk factors contribute only around 30% of total MS risk 
(Burnard et al., 2017; Hollenbach and Oksenberg, 2015). 
Environmental 
While genetic risk factors are likely to contribute to the increased risk of development in 
MS for related individuals, effects relating to the external environment to which 
individuals are exposed have also been postulated as a possible cause of MS, this is 
thought to contribute to the geographical pattern mentioned earlier (Goodin, 2016b). 
One proposed explanation is the, ‘month of birth’ effect, which postulates that individuals 
gestated during the winter months, have a greater likelihood of developing MS. A 
phenomenon reported in Denmark (Templer et al., 1992), Norway (Torkildsen et al., 
2014), Northern Europe, Canada (Sadovnick et al., 2007; Willer et al., 2005) and Australia 
(Staples et al., 2010). A proposed reason for this, is reduced maternal exposure to light, 
resulting in decreased vitamin D availability in utero (Chaudhuri, 2005; Goodin, 2016b; 
Willer et al., 2005). 
Further evidence for the vitamin D hypothesis is the correlation between increased 
dietary vitamin D and low MS incidence in isolated populations within geographical 
regions of otherwise high MS incidence. Dietary sources of vitamin D in high enough 
quantities to make an impact are restricted to a limited number of animal species 
including reindeer and oily fishes (Gillie, 2006). One of these low risk populations is the 
Inuit of North America and Faroe islanders of northern Europe (Sinclair, 1977), whose 
diets include large quantities of vitamin D rich oily fish, and the other is the Sami or Lapps 
of northern Scandinavia whose diet is largely dependent on vitamin D rich reindeer 
(Gillie, 2006; Grønlie et al., 2000; Koch-Henriksen, 1995). 
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An extensive study of sun exposure in Tasmanian MS patients found a strong correlation 
between MS susceptibility and sun exposure between the ages 6 and 15 (no data was 
generated from birth to 5 years old) (van der Mei et al., 2003). In addition, other 
longitudinal studies have found vitamin D intake (whether from exposure to sunlight, 
dietary supplements or a combination of the two) to be inversely correlated with MS 
diagnosis (Munger et al., 2004, 2006). 
In summary, while a number of factors have been discussed as the cause of MS, no single 
factor has yet emerged as the sole origin. With evidence pertaining to so many 
possibilities, a complex epidemiology comprised of multiple contributing factors appears 
more likely. In the absence of an identified pathological root, the development of 
treatment based on the molecular pathology of the already advancing disease course is 
of even greater importance.  
At present no regenerative therapies have been developed for the demyelinating 
disorder Multiple Sclerosis (MS). While anti-inflammatory treatments are available for 
the relapsing and remitting form of the disease, these treatments are not effective in 
preventing disease progression toward the degenerative phase of the disease in the long 
term.  
The Williams lab have previously demonstrated the absence of OPCs in some MS lesions, 
particularly chronic active lesions in which the OPC chemorepellent Sema3A is highly 
expressed (Boyd et al., 2013a). Using our mouse model of focal demyelination in the 
corpus callosum (CC), it was also discovered that recruitment of OPCs to demyelinating 
lesions can be improved by the administration of OPC chemoattractant Sema3F or 
reduced by the addition of OPC chemorepellent Sema3A. These results illustrated a clear 
role for modulators of OPC migration in the regeneration of demyelinated lesions.  
The purpose of this thesis was to improve understanding of the role of OPC migration in 
regeneration by identifying novel modulators of OPC biology in demyelinating injury. By 
bioinformatic analysis of previously published gene expression array data from models 
of demyelination, I successfully identified factors secreted at the injury site, and cell 
surface receptors expressed by OPCs following demyelination. I also optimised the X-
celligence RTCA CIM system as an assay for the simultaneous study of the migration, 
proliferation and differentiation of OPCs in vitro. I then brought these two aspects of the 
project together, to study the effects of factors secreted after demyelinating injury on the 
biology of OPCs in vitro. In this way, I identified and verified the OPC proliferation factor 
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LCN2, the OPC migration factor CXCL12 and finally CX3CL1(fractalkine) which functions 
as chemoattractant for OPCs at a low concentration and differentiation factor for OPCs 
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6.1 CX3CL1 – A Single Molecule Modulates Both the Inflammatory Microglial 
Response and the Reparative OPC Response After Demyelination   
While a number of modulators of OPC migration and differentiation have been 
previously described, in this thesis, a single factor with effects on both migration and 
differentiation is documented. As iterated in chapter 5, in vivo studies of these effects are 
required to fully validate these results, however a model of the activity of OPCs in 
response to CX3CL1 can be hypothesised based on the in vitro results alone. 
In their 2015 study, Lampron and colleagues used the cuprizone demyelination model 
to clearly show that the loss of the CX3CR1/CX3CL1 interaction impaired the clearance 
of myelin debris by microglia (Lampron et al., 2015). Taken with my results, these 
findings paint a picture of a single molecule with the ability to orchestrate the migration 
of both OPCs and microglia.  
As shown in figure 6.1, the model of action I propose for CX3CL1 in focal demyelinating 
injury incorporates both the clearance of debris by microglia and the repair of damaged 
myelin by differentiating OPCs. In the uninjured CNS, the myelin sheath is maintained by 
existing oligodendrocytes which facilitate saltatory conduction and provide trophic 
support to the axons, while OPCs and microglia appear quiescent (see figure 6.1a)). As 
shown in figure 6.1b), following a demyelinating insult, myelin debris is present at the 
lesion site, and the denuded axon, and perhaps activated astrocytes, upregulate the 
release of CX3CL1, both by increased gene expression and by cleavage of the CX3CL1 
chemokine domain. CX3CL1, released from the lesion site, diffuses through the CNS and 
stimulates both OPCs and microglia by binding to CX3CR1 (see figure 6.1c)). Both OPCs 
and microglia sense the gradient of CX3CL1 and migrate up the gradient towards the 
lesion site. On arrival, the solid, high concentration of CX3CL1 induces both cell types to 
cease migration, OPCs then begin to differentiate while the microglia clear myelin debris 
by phagocytosis (see figure 6.1d)). In this way, the OPCs differentiate into mature 
oligodendrocytes, which can access the denuded axon in the absence of any myelin 
debris and reform the myelin sheath, thus protecting the axon from degeneration (see 
figure 6.1e)).  
Figure 6.1f) illustrates the mechanism of gradient sensing (reviewed in Jin, 2013); an 
OPC exposed to a gradient of CX3CL1 at a low concentration senses the occupancy of 
CX3CR1 at only one end of the cell, and migrates in that direction. In the presence of a 
solid high concentration of CX3CL1, the CX3CR1 receptors over the whole cell surface 
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are occupied, and in the absence of any directional cue, the OPC stops migrating and 
differentiates.  
   
 
Figure 6.1 Proposed Mechanism of Action of CX3CL1 in CNS Regeneration a) In the healthy CNS an 
axon is wrapped by the myelin sheath formed by an oligodendrocyte. OPCs and microglia are 
quiescent. b) In demyelinating injury, the oligodendrocyte and myelin are destroyed, leaving myelin 
debris. In response, the axon upregulates the release of CX3CL1. c) Continual release of CX3CL1 from 
the axon establishes a CX3CL1 gradient emanating from the injury site. CX3CL1 binds CX3CR1 on the 
leading edge of OPCs and microglia, inducing chemotaxis towards the injury site. d) On arrival at the 
site of demyelination, the high CX3CL1 concentration induces the cessation of cell migration, microglia 
phagocytose myelin debris and OPCs begin to differentiate into adult OPCs. e) Differentiation of OPCs 
into new oligodendrocytes, which reform the myelin sheath, is completed. f) In a low concentration 
gradient of CX3CL1, only CX3CR1 at the front of the OPCs become occupied by CX3CL1, the OPC senses 
the gradient and begins to migrate. At a high solid concentration of CX3CL1, all CX3CR1 on the surface 
of OPCs becomes occupied by CX3CL1. Complete receptor occupation induces OPC to stop migrating 
before differentiating into an oligodendrocyte.  
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OPCs are widely known as a motile cell type, however the question of how a quiescent 
OPC is induced to become migratory persists. The 3-fold increase in CX3CR1 expression 
in Activated as opposed to Non-activated OPCs that I reported in chapter 5 (as a result 
of my bioinformatic screen in chapter 3), suggests that response to CX3CR1 stimulation 
is a feature of Activated rather than Non-activated or quiescent OPCs. It is therefore likely 
that CX3CR1 expression on OPCs is increased in response to a damage or distress signal, 
released at the earliest stages of demyelination.  
Impact of the Expression of Both CX3CR1 and CX3CL1 on OPCs 
The results in this thesis, show that, at least in vitro, OPCs migrate in response to the 
presence of a chemotactic gradient of CX3CL1. In addition, as shown in figure 6.2 a) 
below, in my analysed results from the Moyon et al., 2015 data set, CX3CL1 is 
significantly more highly expressed in Activated OPCs, than in Non-Activated OPCs (fold 
change = 1.24, p-val = 0.0459 by unpaired t-Test). Expression of CX3CL1 in OPCs from 
non-injured tissue is also fairly high, as shown in figure 6.2b).  
 
Figure 6.2 CX3CL1 is expressed by OPCs a) Results of gene expression array analysis of the data from 
Moyon et al., 2015. Normalised expression is 1.24 times higher in Activated OPCs from cuprizone 
injured brain tissue than in Non-Activated OPCs from uninjured brain tissue (mean of 4 replicates for 
Activated OPCs and 3 replicates for Non-Activated OPCs +/- SEM, p=0.0459 by differential expression 
analysis using Limma). b) Data from RNA-seq for isolated CNS cell types from uninjured tissue, noting 
that the OPC isolate has 5% microglial contamination (Zhang et al., 2014). Expression for each cell type 
calculated as Fragments Per Kilobase of exon per Million fragments mapped (FPKM). In mice, CX3CL1 
is expressed by all cell types but is most highly expressed in neurons and OPCs. 
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There is evidence in the published literature, that migrating cells have the ability to direct 
their own migration, by altering the concentration of chemokinetic particles in their 
immediate environment (Tweedy et al., 2016). In addition to the generation of the 
bioinformatics data, in their 2015 study, Moyon et al., found that the chemokine CCL2 
stimulated chemotaxis of OPCs, and that this acceleration was increased when CCL2 was 
over expressed by the OPCs themselves (Moyon et al., 2015). With the preliminary 
evidence that CX3CL1 is expressed by OPCs, it is possible that these cells may be using 
the secretion of the chemokine to regulate their own migration. If self-secretion of 
CX3CL1 by OPCs follows a similar pattern to that observed for CCL2, it is possible that 
migrating OPCs might secrete CX3CL1 in order to accelerate their migration. However, 
the results in this thesis show that high abundance of CX3CL1 induces the accelerated 
differentiation of OPCs into oligodendrocytes. It could therefore be extrapolated that 
expression of CX3CL1 by OPCs arriving at the demyelinated lesion site, might function as 
a mechanism to drive their differentiation. Thus, accelerating the repair of the lesion, 
though facilitating remyelination.  Investigation of such a phenomenon, is certainly 
dependent on the confirmation of expression of CX3CL1 on actively migrating OPCs in 
the vicinity of a demyelinated lesion in vivo. Confirmation of CX3CL1 expression, could 
be achieved by immunostaining of tissue sections from LPC lesioned tissue, for co-
expression of CX3CL1 with OPC markers such as PDGFα or NG2.  
Neonatal vs Adult OPCs 
A caveat with the experimental design in this thesis, is that the bioinformatics data 
analysed in chapter 3 is from studies in adult tissue, while the OPC cells used for the in 
vitro  experiments in chapter 4 and chapter 5, is from neonatal OPCs. As described in 
chapter 2, in this thesis, relatively pure cultures of OPCs were produced using the shake-
off method first described by McCarthy and de Vellis in 1980, and refined by Milner and 
ffrench-Constant in 1994. In the 1994 study, the authors found that by extended culture, 
the 10% oligodendrocyte 90% OPC culture at 4 hours post shake-off, had differentiated 
into a 95% oligodendrocyte culture by day 10. While this capacity to readily differentiate 
into adult OPCs, makes post shake-off OPCs well suited to the study of factors thought to 
improve OPC maturation, it must be considered that this cultured cell population may 
not accurately reflect the behaviour of OPCs in vivo. However, transplanted OPCs 
produced using the shake-off method, have been shown to effectively myelinate myelin 
deficient ex-vivo cortice tissue (Bin et al., 2012).  
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It is likely that there is some difference in gene expression between the in vivo derived 
OPCs in the Moyon et al., 2015 data set and the post shake-off OPCs used in the in vitro 
experiments in this thesis. However, one of the major findings from Moyon et al., 2015, 
was that the gene expression profile of activated OPCs (derived from globally 
demyelinated, injured tissue) was more similar to the gene expression profile of neonatal 
OPCs, than to OPCs from uninjured tissue (Moyon et al., 2015). This suggests, that 
although post shake-off OPCs are derived from neonatal tissue, the cells may closely 
resemble OPCs active in the repair of adult demyelinated tissue. Regardless of the 
similarity of post shake-off OPCs to OPCs actively repairing adult tissue, the in vitro 
results described herein will need to verified with in vivo experiments investigating the 
expression of CX3CR1 and response to CX3CL1, of in situ OPCs in injured tissue.  
As mentioned in chapter 3, the Huang, Jarjour et al., 2011 data set could be improved by 
expansion into earlier time-points than 5 days post lesion, and with the addition of an 
uninjured control, perhaps with the use of RNA-seq to detect more nuanced gene 
expression changes. In an approach, similar to the one I developed in chapter 3, secreted 
factors highly expressed at the earliest post-lesion time-points, as compared to uninjured 
controls, could be matched with cell surface receptor genes, this time more highly 
expressed in Non-activated as opposed to Activated OPCs. Candidate secreted factors 
could then be added to Non-activated OPCs in vitro, and tested for alterations in gene 
expression (perhaps with a panel of the most differentially expressed genes between 
activated and Non-activated OPCs) by qPCR, microarray or RNA-seq, to find out if 
administration of the secreted factor triggered modification of OPCs to an activated 
phenotype.  
It is also possible that CX3CR1 expression in Non-activated OPCs might be increased in 
response to stimulation by CX3CL1 in a positive regulation loop. In my experiments with 
post shake-off OPCs, I found no evidence of increase CX3CR1 expression in response to 
the addition of CX3CL1(see figure 5.5). However, given their background motility and 
ease of differentiation in vitro, it is likely that post shake-off OPCs represent a somewhat 
activated population in which the expression of CX3CR1 is already high. It has been 
shown that the CX3CR1/CX3CL1 interaction can be used in cell-to-cell adhesion, through 
CX3CL1 in its membrane bound form. CX3CR1/CX3CL1 mediated adhesions are 
preferentially released on the addition of the secreted chemokine domain of CX3CL1 
(Imai et al., 1997). It is therefore possible that quiescent/Non-activated OPCs in the CNS 
parenchyma might use CX3CR1/CX3CL1 interactions to adhere to neighbouring cells, 
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preferentially breaking these adhesions in response to the secreted chemokine domain 
of CX3CL1, thus priming OPCs for migration. This would make CX3CL1 an inducer of not 
only OPC migration and differentiation, but also activation. Such an effect could be tested 
in vitro, by the addition of CX3CL1 to Non-activated OPCs and analysis to look for 
substantial changes of gene expression by qPCR, microarray or RNA-seq. 
In addition to the question of how OPCs are induced to migrate, until now it has also been 
unclear what signals, internal or external, might induce OPCs to stop migrating when 
they get to sites of injury. My in vitro results show that OPC differentiation is accelerated 
in response to a high solid concentration of CX3CL1 (see chapter 5.3.3). As illustrated in 
figure 6.1f), eukaryotic cells sense a ‘spatial gradient’ of chemokine through the 
occupancy of receptors along their length (reviewed in Jin, 2013). In the case of OPCs, 
directional chemotaxis in response to a gradient of chemokine e.g. CX3CL1 is induced by 
occupancy of more receptors (e.g. CX3CR1) at the front of the cell than at the back. 
However, in a high concentration of CX3CL1, complete receptor occupancy essentially 
eliminates the gradient element, and the OPC ceases chemotaxis in the absence of any 
directional cue. This may be able to be tested using a fluorescent-tagged version of a 
chemokine ligand such as CX3CL1, and high resolution live imaging, to visualise receptor 
occupancy and then cellular movement. 
It is of particular interest that the addition of a high concentration of CX3CL1 to X-
celligence RTCA CIM plates resulted in accelerated differentiation of OPCs. Due to the 
loss of gradient sensing, it might have been predicted that addition of such a high 
concentration of chemoattractant would result in the arrest of migration only. In 
contrast, my results show OPC differentiation in the presence of high concentration 
CX3CL1 earlier than expected in culture at only 16.5-18 hours (see figures 5.13b), 
5.14b)), more akin to the level of OPC differentiation at 50 hours in primary culture with 
Sato media only (see figures 4.19a) and 4.22b)). This raises an interesting question as 
to whether the OPC interprets the high CX3CL1 concentration as a direct signal to 
differentiate (which reduces migration), or as a direct signal to cease migration (followed 
by differentiation). In the latter case, this may suggest that cessation of migration is in 
itself a signal to differentiate, indicating that the ‘default setting’ for activated OPCs 
without a directional cue is to differentiate. However, the fact that OPCs cultured in Sato 
media only (and so in the absence of a chemotactic gradient) are highly motile and do 
not exhibit accelerated differentiation suggests that full receptor occupancy of CX3CR1 
by CX3CL1 specifically may be the direct driver of differentiation. This could be tested 
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further by adding other chemokines that are known to be chemorepellents for OPCs, 
such as Netrin-1, and determining whether high concentrations of this only prevent 
migration of OPCs, or whether this also promotes differentiation. 
Investigation of the CX3CR1/CX3CL1 axis using the Cre-Lox System 
As previously mentioned, as well as on OPCs, the CX3CR1 receptor is also expressed by 
microglia in the CNS. In their 2015 study, Lampron et al., found that in CX3CR1 knock-
out mice, the clearance of myelin debris by microglia from sites of cuprizone induced 
demyelination, was impaired (Lampron et al., 2015). However, this study also noted that 
CX3CR1 knock-out impaired the recruitment of OPCs to sites of demyelination, and thus 
did not determine whether the deleterious impact on remyelination could truly be 
attributed to loss of CX3CR1 on microglia, OPCs or a combination of the loss of functional 
CX3CR1 on both cell types. Further studies into the role of the CX3CR1/CX3CL1 axis is 
remyelination must therefore investigate the effect of CX3CR1 knock-out on microglia 
and OPCs in isolation.  
One way of studying the role of CX3CR1 in vivo, would be to use the Cre-Lox system to 
create conditional knock-out mice. Conditional gene targeting by this method, employs 
the insertion of the gene for tamoxifen inducible site-specific recombinase CreER 
(cyclization recombination) under the control of a cell specific marker gene promotor 
sequence, coupled with floxing of an essential exon of the gene to be knocked out 
(reviewed in Feil et al., 2009). 
In the case of targeted CX3CR1 knock-out, mouse lines with tamoxifen inducible CreER 
could be placed under the control of the gene for either PDGFrα in the case of OPCs or 
CD68 in the case of microglia. These inducible Cre mouse lines could then be crossed 
with a CX3CR1 floxed line. In the resulting progeny, on the administration of tamoxifen 
CreER PDGFrα/floxed CX3CR1 mice could be induced to knock out CX3CR1 specifically 
in OPCs on, while CreER CD68/floxed CX3CR1 mice could be induced to knock out 
CX3CR1 specifically in microglia. In vivo, concurrent tamoxifen administration with the 
induction of a demyelinated lesion using LPC in the CreER PDGFrα/floxed CX3CR1 and 
CreER CD68/floxed CX3CR1 mice, could then be used to investigate the behaviour of 
CX3CR1 deficient OPCs or microglia in isolation. Fluorescent microscopy using PDGFrα 
and CD68 antibodies in conjunction with CX3CR1 antibodies, could be used to study 
the activity of OPCs and microglia in demyelinating lesions in the absence of CX3CR1.  
From this experimental design, it would be interesting to establish whether 
CX3CR1+ve OPCs effectively migrate into LPC induced lesion sites and differentiate 
upon arrival, in the absence of CX3CR1+ve microglia. Conversely, it would be 
interesting to determine whether effective myelin clearance by CX3CR1+ve microglia 
in the absence of CX3CR1+ve OPCs, is enough to restore efficient remyelination. 
Bearing in mind the data from Lampron et al., 2015 showing that loss of CX3CR1 results 
in insufficient clearance of myelin debris by microglia and impaired recruitment of 
OPCs following demyelination, it can be hypothesized that active CX3CR1 is required 
on both microglia and OPCs for efficient myelination.  
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6.2 Similarity of the effects of CX3CL1 and CXCL12 on OPCs 
In previously published literature, a number of other factors have been found to improve 
the migration or differentiation of OPCs in models of CNS demyelination. Foremost 
amongst these are CCL2 and IL1β, both of which improve the migration, but not 
differentiation of OPCs (Moyon et al., 2015). As previously highlighted in chapter 1.4.3, 
other factors shown to be chemoattractants for OPCs include FGF-2 (Clemente et al., 
2011), PDGFα (Redwine and Armstrong, 1998; Zhang et al., 2004), prostacyclin 
(Takahashi et al., 2013) and Semaphorin-3F (Piaton et al., 2011; Williams et al., 2007), 
while OPC chemorepellents include Anosmin-1 (Clemente et al., 2011; Murcia-Belmonte 
et al., 2016), Netrin-1 (Jarjour et al., 2003) and Semaphorin-3F (Piaton et al., 2011; 
Williams et al., 2007). However, none of these factors have been shown to improve the 
differentiation of OPCs in the regeneration of demyelinating injury. 
In contrast, factors modulating the differentiation of OPCs into oligodendrocytes have 
also been identified, LINGO-1 for example, has been shown to inhibit the differentiation 
of OPCs in the spinal cords of EAE mice (Mi et al., 2005), with antagonism of this factor 
improving both OPC differentiation and remyelination following injury (Mi et al., 2009). 
On the other hand, factors which improve OPC differentiation into adult 
oligodendrocytes, thus improving remyelination following demyelination. As previously 
mentioned, the major finding from the Huang, Jarjour etl., 2011 paper from which the 
transcriptomic data analysed in chapter 3.2, was that RXR-γ was expressed by OPCs 
during remyelination, and that Knockdown of RXR-γ by RNA interference or RXR-specific 
antagonists resulted in markedly impaired differentiation of OPCs and consequently, 
myelination.  
As noted in chapter 4.6.7, the secreted factor CXCL12, has been found to improve the 
proliferation and differentiation of OPCs during remyelination, and act as a 
chemoattractant for OPCs during development (Dziembowska et al., 2005; Patel et al., 
2012; Williams et al., 2014).  
However, while the secreted factors stated above have all been found to modulate the 
behaviour of OPCs, no single factor has yet been identified which promotes both the 
migration and differentiation of OPCs following demyelinating injury. There is strong 
evidence that both the differentiation and migration of OPCs are impaired in MS lesions 
(Boyd et al., 2013b; Kuhlmann et al., 2008; Shen et al., 2008; Sim et al., 2002; Wolswijk, 
1998; Woodruff et al., 2004). The data in this thesis documents both the expression of 
CX3CL1 during remyelination, and its ability to improve both the migration and 
differentiation of OPCs in vitro. This ability to improve both regeneratively essential 
processes makes CX3CL1 an attractive candidate for further studies and as a putative 
possibility for future regenerative therapy. Targeting of the CX3CL1/CX3CR1 axis, has 
the scope to improve both processes simultaneously, delivering both increased numbers 
of OPCs to the lesion site, and effectively stimulating their differentiation on arrival.  
As described earlier, another factor that I investigated was CXCL12 or SDF-1. In LPC-
induced focal brain demyelination, from the Huang, Jarjour et al., 2011 dataset, CXCl12 
has an extremely similar expression pattern to CX3CL1 (see figures 4.28, and 5.6). Also, 
in the Moyon et al., 2015 cuprizone demyelination data set, CXCR4, (the receptor 
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principally responsible for the activation of downstream signalling in response to 
CXCL12) is more highly expressed in activated OPCs as compared to non-activated OPCs, 
similarly to CX3CR1, although with a much smaller fold-change (see figures 4.29 and 
3.5).  CXCL12 has previously been demonstrated to be a proliferation and differentiation 
factor for OPCs (Patel et al., 2012) and my X-celligence RTCA CIM results show that 
CXCl12 is also a chemoattractant for OPCs (see figure 4.31).  
The similarities in my results for these two factors suggests that they are similarly 
important in the regulation of OPC directed regeneration.  Indeed, it has been previously 
shown that increased binding of CXCL12 to CXCR4 results in an increase in mature 
oligodendrocytes in demyelinated lesions (Williams et al., 2014). However, a major 
complication with the CXCL12 system is the activity of a second cell surface receptor 
CXCR7. Unlike CXCR4, CXCR7 does not actively trigger any downstream signalling 
cascades, and so the binding of CXCL12 to CXCR7 does not induce dynamic cellular 
processes in OPCs such as cell migration, proliferation or maturation. CXCR7 sequesters 
and internalises CXCL12, indirectly controlling the activation of dynamic cell processes 
by limiting the availability of CXCL12 for CXCR4 binding. This dual receptor system 
naturally complicates the development of any potential treatment involving CXCL12 
since effective augmentation of CXCL12 mediated regeneration would require the 
simultaneous agonism of CXCR4 and antagonism of CXCR7 (Williams et al., 2014).  
In addition, according to the Barres database (Zhang  et al., 2014) CXCL12, CXCR4 and 
CXCR7 are all highly expressed in endothelial cells suggesting that intervention into this 
system might impact endothelial cell biology, which may not be beneficial. Taking these 
limitations into account, it is clear that CX3CL1/CXC3CR1 makes a much more attractive 
drug target, requiring only the agonism of a single receptor, without the complication of 
endothelial disruption. It is possible that there may be some redundancy in the function 
of CX3CL1 and CXCL12 and it would be interesting to know if administration of the two 
factors together, or the knock-out of both CX3CR1 and CXCR4, would seriously impact 
remyelination. 
6.3 Targeting the CX3CR1/CX3CL1 Axis as a Treatment for MS 
As mentioned above, current treatments for MS are focussed on treating the 
inflammatory attacks associated with the relapsing and remitting phase of the disease 
course. Although no regenerative therapy is currently commercially available, clinical 
trials in human patients are underway.  
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As previously mentioned, abundance of the protein LINGO-1 has been shown to reduce 
OPC differentiation in the spinal cord (Mi et al., 2005), and antagonism of LINGO-1 has 
been found to increase OPC differentiation and remyelination following LPC induced 
demyelination (Mi et al., 2009). In phase 2 clinical trials, treatment of relapsing and 
remitting and/or secondary progressive MS patients with intravenous infusions of an 
anti-LINGO-1 antibody had mixed results. A SYNERGY trial found no improvement in 
physical or cognitive function in patients. In contrast, a RENEW trial focussing 
exclusively on patients with a single episode of acute optic neuritis, found improvement 
in optic nerve signalling in patients after 6 intravenous treatments of anti-LINGO-1 
antibody (https://www.mssociety.org.uk/node/690821, ClinicalTrials.gov Identifier: 
NCT01721161).  
Another potential therapy is the antihistamine Clesmastine which is being tested as a 
potential remyelinating factor in patients with relapsing and remitting MS 
(https://www.mssociety.org.uk/ms-research/treatments-in-the-pipeline/clemastine).  
Results from a stage 2 clinical trial, showed some improvement in optic nerve signalling, 
suggestive of improved myelin damage repair as a result of suppression of the immune 
response (ClinicalTrials.gov Identifier: NCT02040298). 
While clinical trials of regenerative therapies for MS are still ongoing, further research 
into the improvement of remyelination is needed to identify and implement optimal 
treatment for progressive neurodegeneration. 
An ideal MS treatment to avoid progressive neurodegeneration in MS, might consist of 
augmenting phagocytosis of microglia while controlling inflammation, coupled with 
factors targeting oligodendrocytes (Rivest, 2015).  
My data suggests that modulation of the CX3CR1/CX3CL1 axis would target OPCs as well 
as microglia. A potential treatment in the form of an agonist for CX3CR1, might therefore 
serve the dual purpose of increasing the migration and phagocytosis of debris by 
microglia, and increasing the recruitment and differentiation of OPCs.  
As mentioned in chapter 5.1, a polymorphism in CX3CR1 which reduces its binding 
affinity for CX3CL1 is associated with accelerated progression from relapsing and 
remitting to secondary progressive MS (Arli et al., 2013; Broux et al., 2012; Stojković et 
al., 2012). For treatment of MS where neurodegeneration is prominent, optimal MS 
Page 177 Catriona Ford s1059067 
treatment might combine an agonist for CX3CR1 to encourage regeneration, coupled 
with existing immunomodulators (to combat adaptive immune-driven pathology).  
Given that my results show that the formation of chemotactic gradients is fundamentally 
important for the directional migration of OPCs, a more measured approach might be to 
identify and target the upstream regulators of CX3CL1 expression in neurons or 
astrocytes, or to increase the cleavage of the chemokine domain of CX3CL1 at the lesion 
site. Both of these approaches would result in an increase in local CX3CL1 expression at 
the lesion site, which could then diffuse outward to recruit OPCs and microglia.  
However, some negative effects of the CX3CL1/CX3CR1 axis in MS associated biology 
have also been reported. Increased CX3CL1 has been found in the CSF of MS patients, and 
is thought to be involved in the recruitment of inflammatory T-cells. Administration of 
CX3CL1 to T-cells derived from relapsing and remitting MS patients, has also been shown 
to increase the expression of inflammatory cytokines IFN-γ and TNFα in (Blauth et al., 
2015). CX3CR1+ T-cells have also been shown to follow a gradient of CX3CL1 into sites 
of inflammation and may even kill oligodendrocytes in active MS lesions (Broux et al., 
2012). A 2014 study also found that subcutaneous injection of a CX3CR1 inhibitor, 
reduced disease pathology in EAE rats(Ridderstad Wollberg et al., 2014). However, very 
little of the CX3CR1 inhibitor crossed the blood brain barrier, and the EAE ameliorating 
effect was thought to be the result of blocking the invasion of circulating leukocytes.  
To circumvent these issues, any direct or indirect pharmaceutical modulation of the 
CX3CR1/CX3CL1 axis would require nuanced targeting of OPCs or injured neurons, 
crossing the blood brain barrier. In a previous study, the Williams group used 
nanoparticles with NG2 surface antibodies to target delivery of LIF to OPCs and 
improved remyelination by increasing OPC differentiation in vivo (Rittchen et al., 2015). 
It is therefore possible to envisage a treatment either targeting a CX3CR1 agonist to OPCs 
or targeting distressed neurons with an upstream inducer of CX3CL1 expression. This 
delivery system has both the advantages of targeting specific cells and being small 
enough to cross the blood brain barrier. 
Treatments targeting the CX3CR1/CX3CL1 axis could also be used in the treatment of 
other pathologies. Another injury type which features demyelination is contusion spinal 
cord injury and there is evidence that the transplantation of myelinating cells into spinal 
cord injuries may improve regeneration (reviewed in Myers et al., 2016). In contrast to 
the difficulties in the delivery of pharmaceuticals to MS lesions due to multiple lesions 
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occurring over a considerable timespan, treatments utilising an agonist of CX3CR1 could 
be administered directly into the heart of the spinal cord traumatic lesion site.  
However, it must be noted that, regardless of the mode of delivery, direct injection of 
CX3CL1 or CX3CR1 agonists into the CNS carries considerable risk of off-target effects. A 
more nuanced option, might be to upregulate endogenous expression of CX3CL1 and/or 
CX3CR1 by intralesional injection of lentiviral vectors. Such experiments could be carried 
out in a similar fashion to the overexpression of Semaphorin 3A and Semaphorin 3F 
(Piaton et al., 2011), and Netrin-1 (Tepavčević et al., 2014). Loss of function experiments 
knocking down CX3CL1 or CX3CR1 using siRNAs (short interfering ribonucleic acids), 
could also be used to confirm the importance of the CX3CR1/CX3CL1 axis during 
remyelination.  
6.4 Conclusion 
In this thesis, I combined bioinformatic data analysis and in vitro laboratory techniques 
to identify and verify novel mediators of OPC biology. Using these methods, I have 
created a data resource to make the data accessible to other researchers and identified a 
single factor which modulates both the migration and maturation of OPCs in vitro.  
In conclusion, this thesis represents a body of work which extends current knowledge of 
OPC biology in vitro, and while these results require further verification in in vivo models 
of demyelination, the CX3CR1/CX3CL1 interaction presents a novel possible opportunity 
for the development of regenerative therapies for MS.  
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Abbreviations 
Abbreviation Definition 
WT Wild Type 
VPN Virtual Private Network 
VEGF Vascular Endothelial Growth Factor  
TUNEL Terminal deoxynucleotidyl transferase dUTP nick end labelling 
TNFα Tumour Necrosis Factor Alpha 
TBST Tris Buffered Saline 
SVZ Sub-ventricular Zone 
strep Streptomycin 
Srebf1 Sterol Regulatory Element Binding Transcription Factor 1 
SRA Sequence Read Archive 
SP Secondary Progressive 
Sox10 SRY-Box 10  
Shh Sonic Hedgehog 
Sema Semaphorin 
SEM Standard Error of Mean 
SDS Sodium Dodecyl Sulphate 
RXR-γ  Retinoic acid receptor gamma 
RT-PCR  Reverse Transcription Polymerase Chain Reaction 
RTCA Real-Time Cell Analysis  
RT Room Temperature 
RR Relapsing and Remitting 
RPM Revolutions Per Minute 
RNA-seq Ribonucleic Acid Sequencing 
RNA Ribonucleic Acid 
RIPA Radioimmunoprecipitation Assay  
qPCR Quantitative Polymerase Chain Reaction 
PVDF Polyvinylidene Fluoride  
PTPRZ1 Protein Tyrosine Phosphatase, Receptor Type Z1 
PTPRZ1 Receptor Tyrosine Phosphatase Z1  
PNS Peripheral Nervous System 
PNG Portable Network Graphic 
PLP Proteolipid Protein 




PDL poly-D-lysine  
PDGFα Platelet Derived Growth Factor Alpha 
PDGFRα Platelet Derived Growth Factor Receptor Alpha 
PCNA Proliferating Cell Nuclear Antigen 
PCA Principal Component Analysis 
PC Principal Component 
PBST PBS + 0.05% tween 
PBS Phosphate-Buffered Saline 
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Pax7 paired box protein 7  
OPC Oligodendrocyte Precursor Cell 
Olig2 Oligodendrocyte Lineage Transcription Factor 2 
oC Degrees Centigrade 
Ntrk3 Neurotrophic Receptor Tyrosine Kinase 3 
NSCs Neural Stem Cells 
NG2 Neuron-Glial Antigen 2  
NAWM Normal-appearing White Matter 
Msx3 murine msh homeobox 3  
MS Multiple Sclerosis 
mRNA Messenger Ribonucleic Acid 
MRI Magnetic Resonance Imaging 
MOG myelin oligodendrocyte glycoprotein  
ml Millilitre 
MHCII Major Histocompatibility Class II 
MGE Medial Ganglionic Eminence  
mg Milligram 
MEM Minimum Essential Medium 
MBP Myelin Basic Protein 
MAG myelin associated glycoprotein  
Ltbr Lymphotoxin beta receptor 
LPC Lysophosphatidylcholine 
LINGO-1  Leucine rich repeat and Immunoglobin-like domain-containing protein 1 




JSON JavaScript Object Notation 
js JavaScript  
IUPHAR International Union of Basic and Clinical Pharmacology  
ITS Insulin-transferrin-sodium selenite media supplement 
IP Receptor Prostacyclin receptor  
IL1β Interleukin-1β 
IFNγ Interferon Gamma 
ICC Immunocytochemistry 
HUVECS Human Umbilical Vein Endothelial Cells 
HTML HyperText Markup Language 
HIHS Heat Inactivated Horse Serum 
HGF Hepatocyte Growth Factor  
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid  
GUI Graphical User Interface 
Gsh2 genetic screened homeobox protein 2  
Grm5 Glutamate Metabotropic Receptor 5 
GFP Green Fluorescent Protein 
GFAP Glial fibrillary acidic protein  
GEO Gene Expression Omnibus 
GAPDH Glyceraldehyde 3-phosphate dehydrogenase  
Fzd1 Frizzled Class Receptor 1 
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FPKM Fragments Per Kilobase of exon per Million fragments mapped  
FIJI Fiji Is Just ImageJ 
Fgfr1 Fibroblast Growth Factor Receptor 1 
FGF8 Fibroblast growth factor 8  
FGF2 Fibroblast Growth Factor 2 
FBS Foetal Bovine Serum 
Emx1 Empty Spiracles Homeobox 1 protein  
EGF Epidermal Growth Factor  
ECM Extracellular matrix  
ECL Enhanced Chemoluminescence 
EAE Experimental Autoimmune Encephalitis  
EAE Experimental Autoimmune Encephalomyelitis 
dpl Days Post lesion 
DNA Deoxyribonucleic Acid 
DMEM Dulbecco’s modified Eagle medium 
DCC Deleted in Colorectal Cancer  
DBX1 developing brain homeobox 1 
Darc Duffy antigen receptor for chemokines  
CXCR7 C-X-C chemokine receptor type 7 
CXCR4 C-X-C chemokine receptor type 4 
CXCL12 C-X-C motif chemokine 12  
CX3CR1 CX3C chemokine receptor 1 
CSV Comma-separated Variables 
CSS Cascading Style Sheets 
CSF Cerebrospinal Fluid 
CO2 Carbon Dioxide 
CNTN1 Contactin-1 
CNS  Central Nervous System 
CNP 2’,3’-Cyclic nucleotide 3’-phosphodiesterase 
cm Centimetre 
CIM Cell Invasion Migration 
CI Cell Index 
CGI Common Gateway Interface 
CD68 Cluster of Differentiation 68 
CD4 Cluster of Differentiation 4 
CD28 Cluster of Differentiation 28 
CCP Caudal Cerebellar Peduncle 
CCL2 Chemokine (C-C motif) ligand 2  
CC Corpus Callosum 
BSA Bovine Serum Albumin 
BPS British Pharmacological Society 
BCA Bicinchoninic Acid Assay  
BBB Blood Brain Barrier 
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Appendix 1. Rotations from Principal Component Analysis 
Huang, Jarjour et al., 2011 Data 
The following tables detail the 10 genes which contribute most to each of the principal 
components identified for this data set (see Chapter 3.2.3).  
A ninth principal component was also identified, but this has been omitted here because with 
a standard deviation of 1.673e-13, its contribution to overall variance is negligible (see 
appendix figure 1).  
 
Appendix figure 1. Percentage of variance between arrays in Huang, Jarjour et al., 2011 
data captured by each principal component PC1captures most of the variation and PC2-PC8 
each capture a smaller portion of the variation, PC9 captures almost no variation. 
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Gene Names and Gene Descriptions are taken from the annotation file for the Illumina 
ratRef-12 v1.5.0.34 expression bead chip (GEO Accession: GPL8031). Blank cells indicate 
features which were not fully annotated for this chip release.  
 
Principal Component 1  - Accounting for 29.51 % of variance between arrays 
Gene Name Gene Description 
Contribution to 
Variation 
 (scale -1 to 1) 
Vps36 vacuolar protein sorting 36 homolog (S. cerevisiae) 0.012282536 
Ier3 immediate early response 3 0.012243057 
Sh3bgrl3 SH3 domain binding glutamate-rich protein like 3 0.012222004 





Nipsnap3b nipsnap homolog 3B (C. elegans) 0.012218185 
Naaa N-acylethanolamine acid amidase 0.012201257 
Iqgap3 IQ motif containing GTPase activating protein 3 0.012193254 
Ddx3x DEAD (Asp-Glu-Ala-Asp) box helicase 3, X-linked 0.012184154 
Emg1 EMG1 N1-specific pseudouridine methyltransferase 0.012182846 
 
 
Principal Component 2  - Accounting for 13.24 % of variance between arrays 
Gene Name Gene Description 
Contribution to 
Variation 
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 (scale -1 to 1) 
Aig1 androgen-induced 1 0.017414378 
Ubac1 UBA domain containing 1 0.017391747 
Lbx1 ladybird homeobox 1 0.017339586 
Plekhm2 
pleckstrin homology domain containing, family M 
(with RUN domain) member 2 
0.017248307 
Gripap1 GRIP1 associated protein 1 0.016966322 
  0.01678169 
Olr237 olfactory receptor 237 0.016649064 
Tmem106c transmembrane protein 106C 0.016648837 
Nmrk1 nicotinamide riboside kinase 1 0.016646606 
  0.016604328 
 
 
Principal Component 3  - Accounting for 11.81 % of variance between arrays 
Gene Name Gene Description 
Contribution to 
Variation 
 (scale -1 to 1) 
Vom2r28 vomeronasal 2 receptor, 28 0.018141498 
Cdr2l cerebellar degeneration-related protein 2-like 0.018016473 
Tmem129 transmembrane protein 129 0.017878401 
Sp6 Sp6 transcription factor 0.017874195 
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  0.01779482 
Ltbp1 
latent transforming growth factor beta binding 
protein 1 
0.017647227 
Kdm4c lysine (K)-specific demethylase 4C 0.017526853 
Nupl1 nucleoporin like 1 0.017512411 
  0.01750277 
Olr299 olfactory receptor 299 0.017495608 
 
Principal Component 4  - Accounting for 11.11 % of variance between arrays 
Gene Name Gene Description 
Contribution to 
Variation 
 (scale -1 to 1) 
  0.019421642 
  0.019176375 
  0.019122428 
Sema3d 
sema domain, immunoglobulin domain (Ig), short 
basic domain, secreted, (semaphorin) 3D 
0.01905317 
Ttl tubulin tyrosine ligase 0.01898213 
Wfdc6b WAP four-disulphide core domain 6B 0.018889488 
  0.018717846 
Parvb parvin, beta 0.018458778 
Apc2 adenomatosis polyposis coli 2 0.018369191 
  0.018286988 
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Principal Component 5  - Accounting for 10.32 % of variance between arrays 
Gene Name Gene Description 
Contribution to 
Variation 





Olr36 olfactory receptor 36 0.019757322 









Zfp108 zinc finger protein 108 0.018462245 




Principal Component 6  - Accounting for 8.56% of variance between arrays 
Gene Name Gene Description 
Contribution to 
Variation 
 (scale -1 to 1) 
  0.021155288 
  0.02100968 
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  0.020966817 
  0.020843463 
  0.020267658 
Mrpl50 mitochondrial ribosomal protein L50 0.020227086 
  0.02021823 
Lefty1 left right determination factor 1 0.02018212 
Foxn1 forkhead box N1 0.020111267 
Olr1600 olfactory receptor 1600 0.020107981 
 
Principal Component 7  - Accounting for 8.05% of variance between arrays 
Gene Name Gene Description 
Contribution to 
Variation 
 (scale -1 to 1) 
  
0.021941456 









Crocc ciliary rootlet coiled-coil, rootletin 0.020283244 
Olr103 olfactory receptor 103 0.020131155 
  
0.020039737 




Principal Component 8  - Accounting for 7.4% of variance between arrays 
Gene Name Gene Description 
Contribution to 
Variation 
 (scale -1 to 1) 
Bag4 BCL2-associated athanogene 4 0.022817024 
  
0.022597445 














Moyon et al., 2015 Data 
The following tables detail the 10 genes which contribute most to each of the principal 
components identified for this data set (see Chapter 3.3.5).  
A seventh principal component was also identified, but this has been omitted here because 
with a standard deviation of 8.668e-12, its contribution to overall variance is negligible (see 
appendix figure 2B).  
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Appendix figure 2 Percentage of variance between arrays in Moyon et al., 2015 data 
captured by each principal component Principal Component Analysis identified six Principal 
Components which contributed to the variations in the data, Principal Component 1 contributing 
17.73%, Principal Component 2 contributing 16.69%, Principal Component 3 contributing 16.39%, 
Principal Component 4 contributing 14.52%, Principal Component 5 contributing 13.26% and Principal 
Component 6 contributing 11.41% 
Gene Names and Gene Descriptions are taken from the raw data file provided for this data 
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Principal Component 1  - Accounting for 27.74 % of variance between arrays 
 
Gene Name Gene Description 
Contribution to 
Variation 
 (scale -1 to 1) 
 





Mus musculus GRAM domain containing 1B 
(Gramd1b), 
 mRNA [NM_172768] 
0.008905 
Defa-rs10 





Mus musculus synaptojanin 2 (Synj2), transcript 













Mus musculus microtubule associated 




Mus musculus SET domain containing (lysine 
methyltransferase) 7 (Setd7), mRNA [NM_080793] 
0.008842 
Trim13 
Mus musculus tripartite motif-containing 13 
(Trim13),  
 transcript variant 1, mRNA [NM_001164220] 
0.008839 
Fgfr2 
Mus musculus fibroblast growth factor receptor 2 
(Fgfr2),  
0.008839 
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Principal Component 2  - Accounting for 16.68 % of variance between arrays 
 
Gene Name Gene Description 
Contribution to 
Variation 
(scale -1 to 1) 
Timm8a1 
Mus musculus translocase of inner mitochondrial 
membrane 8 homolog a1 (yeast) (Timm8a1), nuclear 




Mus musculus Parkinson disease (autosomal recessive, 
early onset) 7 (Park7), mRNA [NM_020569] 
0.011357 
Ndufa7 
Mus musculus NADH dehydrogenase (ubiquinone) 1 












Mus musculus serine (or cysteine) peptidase inhibitor, 
clade F, member 1 (Serpinf1), mRNA [NM_011340] 
0.011247 
Spcs2 
Mus musculus signal peptidase complex subunit 2 
homolog (S. cerevisiae) (Spcs2), mRNA [NM_025668] 
0.011223 
Tpm1 
Mus musculus tropomyosin 1, alpha (Tpm1), transcript 
variant 1, mRNA [NM_001164248] 
0.011178 
 
Putative uncharacterized proteinMCG13105, isoform 
Crab ; [Source:UniProtKB/TrEMBL;Acc:Q9D5E6] 
[ENSMUST00000094228] 
0.011172 
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 Gene name and description as yet uncharacterised 0.011171 
Page 215 Catriona Ford s1059067 
Principal Component 3  - Accounting for 16.39 % of variance between arrays 
 




 (scale -1 
to 1) 
St3gal6 
Mus musculus ST3 beta-galactoside alpha-2,3-sialyltransferase 6 
(St3gal6), mRNA [NM_018784] 
0.011374 
Ccr8 








Mus musculus potassium inwardly rectifying channel, subfamily J, 
member 11 (Kcnj11), mRNA [NM_010602] 
0.011341 
LOC100047052 
PREDICTED: Mus musculus similar to Aptx protein 
(LOC100047052), mRNA [XM_001477288] 
0.011307 
Scgb3a1 
Mus musculus secretoglobin, family 3A, member 1 (Scgb3a1), 
transcript variant B, mRNA [NM_170727] 
0.011271 
Calb1 
Calbindin (Vitamin D-dependent calcium-binding protein, avian-





PREDICTED: Mus musculus predicted gene, 




Mus musculus a disintegrin and metallopeptidase domain 34 
(Adam34), mRNA [NM_145745] 
0.011193 


















Principal Component 4  - Accounting for 14.52 % of variance between arrays 
 
Gene Name Gene Description 
Contribution to 
Variation 



















Mus musculus lysosomal trafficking 
regulator (Lyst), mRNA [NM_010748] 
0.011668 
Ankfy1 
Mus musculus ankyrin repeat and FYVE 




Mus musculus titin (Ttn), transcript variant 
N2-A, mRNA [NM_011652] 
0.011627 
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Catsper4 
Mus musculus cation channel, sperm 




Mus musculus killer cell lectin-like receptor, 








Mus musculus ER degradation enhancer, 














Principal Component 5  - Accounting for 13.26 % of variance between arrays 
 
Gene Name Gene Description 
Contribution 
to Variation 
 (scale -1 to 1) 
Olfr262 




Mus musculus paired-Ig-like receptor A3 (Pira3), 
transcript variant 1, mRNA [NM_011090] 
0.012509 
Olfr1504 
Mus musculus olfactory receptor 1504 
(Olfr1504), mRNA [NM_146634] 
0.012463 
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Olfr860 




Mus musculus intercellular adhesion molecule 2 
(Icam2), mRNA [NM_010494] 
0.012445 
Lep Mus musculus leptin (Lep), mRNA [NM_008493] 0.012444 
 





Mus musculus lin-28 homolog B (C. elegans) 
(Lin28b), mRNA [NM_001031772] 
0.012342 
AW413774 
UI-M-AQ0-cix-n-17-0-UI.s1 NIH_BMAP_MHI Mus 
musculus cDNA clone UI-M-AQ0-cix-n-17-0-UI 3', 
mRNA sequence [CD775100] 
0.01234 
Prrt4 
Mus musculus proline-rich transmembrane 
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Principal Component 6  - Accounting for 11.41 % of variance between arrays 
 
Gene Name Gene Description 
Contribution to 
Variation 
 (scale -1 to 1) 
Ppfia4 
Mus musculus protein tyrosine 
phosphatase, receptor type, f polypeptide 
(PTPRF), interacting protein (liprin), alpha 
4 (Ppfia4), mRNA [NM_001144855] 
0.013687 
 





Mus musculus predicted gene 10436 
(Gm10436), mRNA [NM_001105254] 
0.013453 
Vwce 
Mus musculus von Willebrand factor C and 
EGF domains (Vwce), mRNA [NM_027913] 
0.01344 
9130023H24Rik 
Mus musculus RIKEN cDNA 9130023H24 
gene (9130023H24Rik), mRNA [NM_177001] 
0.013416 
Gm7157 
PREDICTED: Mus musculus hypothetical 




Mus musculus ribosomal protein S6 kinase 









Mus musculus 6E6 monoclonal antibody 
heavy chain variable region, (IgH) mRNA, 
partial cds. [AF045501] 
0.013258 
Gm7102 
PREDICTED: Mus musculus predicted gene, 
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Appendix 2 Secreted Factors Correlating with PDGFα 
Illumina ID Gene 
Symbol 
Log2 Fold Change Correlation 
with 
PDGFα 
d28.vs.d5 d28.vs.d14 d14.vs.d5 d14.vs.d28 d5.vs.d14 d5.vs.d28 
ILMN_56728 Pdgfα 0.757308 -0.30322 -0.21195 0.303217 0.211945 -0.75731 1 
ILMN_68952 Serinc1 0.575799 -0.23147 -0.15857 0.231474 0.158565 -0.5758 0.999991 
ILMN_52954 Ift80 1.140213 -0.47344 -0.31325 0.473439 0.313254 -1.14021 0.999908 
ILMN_53418 Ldhb 1.285169 -0.53626 -0.38314 0.536258 0.383139 -1.28517 0.9998 
ILMN_56273 Bnip3 0.844723 -0.32017 -0.24568 0.320166 0.245678 -0.84472 0.999775 
ILMN_59511 S100b 3.381442 -1.25936 -0.80733 1.259356 0.807334 -3.38144 0.99914 
ILMN_65990 Ppp1r14c 1.376483 -0.59288 -0.32966 0.592876 0.329661 -1.37648 0.998974 
ILMN_50866 Calm3 0.676841 -0.27367 -0.23161 0.273669 0.231606 -0.67684 0.998591 
ILMN_58575 Smox 0.483747 -0.17176 -0.15454 0.17176 0.154541 -0.48375 0.99854 
ILMN_53798 Fbxo2 1.171829 -0.39801 -0.34353 0.398013 0.343527 -1.17183 0.998533 
ILMN_69508 Etv1 0.754431 -0.27392 -0.25858 0.273916 0.258579 -0.75443 0.99786 
ILMN_59598 Dstyk 1.045431 -0.48887 -0.34881 0.488867 0.348805 -1.04543 0.997745 
ILMN_57362 Gstm1 0.434823 -0.17493 -0.15778 0.174927 0.157781 -0.43482 0.997513 
ILMN_63000 H3f3b 0.542029 -0.19941 -0.19352 0.199408 0.19352 -0.54203 0.997244 
ILMN_60723 Msl1 0.682511 -0.31422 -0.24517 0.314216 0.245169 -0.68251 0.996949 
ILMN_49101 Kank1 0.633886 -0.24818 -0.23654 0.248184 0.236537 -0.63389 0.996757 
ILMN_69711 Efcab2 0.613548 -0.23405 -0.22782 0.234053 0.227824 -0.61355 0.996699 
ILMN_49826 Rras2 0.624546 -0.18956 -0.17563 0.189561 0.175634 -0.62455 0.996495 
ILMN_61688 Olfml2a 0.803662 -0.29253 -0.29851 0.292528 0.298512 -0.80366 0.99621 
ILMN_56986 Scg3 2.068466 -0.63785 -0.65832 0.637849 0.658316 -2.06847 0.996067 
ILMN_63650 Ankrd46 0.573237 -0.22943 -0.22255 0.229428 0.222547 -0.57324 0.995794 
ILMN_59532 Hmces 0.513831 -0.2252 -0.19944 0.225199 0.199441 -0.51383 0.995712 
ILMN_70002 Cdh1 2.295962 -0.68206 -0.55832 0.68206 0.558315 -2.29596 0.99569 
ILMN_55045 Add3 1.234028 -0.36878 -0.38181 0.368779 0.381809 -1.23403 0.995629 
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ILMN_161762 Fsd1 0.647391 -0.21926 -0.23633 0.219257 0.236334 -0.64739 0.995557 
ILMN_60221 Sphk1 0.512689 -0.20696 -0.20107 0.206961 0.201074 -0.51269 0.995524 
ILMN_58987 Nqo1 1.080322 -0.35383 -0.38572 0.353833 0.385722 -1.08032 0.995447 
ILMN_65766 Lrrn1 0.674218 -0.19843 -0.20805 0.198426 0.208046 -0.67422 0.995284 
ILMN_50277 Lppr3 0.850471 -0.33202 -0.33687 0.332021 0.336872 -0.85047 0.995041 
ILMN_55981 Zfp191 0.822636 -0.35745 -0.32886 0.357454 0.328859 -0.82264 0.994893 
ILMN_69655 Fmo1 0.97179 -0.51131 -0.31443 0.511305 0.31443 -0.97179 0.994716 
ILMN_57630 Msmo1 1.500514 -0.43011 -0.4619 0.430105 0.461901 -1.50051 0.994645 
ILMN_57744 Fbln5 1.851357 -0.53364 -0.599 0.533641 0.598996 -1.85136 0.994249 
ILMN_52545 Fam135a 0.890648 -0.46395 -0.31566 0.463949 0.315661 -0.89065 0.994175 
ILMN_50962 Fkbp1a 0.56632 -0.16136 -0.18003 0.161362 0.180034 -0.56632 0.994166 
ILMN_60627 Wfikkn1 0.976336 -0.36007 -0.39141 0.360066 0.391411 -0.97634 0.99409 
ILMN_67767 Tars 0.488348 -0.14929 -0.17352 0.149295 0.173519 -0.48835 0.994068 
ILMN_54050 Pmp22 3.369227 -1.00929 -1.17943 1.009286 1.179434 -3.36923 0.993899 
ILMN_67298 Thra 1.208452 -0.46691 -0.49464 0.46691 0.494644 -1.20845 0.993831 
ILMN_161522 Tmem98 1.085483 -0.29697 -0.31774 0.296972 0.317745 -1.08548 0.993756 
ILMN_57296 Mpp6 1.82437 -0.76711 -0.76189 0.767107 0.761891 -1.82437 0.993456 
ILMN_52052 Auh 0.915476 -0.46603 -0.35285 0.466031 0.352846 -0.91548 0.993356 
ILMN_52636 Nedd4 0.755968 -0.20529 -0.1817 0.205293 0.181701 -0.75597 0.993354 
ILMN_67988 Lcat 2.511385 -0.68233 -0.58614 0.68233 0.586138 -2.51139 0.99317 
ILMN_60826 Gltp 0.510633 -0.16901 -0.20151 0.169008 0.201514 -0.51063 0.992872 
ILMN_51725 Vom2r79 1.573979 -0.58636 -0.22726 0.586358 0.227257 -1.57398 0.992562 
ILMN_66590 Tspan33 1.095421 -0.29775 -0.35825 0.297754 0.358246 -1.09542 0.992531 
ILMN_51890 Msx1 0.647466 -0.18867 -0.23519 0.188674 0.23519 -0.64747 0.992371 
ILMN_60514 Flrt3 1.494126 -0.42382 -0.28705 0.423824 0.287049 -1.49413 0.992264 
ILMN_63775 Slc9a6 0.901287 -0.24548 -0.18729 0.245477 0.187293 -0.90129 0.992154 
ILMN_48364 Olfml3 0.833438 -0.21509 -0.24861 0.215086 0.248612 -0.83344 0.991996 
ILMN_52414 Zfp111 0.586089 -0.15743 -0.19474 0.157434 0.194743 -0.58609 0.99196 
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ILMN_51350 RGD1564482 1.019166 -0.32499 -0.40418 0.324995 0.404177 -1.01917 0.991919 
ILMN_60172 Eif1b 0.657883 -0.22696 -0.27215 0.226962 0.272153 -0.65788 0.991911 
ILMN_50331 Rab38 0.567792 -0.14382 -0.16794 0.143815 0.167945 -0.56779 0.991498 
ILMN_50029 St3gal2 0.579875 -0.25424 -0.25468 0.254244 0.254677 -0.57988 0.991319 
ILMN_48088 Ifitm3 1.065912 -0.27003 -0.32543 0.270025 0.325427 -1.06591 0.991274 
ILMN_53129 Mfap5 1.01008 -0.26078 -0.22183 0.260785 0.221831 -1.01008 0.991236 
ILMN_61532 Slc16a11 0.638946 -0.20292 -0.25866 0.202915 0.258656 -0.63895 0.991078 
ILMN_60143 Katnal1 0.548705 -0.21125 -0.24043 0.211252 0.240431 -0.5487 0.990959 
ILMN_57534 Mdga2 0.801211 -0.38174 -0.35062 0.38174 0.350617 -0.80121 0.990731 
ILMN_55662 Ispd 1.483797 -0.44926 -0.58896 0.449263 0.588957 -1.4838 0.990671 
ILMN_68729 Sgcg 0.631881 -0.31049 -0.27434 0.310494 0.274345 -0.63188 0.990524 
ILMN_67593 Ephb1 1.225692 -0.42207 -0.52385 0.422067 0.523845 -1.22569 0.990496 
ILMN_48994 Cbs 1.395316 -0.3392 -0.34681 0.3392 0.346809 -1.39532 0.990333 
ILMN_70295 Dock6 0.337892 -0.14082 -0.15189 0.14082 0.151885 -0.33789 0.990253 
ILMN_68478 Leprel1 0.554055 -0.31683 -0.13977 0.316827 0.139773 -0.55405 0.990187 
ILMN_68736 Rab40b 1.057837 -0.25631 -0.3126 0.256305 0.312595 -1.05784 0.990163 
ILMN_70349 Hspb1 1.623773 -0.40407 -0.53105 0.404074 0.531048 -1.62377 0.989953 
ILMN_69714 Gas7 2.151464 -1.24383 -0.73613 1.243835 0.736129 -2.15146 0.989911 
ILMN_49693 Gpx7 0.472111 -0.17292 -0.20954 0.172919 0.209541 -0.47211 0.989726 
ILMN_60484 Serpina3n 0.74164 -0.17599 -0.21199 0.175989 0.211988 -0.74164 0.989681 
ILMN_48530 Swap70 0.438916 -0.21876 -0.1946 0.218759 0.1946 -0.43892 0.989388 
ILMN_48179 Ifitm6 0.628808 -0.29162 -0.28733 0.291623 0.287326 -0.62881 0.989112 
ILMN_56934 Ptges2 0.368671 -0.1791 -0.16667 0.179104 0.166674 -0.36867 0.989013 
ILMN_66879 Lingo1 0.995876 -0.22939 -0.26901 0.229388 0.269008 -0.99588 0.988853 
ILMN_62037 Zfp61 0.602912 -0.13867 -0.1689 0.138672 0.168897 -0.60291 0.988764 
ILMN_61591 Myh14 1.884044 -0.758 -0.87438 0.758002 0.87438 -1.88404 0.988412 
ILMN_48846 Mbp 3.174381 -1.64318 -1.41215 1.64318 1.412151 -3.17438 0.988345 
ILMN_61213 Pja2 0.54123 -0.1607 -0.22797 0.160701 0.227968 -0.54123 0.987805 
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ILMN_50141 Camk2n1 2.104289 -0.4751 -0.63878 0.475102 0.638781 -2.10429 0.987758 
ILMN_56539 Slc13a3 0.960586 -0.36637 -0.44858 0.36637 0.448585 -0.96059 0.987544 
ILMN_53466 Chd6 0.506475 -0.28571 -0.21413 0.285712 0.214133 -0.50648 0.987145 
ILMN_63176 Camk2g 0.867561 -0.20679 -0.15857 0.206791 0.158574 -0.86756 0.986685 
ILMN_63705 Gadd45a 0.992869 -0.48884 -0.46958 0.488842 0.469585 -0.99287 0.986583 
ILMN_52973 Socs5 1.117396 -0.2389 -0.3165 0.238899 0.316502 -1.1174 0.986392 
ILMN_54579 Cspg4 0.717346 -0.15291 -0.1879 0.152912 0.187899 -0.71735 0.986348 
ILMN_63299 Rcn2 0.300591 -0.1262 -0.1452 0.126197 0.145205 -0.30059 0.986324 
ILMN_50820 Pik3ip1 0.691546 -0.39426 -0.29635 0.394265 0.296347 -0.69155 0.986245 
ILMN_49961 Tenm3 0.937817 -0.35838 -0.44947 0.358376 0.44947 -0.93782 0.98602 
ILMN_53457 Cabp2 0.472332 -0.20493 -0.23026 0.204934 0.230261 -0.47233 0.985837 
ILMN_64601 Ephx1 0.691564 -0.31636 -0.33745 0.316357 0.337452 -0.69156 0.985647 
ILMN_66945 S100a16 1.312002 -0.81678 -0.41788 0.816784 0.417883 -1.312 0.985519 
ILMN_61454 Gjc3 1.277384 -0.52735 -0.62988 0.527353 0.629876 -1.27738 0.984943 
ILMN_67098 Hsd17b8 0.338193 -0.1855 -0.15763 0.185495 0.157632 -0.33819 0.984534 
ILMN_48324 Sbds 0.95934 -0.4738 -0.47121 0.473797 0.471213 -0.95934 0.984438 
ILMN_64613 Ntng1 0.915651 -0.54775 -0.38464 0.54775 0.384642 -0.91565 0.984411 
ILMN_50322 Map1lc3a 0.612286 -0.20661 -0.29141 0.20661 0.291413 -0.61229 0.984323 
ILMN_61374 Arhgap12 0.340517 -0.18375 -0.16224 0.18375 0.162239 -0.34052 0.984023 
ILMN_64243 Cntn1 1.000261 -0.3005 -0.46529 0.300503 0.465289 -1.00026 0.982935 
ILMN_63421 Kcnmb4 1.218446 -0.30485 -0.51268 0.304845 0.512679 -1.21845 0.982887 
ILMN_51080 Col5a2 1.940938 -0.58372 -0.90918 0.583725 0.909182 -1.94094 0.982537 
ILMN_66097 Slc9a3r2 0.349734 -0.15221 -0.18094 0.15221 0.180937 -0.34973 0.981856 
ILMN_60885 Gabbr1 0.623019 -0.22913 -0.31556 0.229126 0.315562 -0.62302 0.981734 
ILMN_49570 Mia 0.353353 -0.1749 -0.18129 0.174898 0.181286 -0.35335 0.981688 
ILMN_53898 Grk4 0.929991 -0.29637 -0.4517 0.296366 0.451697 -0.92999 0.981684 
ILMN_56170 Acsl3 1.504282 -0.28579 -0.32464 0.285788 0.324639 -1.50428 0.981379 
ILMN_50723 Sgca 1.089486 -0.69514 -0.24803 0.695143 0.248029 -1.08949 0.981329 
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ILMN_51104 Aldh7a1 0.324873 -0.17396 -0.16602 0.173962 0.166015 -0.32487 0.980332 
ILMN_68043 Fam132a 1.075395 -0.20011 -0.21957 0.20011 0.219566 -1.0754 0.980098 
ILMN_65342 Clk1 0.885357 -0.53448 -0.42319 0.534484 0.423195 -0.88536 0.979235 
ILMN_53709 Cmtm8 0.735985 -0.12554 -0.21424 0.125539 0.214241 -0.73599 0.978874 
ILMN_68066 Lnx1 0.340947 -0.19688 -0.17207 0.196884 0.172071 -0.34095 0.978537 
ILMN_56373 Atp1b2 2.587743 -0.43385 -0.67157 0.433845 0.671569 -2.58774 0.978459 
ILMN_61541 Lrrn2 0.691199 -0.20376 -0.34357 0.203761 0.343566 -0.6912 0.978001 
ILMN_61050 Ythdc1 0.399741 -0.25645 -0.1803 0.256448 0.180296 -0.39974 0.977897 
ILMN_60705 Pnisr 0.611362 -0.16863 -0.29968 0.16863 0.299683 -0.61136 0.977066 
ILMN_66203 Gas2 0.777389 -0.19668 -0.36991 0.196679 0.369906 -0.77739 0.976431 
ILMN_55909 Aplp1 3.194083 -1.80168 -1.69989 1.801679 1.699893 -3.19408 0.976143 
ILMN_48800 Dpy19l1 0.77078 -0.47953 -0.38186 0.479533 0.381863 -0.77078 0.975916 
ILMN_66383 Sfxn5 0.662088 -0.44933 -0.1501 0.449327 0.150098 -0.66209 0.975651 
ILMN_48420 Thbs2 1.484524 -0.36726 -0.72033 0.367261 0.72033 -1.48452 0.974388 
ILMN_66793 Smim22 0.425039 -0.21289 -0.24032 0.212891 0.24032 -0.42504 0.974206 
ILMN_52287 Adhfe1 1.018982 -0.65081 -0.50789 0.650807 0.507885 -1.01898 0.974078 
ILMN_67905 Rgs3 0.962378 -0.41311 -0.54721 0.413111 0.547208 -0.96238 0.974021 
ILMN_63500 Zfp612 0.407167 -0.23886 -0.21964 0.238865 0.219643 -0.40717 0.973796 
ILMN_54685 Asrgl1 1.510989 -0.92615 -0.79259 0.92615 0.792592 -1.51099 0.973602 
ILMN_51872 Gpt 0.55928 -0.16607 -0.29502 0.166073 0.295018 -0.55928 0.973525 
ILMN_55706 C1s 1.171874 -0.17112 -0.26556 0.171122 0.265563 -1.17187 0.973292 
ILMN_66745 Ift81 0.678855 -0.34163 -0.3881 0.341632 0.3881 -0.67885 0.973199 
ILMN_63225 Taf15 0.28847 -0.17906 -0.15251 0.179058 0.152512 -0.28847 0.972489 
ILMN_50918 Rilpl1 0.886287 -0.4531 -0.51235 0.453096 0.512346 -0.88629 0.972024 
ILMN_61402 Ptprn 0.64 -0.4285 -0.31704 0.428497 0.317036 -0.64 0.971224 
ILMN_52684 Col5a3 1.329996 -0.81978 -0.7219 0.819783 0.721901 -1.33 0.971191 
ILMN_61722 Sirt4 0.268724 -0.17302 -0.14079 0.173017 0.140791 -0.26872 0.970968 
ILMN_50313 Fank1 0.305505 -0.15944 -0.17821 0.159437 0.178212 -0.3055 0.970913 
Page 225 Catriona Ford s1059067 
ILMN_58657 Trim45 1.124426 -0.52821 -0.66256 0.528212 0.662562 -1.12443 0.970885 
ILMN_66452 Phlda1 0.28362 -0.11645 -0.16685 0.116448 0.166845 -0.28362 0.970304 
ILMN_62203 Kcnk2 1.48101 -0.20312 -0.30175 0.203122 0.30175 -1.48101 0.970261 
ILMN_48078 Pdk2 1.148226 -0.26585 -0.57652 0.265855 0.576518 -1.14823 0.969721 
ILMN_54786 Map3k4 0.601584 -0.40136 -0.30919 0.401364 0.309186 -0.60158 0.969705 
ILMN_50272 Ttc39a 0.371865 -0.16279 -0.2224 0.162794 0.222397 -0.37186 0.96922 
ILMN_50783 Papss1 0.891342 -0.31726 -0.51733 0.317263 0.517333 -0.89134 0.969208 
ILMN_66756 Cpxm2 0.681773 -0.24157 -0.39534 0.24157 0.395336 -0.68177 0.969201 
ILMN_64013 Mterfd3 0.575695 -0.24679 -0.34564 0.246788 0.345642 -0.57569 0.968654 
ILMN_68863 Pfkm 1.57663 -0.23611 -0.2344 0.236111 0.2344 -1.57663 0.968455 
ILMN_65644 Pde9a 0.839791 -0.16474 -0.39971 0.164742 0.399706 -0.83979 0.968038 
ILMN_52471 Prss23 2.072873 -0.62104 -1.16799 0.621041 1.16799 -2.07287 0.967731 
ILMN_60483 Cldn19 3.538925 -0.44506 -0.71731 0.445063 0.717308 -3.53893 0.967588 
ILMN_61221 Sdc2 1.261628 -0.1464 -0.38596 0.1464 0.385964 -1.26163 0.966764 
ILMN_62327 Wdr60 0.506755 -0.33732 -0.27617 0.33732 0.276172 -0.50676 0.966577 
ILMN_57086 Slc44a1 1.932215 -0.4587 -1.02135 0.458705 1.021346 -1.93221 0.966339 
ILMN_50840 Rai2 0.5837 -0.22819 -0.35453 0.22819 0.354532 -0.5837 0.966203 
ILMN_68665 Txndc15 0.787069 -0.53901 -0.41904 0.539007 0.419043 -0.78707 0.965988 
ILMN_55428 Csrp2 1.940364 -0.22117 -0.4422 0.221173 0.442197 -1.94036 0.965969 
ILMN_64277 Mboat2 1.571466 -0.77987 -0.97091 0.779871 0.970913 -1.57147 0.965898 
ILMN_65301 Gpx2 0.901734 -0.31427 -0.53795 0.314268 0.537955 -0.90173 0.965816 
ILMN_60583 Gtf3c1 0.871775 -0.5271 -0.52099 0.527099 0.520988 -0.87177 0.964797 
ILMN_70164 Cxcl12 1.281015 -0.15287 -0.2338 0.152866 0.233803 -1.28102 0.964678 
ILMN_60327 Armc1 0.306346 -0.12961 -0.19081 0.129611 0.190807 -0.30635 0.964513 
ILMN_65756 Extl2 0.455248 -0.35347 -0.16423 0.353469 0.164231 -0.45525 0.96364 
ILMN_64766 Ndufa10l1 0.300159 -0.15976 -0.18871 0.159759 0.188708 -0.30016 0.963345 
ILMN_50988 Pithd1 0.741508 -0.29297 -0.46364 0.292973 0.46364 -0.74151 0.963085 
ILMN_58724 Hmgcr 1.165786 -0.48244 -0.73454 0.482442 0.734539 -1.16579 0.962902 
Page 226 Catriona Ford s1059067 
ILMN_63261 Aspa 0.315719 -0.14853 -0.2007 0.148526 0.200704 -0.31572 0.962898 
ILMN_64984 Pde6d 0.628999 -0.41562 -0.36534 0.415618 0.365341 -0.629 0.962752 
ILMN_63999 Tspan12 1.174036 -0.87669 -0.57688 0.87669 0.576881 -1.17404 0.962304 
ILMN_66930 Lipe 0.638244 -0.31533 -0.408 0.315328 0.408 -0.63824 0.962215 
ILMN_160783 Cd99 0.635349 -0.50152 -0.21823 0.501519 0.21823 -0.63535 0.961635 
ILMN_48754 Mbtps1 0.339805 -0.21417 -0.20717 0.21417 0.207169 -0.3398 0.961325 
ILMN_57400 Gpr182 0.305684 -0.19479 -0.18551 0.194793 0.185514 -0.30568 0.961206 
ILMN_61581 Gemin2 0.466155 -0.2324 -0.3014 0.232403 0.301403 -0.46616 0.96088 
ILMN_54143 Rbm10 0.286479 -0.16571 -0.1819 0.165713 0.181899 -0.28648 0.96059 
ILMN_56965 Lztr1 0.294097 -0.20271 -0.17087 0.202706 0.170872 -0.2941 0.960074 
ILMN_60796 Pon2 0.432049 -0.26035 -0.27316 0.260345 0.273155 -0.43205 0.959762 
ILMN_53475 Hpdl 0.741304 -0.49567 -0.44608 0.495669 0.44608 -0.7413 0.959355 
ILMN_52725 Tmeff2 2.812565 -0.47797 -1.41982 0.477968 1.419815 -2.81257 0.959038 
ILMN_60058 Pim3 0.674003 -0.34835 -0.44243 0.34835 0.442428 -0.674 0.958904 
ILMN_58363 Plagl1 0.247279 -0.16312 -0.15248 0.16312 0.152483 -0.24728 0.958092 
ILMN_64993 Mcoln1 0.295815 -0.14701 -0.19595 0.147008 0.195955 -0.29581 0.958031 
ILMN_69134 Tgfb2 1.348734 -0.40721 -0.8363 0.407211 0.836304 -1.34873 0.957445 
ILMN_64092 Mrps35 0.263678 -0.145 -0.17435 0.144999 0.174351 -0.26368 0.957302 
ILMN_54466 Prkar1a 0.378839 -0.30362 -0.17021 0.303623 0.170205 -0.37884 0.957158 
ILMN_48827 Tfip11 0.366016 -0.22699 -0.23741 0.22699 0.237408 -0.36602 0.956174 
ILMN_53275 Opn4 0.28809 -0.17653 -0.18787 0.176531 0.187872 -0.28809 0.956059 
ILMN_61653 Porcn 0.514093 -0.21217 -0.34442 0.212173 0.344419 -0.51409 0.955206 
ILMN_55333 Cd82 0.297147 -0.23478 -0.15248 0.234781 0.152484 -0.29715 0.954806 
ILMN_54140 Gabarapl2 0.471932 -0.22382 -0.32094 0.223825 0.320936 -0.47193 0.954699 
ILMN_60306 Cspg5 0.914515 -0.53598 -0.61269 0.535984 0.612694 -0.91452 0.954478 
ILMN_62183 Gadd45b 0.552552 -0.42487 -0.30379 0.424873 0.303789 -0.55255 0.954471 
ILMN_48162 Spa17 0.793317 -0.51402 -0.51448 0.514019 0.514482 -0.79332 0.954363 
ILMN_57380 Dbndd2 1.829505 -0.59799 -1.18463 0.597995 1.184631 -1.8295 0.954329 
Page 227 Catriona Ford s1059067 
ILMN_62814 Csad 1.119739 -0.66042 -0.75056 0.66042 0.750561 -1.11974 0.954258 
ILMN_60456 Son 0.27449 -0.20858 -0.15538 0.208581 0.155381 -0.27449 0.953989 
ILMN_161842 Ppp1r1b 1.854326 -0.19535 -0.21343 0.195351 0.213425 -1.85433 0.953823 
ILMN_61980 Rhbdf1 0.408915 -0.14434 -0.27002 0.144343 0.27002 -0.40891 0.953818 
ILMN_61216 Khdrbs3 0.684328 -0.29854 -0.46628 0.298538 0.46628 -0.68433 0.953745 
ILMN_59243 Prepl 0.233449 -0.15063 -0.15339 0.150632 0.153387 -0.23345 0.95325 
ILMN_70245 Tspan6 0.608535 -0.14548 -0.36686 0.14548 0.366865 -0.60854 0.953215 
ILMN_67199 Obp3 0.249846 -0.16757 -0.16158 0.167574 0.161581 -0.24985 0.952924 
ILMN_64748 Ndrg2 3.23491 -0.24336 -0.57538 0.243361 0.57538 -3.23491 0.952709 
ILMN_62739 Camlg 0.240102 -0.18491 -0.13705 0.184911 0.137052 -0.2401 0.95226 
ILMN_66651 Plekhb1 2.923639 -0.39621 -1.48356 0.396205 1.483559 -2.92364 0.951608 
ILMN_52336 Abat 0.766703 -0.17167 -0.45986 0.171666 0.459861 -0.7667 0.951586 
ILMN_56457 Ndufv2 0.253646 -0.1718 -0.16561 0.171803 0.165606 -0.25365 0.951495 
ILMN_60579 Nudt6 0.443559 -0.25512 -0.30684 0.255122 0.306845 -0.44356 0.951135 
ILMN_49445 Prickle1 1.284204 -0.52098 -0.88575 0.520983 0.885752 -1.2842 0.950941 
ILMN_54589 Eml2 1.303367 -0.89431 -0.85199 0.894313 0.851986 -1.30337 0.950665 
ILMN_49883 Piga 0.379278 -0.24198 -0.25752 0.241978 0.257523 -0.37928 0.95026 
ILMN_62489 Hdac11 2.958958 -0.41028 -1.54298 0.410281 1.542977 -2.95896 0.950054 
ILMN_63557 Fbxo36 0.494046 -0.29939 -0.34139 0.299388 0.341385 -0.49405 0.950003 
ILMN_56185 Tmem98 1.497531 -0.60432 -1.04221 0.604315 1.042206 -1.49753 0.949569 
ILMN_57894 Dpysl5 0.345344 -0.18478 -0.24493 0.184782 0.244931 -0.34534 0.948949 
ILMN_65986 Kctd13 0.431623 -0.20597 -0.3064 0.205967 0.306399 -0.43162 0.948923 
ILMN_50342 Mob2 0.224193 -0.14356 -0.15424 0.14356 0.154241 -0.22419 0.948657 
ILMN_52250 Prpsap2 0.54033 -0.3671 -0.36283 0.367104 0.362834 -0.54033 0.948564 
ILMN_57817 Ubxn11 0.300507 -0.2538 -0.14801 0.253802 0.148006 -0.30051 0.948292 
ILMN_53767 Spata22 0.529499 -0.45143 -0.26778 0.451432 0.267782 -0.5295 0.946275 
ILMN_68026 Usp53 0.586036 -0.39825 -0.40465 0.398251 0.40465 -0.58604 0.945633 
ILMN_66312 Baz2b 0.792967 -0.52551 -0.55657 0.525508 0.556572 -0.79297 0.944984 
Page 228 Catriona Ford s1059067 
ILMN_66143 Sgcd 0.415123 -0.16504 -0.29812 0.165044 0.298125 -0.41512 0.944644 
ILMN_67028 Fut9 0.406326 -0.2661 -0.28933 0.266097 0.289332 -0.40633 0.943803 
ILMN_56866 Nthl1 0.383615 -0.23511 -0.27871 0.235114 0.27871 -0.38362 0.943495 
ILMN_51069 Map4k3 0.358363 -0.19142 -0.2645 0.191415 0.2645 -0.35836 0.943439 
ILMN_62833 Pgf 0.658207 -0.27611 -0.48002 0.27611 0.480016 -0.65821 0.943366 
ILMN_67627 Pdp2 0.316268 -0.21419 -0.22368 0.214193 0.223678 -0.31627 0.943141 
ILMN_63965 Cttn 0.315382 -0.14596 -0.23391 0.14596 0.233908 -0.31538 0.942232 
ILMN_60775 Clcc1 0.795931 -0.6489 -0.49156 0.648897 0.491558 -0.79593 0.941772 
ILMN_63795 Eif2ak3 0.328755 -0.15125 -0.24451 0.15125 0.244508 -0.32876 0.941735 
ILMN_49215 Ivns1abp 0.660324 -0.52212 -0.42488 0.522116 0.424884 -0.66032 0.941716 
ILMN_48076 Ncl 0.490319 -0.4357 -0.23887 0.435698 0.238866 -0.49032 0.941701 
ILMN_59153 Igfbp3 2.082734 -0.17205 -0.15984 0.172047 0.159841 -2.08273 0.941571 
ILMN_56719 Ybx3 0.594336 -0.29382 -0.44425 0.293821 0.444245 -0.59434 0.941568 
ILMN_66695 Rer1 0.295534 -0.24456 -0.17985 0.24456 0.179845 -0.29553 0.941187 
ILMN_51807 Ttc30a1 0.368233 -0.20281 -0.27685 0.202812 0.276853 -0.36823 0.940566 
ILMN_54533 Wbp1 0.521151 -0.32751 -0.38534 0.327506 0.385336 -0.52115 0.940515 
ILMN_55168 B3gnt1 0.465491 -0.22901 -0.35082 0.229012 0.35082 -0.46549 0.940281 
ILMN_69740 Atp1b3 0.408226 -0.30935 -0.27906 0.309345 0.279061 -0.40823 0.939962 
ILMN_62813 Ninj2 1.615356 -0.50527 -1.14746 0.505268 1.147461 -1.61536 0.939809 
ILMN_69576 Nim1k 0.345277 -0.27688 -0.22537 0.276884 0.225371 -0.34528 0.939316 
ILMN_57557 Txnip 0.823477 -0.40131 -0.6254 0.401314 0.6254 -0.82348 0.939026 
ILMN_48339 Mup5 0.413905 -0.31595 -0.2857 0.315946 0.285699 -0.4139 0.938497 
ILMN_63761 Slitrk6 2.257098 -0.67606 -1.60944 0.676064 1.609445 -2.2571 0.937826 
ILMN_58642 Map1lc3b 0.348656 -0.23875 -0.25703 0.238754 0.257027 -0.34866 0.937735 
ILMN_57620 Zdhhc1 0.415743 -0.28507 -0.30709 0.285067 0.307089 -0.41574 0.937434 
ILMN_54828 Zfp287 0.282368 -0.2485 -0.16499 0.248501 0.164993 -0.28237 0.936368 
ILMN_48331 Bbs2 0.608514 -0.37034 -0.47012 0.370341 0.47012 -0.60851 0.93523 
ILMN_58594 Tecta 1.736602 -0.6765 -1.32152 0.676503 1.321515 -1.7366 0.934945 
Page 229 Catriona Ford s1059067 
ILMN_63913 Lrig1 0.31106 -0.13814 -0.24101 0.138143 0.241009 -0.31106 0.934663 
ILMN_62209 Med25 0.364839 -0.18257 -0.28522 0.182573 0.285222 -0.36484 0.934578 
ILMN_67903 Car2 3.300326 -1.02925 -2.4257 1.02925 2.425702 -3.30033 0.934282 
ILMN_58400 Atraid 0.421814 -0.19141 -0.32915 0.191411 0.329153 -0.42181 0.933817 
ILMN_56168 Hbp1 0.362379 -0.24905 -0.27619 0.249053 0.276193 -0.36238 0.933365 
ILMN_68489 Banp 0.34028 -0.16234 -0.27022 0.162344 0.270215 -0.34028 0.931546 
ILMN_58046 Poldip2 0.326707 -0.16792 -0.26065 0.167917 0.260648 -0.32671 0.931384 
ILMN_50144 Lrrc8d 0.383122 -0.31564 -0.26706 0.315643 0.267057 -0.38312 0.931301 
ILMN_52202 Dync2li1 0.42273 -0.33218 -0.30996 0.332175 0.309956 -0.42273 0.93023 
ILMN_51112 Slc22a17 1.204944 -0.89212 -0.91761 0.892119 0.917615 -1.20494 0.929789 
ILMN_69297 Maged2 0.502105 -0.48391 -0.2466 0.483907 0.246598 -0.50211 0.929155 
ILMN_69429 Fam19a5 0.801163 -0.36957 -0.64463 0.36957 0.644634 -0.80116 0.928818 
ILMN_68518 Mapk1ip1 0.615321 -0.52036 -0.43084 0.520359 0.430839 -0.61532 0.928464 
ILMN_52809 Pax3 0.833426 -0.47972 -0.67735 0.479725 0.677347 -0.83343 0.928184 
ILMN_51508 Pkig 0.359176 -0.24727 -0.28626 0.247269 0.286262 -0.35918 0.92723 
ILMN_69940 Reck 1.865832 -0.63478 -1.45509 0.634782 1.455093 -1.86583 0.926913 
ILMN_66191 Rnase4 1.891119 -0.86079 -1.54627 0.860793 1.546268 -1.89112 0.925751 
ILMN_48334 Grip2 1.283719 -0.39466 -0.99481 0.394662 0.994814 -1.28372 0.924768 
ILMN_62000 Sh3tc2 0.825902 -0.30109 -0.66131 0.301088 0.661307 -0.8259 0.924241 
ILMN_63894 Snrnp70 0.348598 -0.1361 -0.28286 0.136102 0.282858 -0.3486 0.92372 
ILMN_68813 Snx13 0.379807 -0.19033 -0.31683 0.190329 0.316835 -0.37981 0.923476 
ILMN_49072 Egfl6 0.774028 -0.6934 -0.53936 0.693402 0.539357 -0.77403 0.92291 
ILMN_61585 Park7 0.297226 -0.20129 -0.24567 0.201287 0.245672 -0.29723 0.922454 
ILMN_61671 Krt8 0.893838 -0.3061 -0.71555 0.3061 0.715548 -0.89384 0.922383 
ILMN_49202 Gxylt1 0.309041 -0.2409 -0.24404 0.240897 0.244042 -0.30904 0.922211 
ILMN_49004 Lgi4 3.53074 -1.00322 -2.75176 1.003218 2.751757 -3.53074 0.921062 
ILMN_68125 Pum1 0.274917 -0.24152 -0.20326 0.241518 0.203257 -0.27492 0.919783 
ILMN_69723 Sult5a1 1.400629 -0.93232 -1.19035 0.932319 1.190354 -1.40063 0.918579 
Page 230 Catriona Ford s1059067 
ILMN_51918 Ephb6 1.605997 -0.61276 -1.33549 0.612758 1.335487 -1.606 0.918479 
ILMN_59966 Irf2bp1 0.413137 -0.20717 -0.35463 0.207167 0.354634 -0.41314 0.918238 
ILMN_58274 MGC95210 0.314857 -0.27803 -0.2391 0.278029 0.239102 -0.31486 0.916677 
ILMN_52209 Asb8 0.311399 -0.25558 -0.25248 0.255579 0.252477 -0.3114 0.915452 
ILMN_66938 Tubgcp5 0.212218 -0.15474 -0.18072 0.154741 0.180716 -0.21222 0.915265 
ILMN_53311 Fam214a 1.289121 -0.6605 -1.12898 0.660504 1.128976 -1.28912 0.914693 
ILMN_59664 Notch4 0.382665 -0.32309 -0.30711 0.323093 0.307105 -0.38267 0.914571 
ILMN_51414 Smpd1 0.619033 -0.50406 -0.50946 0.504056 0.509465 -0.61903 0.914103 
ILMN_60666 Ivd 0.43369 -0.40726 -0.31586 0.407259 0.315856 -0.43369 0.913952 
ILMN_53337 Fundc2 0.370826 -0.29451 -0.30993 0.29451 0.309934 -0.37083 0.913647 
ILMN_68712 Tcf7l1 0.689865 -0.42383 -0.61087 0.423832 0.610871 -0.68987 0.912935 
ILMN_69178 Chpf 0.948955 -1.01129 -0.42474 1.011286 0.424738 -0.94895 0.912365 
ILMN_68361 Mettl14 0.293021 -0.14628 -0.25993 0.146281 0.259932 -0.29302 0.911881 
ILMN_67682 Ppcdc 0.333056 -0.22104 -0.29593 0.221041 0.29593 -0.33306 0.911214 
ILMN_54426 Arsk 0.382162 -0.16133 -0.33441 0.161325 0.334406 -0.38216 0.911203 
ILMN_52846 Baalc 1.470599 -0.60277 -1.28801 0.602772 1.288005 -1.4706 0.910246 
ILMN_52426 Fgfr3 0.376226 -0.21355 -0.33934 0.213553 0.339336 -0.37623 0.909766 
ILMN_60149 Fjx1 0.954474 -0.38612 0.180982 0.386124 -0.18098 -0.95447 0.909711 
ILMN_57440 Cpz 0.363358 -0.26742 -0.32076 0.267423 0.320764 -0.36336 0.909295 
ILMN_53665 Serpine2 0.628685 -0.47911 -0.55105 0.47911 0.551047 -0.62869 0.908943 
ILMN_70135 Hexim2 0.428548 -0.43013 -0.30472 0.430126 0.304716 -0.42855 0.907379 
ILMN_66636 Acbd5 0.496908 -0.52091 -0.31621 0.520907 0.31621 -0.49691 0.907298 
ILMN_53021 Tdrd7 0.318091 -0.18691 -0.2909 0.186914 0.290903 -0.31809 0.907146 
ILMN_70001 Vkorc1 0.556043 -0.19095 -0.48259 0.190953 0.482588 -0.55604 0.906721 
ILMN_56587 Wnt6 0.506405 -0.49216 -0.38368 0.49216 0.383678 -0.50641 0.906542 
ILMN_54969 Csrp1 2.288624 -1.48362 -2.10371 1.483618 2.103709 -2.28862 0.905542 
ILMN_59974 Rbm46 0.529997 -0.23017 -0.47857 0.230166 0.478571 -0.53 0.905491 
ILMN_56270 Dvl1 0.914776 -0.36111 -0.81599 0.361105 0.815989 -0.91478 0.905424 
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ILMN_58763 Arhgef12 0.290371 -0.15986 -0.26759 0.159856 0.267585 -0.29037 0.905417 
ILMN_57624 Mlycd 0.426709 -0.42156 -0.32115 0.421555 0.321153 -0.42671 0.905106 
ILMN_56650 Arfgap2 0.357947 -0.38123 -0.22654 0.381227 0.226537 -0.35795 0.904973 
ILMN_55980 Gstp1 0.975592 -0.63264 -0.90093 0.632635 0.900928 -0.97559 0.904682 
ILMN_48049 LOC306766 0.43785 -0.19819 -0.39992 0.198186 0.399921 -0.43785 0.904103 
ILMN_55681 Inppl1 0.653057 -0.4514 -0.61066 0.451399 0.610659 -0.65306 0.901321 
ILMN_56108 Lrrc17 0.752673 -0.3301 -0.69505 0.330103 0.695049 -0.75267 0.901018 
ILMN_52926 Rabep1 0.63131 -0.60593 -0.51513 0.605927 0.51513 -0.63131 0.900886 
ILMN_69233 Ppfibp2 1.045335 -1.16764 -0.57557 1.16764 0.575569 -1.04534 0.900878 
ILMN_59969 Inpp5f 0.396813 -0.36145 -0.34408 0.361454 0.344078 -0.39681 0.898884 
ILMN_63079 Syf2 0.260942 -0.14884 -0.24901 0.148843 0.249006 -0.26094 0.8986 
ILMN_70333 Thumpd1 0.303478 -0.24683 -0.28023 0.246826 0.280225 -0.30348 0.897653 
ILMN_50863 Agt 4.106979 -0.44443 0.4709 0.444434 -0.4709 -4.10698 0.897533 
ILMN_65512 Tfdp2 0.987901 -1.1088 -0.6 1.108795 0.600001 -0.9879 0.89745 
ILMN_54906 Fam98a 0.422562 -0.35518 -0.38814 0.35518 0.388144 -0.42256 0.896645 
ILMN_59287 Nfib 1.143737 -0.36604 0.245553 0.366036 -0.24555 -1.14374 0.895473 
ILMN_58852 Nr4a2 0.801491 -0.80614 -0.6559 0.806136 0.655901 -0.80149 0.895373 
ILMN_62715 Zfp523 0.479737 -0.55542 -0.23953 0.555418 0.239528 -0.47974 0.895191 
ILMN_63786 Odc1 1.54088 -0.51119 0.336871 0.51119 -0.33687 -1.54088 0.894853 
ILMN_59897 Ppp1r36 1.464292 -1.07456 -1.41046 1.074557 1.41046 -1.46429 0.89448 
ILMN_51536 Dcp1b 0.2964 -0.24876 -0.27682 0.248756 0.276825 -0.2964 0.894168 
ILMN_65976 Dynlrb2 0.306383 -0.33941 -0.21313 0.339407 0.213129 -0.30638 0.893986 
ILMN_48166 Aldh1a1 3.674375 -0.36355 0.437624 0.363548 -0.43762 -3.67437 0.893518 
ILMN_48065 Itih3 2.24726 -0.1795 0.239547 0.179498 -0.23955 -2.24726 0.892568 
ILMN_63177 Igf2 2.439964 0.173766 -0.23393 -0.17377 0.233929 -2.43996 0.89068 
ILMN_69751 Ucn2 0.621656 -0.55428 -0.5803 0.554277 0.580296 -0.62166 0.890457 
ILMN_56354 Lars 0.209346 -0.20305 -0.18672 0.203047 0.186721 -0.20935 0.88972 
ILMN_69106 Srp19 0.26736 -0.25293 -0.2429 0.252929 0.242899 -0.26736 0.889635 
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ILMN_61414 Sema4g 1.493402 -0.38001 0.317995 0.380012 -0.31799 -1.4934 0.888869 
ILMN_58686 Wsb1 0.300092 -0.18581 -0.30101 0.185809 0.301007 -0.30009 0.888543 
ILMN_49569 Kcnc2 1.61391 -0.23522 0.266356 0.235218 -0.26636 -1.61391 0.888178 
ILMN_54818 Rhpn1 1.339572 -0.4201 -1.25124 0.420098 1.251244 -1.33957 0.887716 
ILMN_57996 St3gal4 1.311214 -0.63058 -1.3002 0.63058 1.300196 -1.31121 0.887612 
ILMN_58793 Ly6g6e 1.719475 -0.56639 0.407301 0.566389 -0.4073 -1.71948 0.887215 
ILMN_68994 Hspb6 0.772838 -0.34143 0.192693 0.341432 -0.19269 -0.77284 0.887137 
ILMN_50148 Psmc1 0.397075 -0.4486 -0.29704 0.448597 0.297036 -0.39708 0.886608 
ILMN_55504 Sparc 1.119268 -0.29636 0.249844 0.296359 -0.24984 -1.11927 0.886016 
ILMN_62734 Acot8 0.24995 -0.18328 -0.25224 0.183278 0.252244 -0.24995 0.885729 
ILMN_62790 Chi3l1 1.656743 -0.23194 0.279576 0.231944 -0.27958 -1.65674 0.885418 
ILMN_51519 Gprc5b 2.704582 -0.86692 0.648274 0.866922 -0.64827 -2.70458 0.885284 
ILMN_69708 Ubl3 0.435672 -0.16168 -0.42215 0.161683 0.422153 -0.43567 0.885253 
ILMN_51972 Armcx1 1.097648 -0.36147 0.268674 0.361471 -0.26867 -1.09765 0.883925 
ILMN_53433 Sdhc 0.315238 -0.20022 -0.32375 0.200221 0.323745 -0.31524 0.883556 
ILMN_58184 Asgr1 2.026775 -0.33906 0.382971 0.339055 -0.38297 -2.02677 0.883488 
ILMN_59402 Chst9 0.350363 -0.2695 -0.35572 0.269504 0.355724 -0.35036 0.88338 
ILMN_54990 Zfp282 0.395114 -0.48054 -0.2315 0.480538 0.231496 -0.39511 0.882968 
ILMN_53272 Ngb 0.375077 -0.44243 -0.26742 0.442426 0.267416 -0.37508 0.882149 
ILMN_58183 S100a6 1.449354 -0.21996 0.268208 0.219959 -0.26821 -1.44935 0.881685 
ILMN_70000 Ptgds 3.259062 -0.23552 0.429972 0.235516 -0.42997 -3.25906 0.881426 
ILMN_50582 Zmynd10 0.403167 -0.42918 -0.35644 0.429176 0.356439 -0.40317 0.880819 
ILMN_67134 Dcakd 0.872173 -0.57952 -0.90938 0.579521 0.909377 -0.87217 0.880257 
ILMN_52871 Srpk2 0.481601 -0.25424 -0.49944 0.254244 0.499445 -0.4816 0.879358 
ILMN_49169 Vamp2 0.737709 -0.18047 0.171805 0.180468 -0.1718 -0.73771 0.879171 
ILMN_57099 Xrcc6 0.249628 -0.29005 -0.19818 0.290047 0.198183 -0.24963 0.878243 
ILMN_49058 Smim14 0.677272 -0.8244 -0.47601 0.824396 0.476006 -0.67727 0.877198 
ILMN_52836 Thnsl2 0.607994 -0.37044 -0.64367 0.370441 0.643668 -0.60799 0.876678 
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ILMN_58860 Tmprss7 0.324349 -0.15653 -0.33755 0.156532 0.337548 -0.32435 0.876475 
ILMN_60157 Gpr19 0.595824 -0.73113 -0.41862 0.731126 0.418624 -0.59582 0.87573 
ILMN_63943 LOC498460 0.416697 -0.51486 -0.28638 0.514856 0.286376 -0.4167 0.875329 
ILMN_61545 Cx3cl1 0.846627 -0.41492 0.236248 0.41492 -0.23625 -0.84663 0.875092 
ILMN_68170 Srpk3 0.514691 -0.55252 -0.47687 0.552519 0.476873 -0.51469 0.87467 
ILMN_52687 Acot7 0.813184 -0.65547 -0.85833 0.65547 0.858326 -0.81318 0.874556 
ILMN_57073 Plp1 0.780398 -0.3856 0.219338 0.385595 -0.21934 -0.7804 0.874227 
ILMN_50763 Itga7 3.066619 -0.8345 0.7852 0.834496 -0.7852 -3.06662 0.873077 
ILMN_48356 Mcee 0.450297 -0.55197 -0.33757 0.551966 0.337567 -0.4503 0.872865 
ILMN_58155 Ogn 3.025819 0.413048 -0.52193 -0.41305 0.521933 -3.02582 0.871941 
ILMN_70122 Ano4 1.891353 -1.05205 -2.03701 1.05205 2.037011 -1.89135 0.871482 
ILMN_64681 Igfbp6 0.697563 -0.15862 0.172999 0.158619 -0.173 -0.69756 0.870032 
ILMN_52681 Kcnb1 1.254588 -0.44044 0.354648 0.44044 -0.35465 -1.25459 0.869494 
ILMN_49364 Pigq 0.665381 -0.57014 -0.71324 0.570141 0.713238 -0.66538 0.869451 
ILMN_53766 Mfap4 1.420806 -0.66531 0.416819 0.665308 -0.41682 -1.42081 0.869321 
ILMN_55417 Scnn1a 0.401896 -0.34744 -0.43239 0.347443 0.432386 -0.4019 0.868404 
ILMN_51228 Mme 1.377739 -0.54851 0.401925 0.548509 -0.40192 -1.37774 0.868377 
ILMN_57698 Reln 1.067384 -0.22508 0.26973 0.22508 -0.26973 -1.06738 0.865181 
ILMN_50326 Brinp2 0.452667 -0.5992 -0.26455 0.599198 0.264548 -0.45267 0.865138 
ILMN_64015 Slc25a17 0.463795 -0.22545 0.141279 0.225449 -0.14128 -0.4638 0.864632 
ILMN_55604 Fat3 0.873528 -0.33355 0.261381 0.333552 -0.26138 -0.87353 0.864312 
ILMN_60298 Golga2 0.612633 -0.78928 -0.45463 0.789279 0.45463 -0.61263 0.864286 
ILMN_60499 Lrp11 0.985249 -0.15472 -0.92097 0.154723 0.92097 -0.98525 0.863728 
ILMN_59575 Ermn 3.993838 -1.47312 1.19574 1.473119 -1.19574 -3.99384 0.863447 
ILMN_69046 Mog 4.972703 -0.97007 1.243811 0.970067 -1.24381 -4.9727 0.863406 
ILMN_54984 Prrx2 0.696628 -0.2228 0.20281 0.222798 -0.20281 -0.69663 0.863108 
ILMN_68931 Ptk2 0.940038 -0.55641 0.284019 0.556407 -0.28402 -0.94004 0.862415 
ILMN_66374 Lmo4 0.885517 -0.49354 0.273578 0.493542 -0.27358 -0.88552 0.861321 
Page 234 Catriona Ford s1059067 
ILMN_56280 Il16 0.914023 -0.36388 0.282177 0.363881 -0.28218 -0.91402 0.86102 
ILMN_51759 Gdf1 0.666129 -0.15914 0.181792 0.15914 -0.18179 -0.66613 0.860959 
ILMN_57699 Cyp4b1 0.264221 -0.27098 -0.28111 0.270983 0.28111 -0.26422 0.86029 
ILMN_66294 Pam 1.37501 -0.37078 0.395083 0.370777 -0.39508 -1.37501 0.858993 
ILMN_54063 Entpd2 1.946166 0.318726 -0.33072 -0.31873 0.330723 -1.94617 0.858744 
ILMN_65264 Olfml2b 1.116743 0.200122 -0.36271 -0.20012 0.362707 -1.11674 0.858559 
ILMN_69434 Chchd10 0.653646 -0.13323 0.173497 0.133231 -0.1735 -0.65365 0.858313 
ILMN_49640 Ddit4 1.051303 -0.22736 0.28936 0.22736 -0.28936 -1.0513 0.856173 
ILMN_48761 Lect1 3.295582 0.597862 -1.25157 -0.59786 1.251565 -3.29558 0.856028 
ILMN_64063 Slc6a13 1.544595 -0.23231 0.379755 0.232315 -0.37975 -1.54459 0.855962 
ILMN_58912 Pygm 1.762849 -0.33126 0.46536 0.331264 -0.46536 -1.76285 0.855928 
ILMN_50593 Thrsp 2.592179 0.389345 -0.26068 -0.38935 0.260677 -2.59218 0.855903 
ILMN_65901 Ppap2b 0.59189 -0.37643 0.18469 0.376432 -0.18469 -0.59189 0.855861 
ILMN_67775 Atp13a4 1.004446 -0.3563 0.317534 0.356303 -0.31753 -1.00445 0.855029 
ILMN_61557 Gldn 3.45339 0.649635 -0.90523 -0.64964 0.905235 -3.45339 0.85344 
ILMN_55839 Zfp775 0.330413 -0.46048 -0.14653 0.460482 0.146527 -0.33041 0.853085 
ILMN_53099 Abcb9 0.752201 -0.22912 0.234442 0.229118 -0.23444 -0.7522 0.852307 
ILMN_54221 Tyro3 2.560529 -0.54029 0.726271 0.540293 -0.72627 -2.56053 0.851466 
ILMN_67316 Tm9sf4 0.334027 -0.17272 -0.38769 0.172723 0.387693 -0.33403 0.851242 
ILMN_55031 Tnnc1 0.642616 -0.75942 -0.66152 0.759421 0.661516 -0.64262 0.851235 
ILMN_70398 Macrod1 1.008101 -0.26711 -1.07077 0.267107 1.070769 -1.0081 0.850436 
ILMN_66726 Ptn 2.705863 -0.60165 -2.8071 0.601652 2.807095 -2.70586 0.85008 














Appendix 3. Cell Surface Receptors with Known Ligands Identified as More Highly Expressed in Activated OPCs as  
compared to Non-activated OPCs, from Moyon et al., 2015 Dataset. 





adj.P.Val Known Ligands 
A_55_P2045007 Hrh1 0.879083 0.045517 histamine 
A_55_P2033425 Grm5 0.469783 0.039461  L-glutamic acid, L-aspartic acid, L-serine-O-phosphate, NAAG and L-
cysteine sulphinic acid 
A_51_P511015 Fzd9 0.880167 0.035839 Wnt 
A_55_P2002557 Srebf1 0.790624 0.035013  A series of oxysterols are natural ligands 
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A_51_P156274 Ltbr 1.163964 0.0314 LIGHT (TNFSF14, O43557), lymphotoxin 
β2α1 heterotrimer (LTA, LTB, Q06643, P01374) 
A_51_P404077 Fzd2 0.684819 0.029232 Wnt-5a 
A_55_P2003053 Dct 0.718064 0.026886 5-hydroxytryptamine 
A_52_P110052 Darc 0.709832 0.024579 CXCL5 (CXCL5, P42830), CXCL6 (CXCL6, P80162), CXCL8 (CXCL8, 
P10145), CXCL11 (CXCL11, O14625), CCL2 (CCL2, P13500), CCL5 (CCL5, 
P13501), CCL7 (CCL7, P80098), CCL11 (CCL11, P51671), CCL14 (CCL14, 
Q16627), CCL17 (CCL17, Q92583) 
A_55_P2007964 Cx3cr1 1.610647 0.020778 Cx3cl1 
A_55_P1961466 Dct 0.874146 0.020673 5-hydroxytryptamine 
A_66_P118329 Ntrk3 0.739135 0.018645 10+ ligands 
A_55_P2185332 Il17rc 0.821857 0.018184 IL-17A 
A_55_P2025078 Csf1r 2.182575 0.01347 IL4, M-CSF 
A_55_P2064043 Cd44 1.086395 0.012072 (-)-adrenaline 
(-)-noradrenaline 
A_52_P354744 Slc2a3 1.019572 0.010191 [3H]2-deoxyglucose 
A_52_P192426 Tnfrsf1a 1.180514 0.008784 TNF, lymphotoxin-α 
A_55_P2057777 Fgfr1 0.947437 0.008597 FGF-1 (FGF1, P05230), FGF-2 (FGF2, P09038), FGF-4 (FGF4, P08620) > 
FGF-5 (FGF5, P12034), FGF-6 (FGF6, P10767 
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A_55_P2006792 Ntrk2 0.769007 0.008143 BDNF (BDNF, P23560), neurotrophin-4 (NTF4, P34130) > 
neurotrophin-3 (NTF3, P20783) 
A_52_P317393 Gpr56 1.082123 0.007508 collagen III, transglutaminase 
A_55_P2159710 Acvr1 0.739323 0.007368 Activin-A 
A_55_P2051099 Tnfrsf1a 1.347615 0.006373 TNF, lymphotoxin-α 
A_51_P345649 Pdgfrα 1.150499 0.00535 PDGFα 
A_55_P1991985 Ptprs 0.964322 0.003744 chondroitin sulphate proteoglycan 3 (NCAN, O14594), netrin-G3 
ligand (LRRC4B, Q9NT99)  
A_55_P2068892 Il6ra 1.52813 0.002956 IL6 
A_55_P2000439 Ptprz1 2.159583 0.001322 contactin-1 (CNTN1, Q12860), pleiotrophin (PTN, C9JR52) 
A_51_P507053 Slc38a1 1.891604 0.000515 [14C]alanine, [3H]alanine 
A_51_P110759 Slc1a1 2.05887 0.00044 [3H]ETB-TBOA (Binding) pKd 6.5 [47] - Rat, [3H]L-aspartic acid, [3H]D-
aspartic acid 
A_51_P170463 Gpr17 2.862208 0.000424 cysteinyl-leukotrienes (CysLTs), uracil nucleotides (Proposed, 1 
publication) 
A_55_P2008061 Itpr2 2.225311 0.00028 cytosolic Ca2+, IP3 
A_52_P597634 Fzd1 1.796602 0.000197 Wnt-1, Wnt-2, Wnt-5a, Wnt-3a, Wnt-7b 
A_52_P665675 Abca1 2.06571 0.000179 bihelical apoA-I mimetic peptide 5A 
A_55_P2051414 Axl 1.698749 0.000172 10+ known endogenous ligands 
A_51_P131408 Tnfrsf12a 2.881712 1.26E-05 TWEAK 
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Appendix 3 R code used for bioinformatic analyses in 
 Chapter 3 
Huang, Jarjour et al., 2011, Illumina Bead Chip Data Analysis 
















#Read in targets file which defines the names of the arrays, 
targets <- readTargets("targets.txt") 
targets <- readTargets("targets.txt", row.names="SampleName") 
# Read in background corrected Illumina bead chip data 
BSData <- readBeadSummaryData(dataFile = "GSE24821_non-
normalized.txt.gz",  
 ProbeID = "ID_REF", skip = 4, columns = list(exprs = 
"AVG_Signal", Detection = "Detection Pval"),  
  illuminaAnnotation="illuminaRatv1") 
# Extract expression values from Illumina bead chip data 
bd<- exprs(BSData) 
#Boxplot of data 
png("boxplot_pre-norm_illumina.png") 
boxplot(log2(bd), las=2, range=1.5, col=c(rep("yellow",3), 
rep("orange",3), rep("red",3))) 
dev.off() 
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#Convert expression data to matrix 
d_log_matrix <- as.matrix(bd) 
## Desity plot of data 
png("density_post_norm_illumina.png") 
plot (density(d_log_matrix[,1]), col="yellow") 
lines (density(d_log_matrix[,2]), col="yellow") 
lines (density(d_log_matrix[,3]), col="yellow") 
lines (density(d_log_matrix[,4]), col="orange") 
lines (density(d_log_matrix[,5]), col="orange") 
lines (density(d_log_matrix[,6]), col="orange") 
lines (density(d_log_matrix[,7]), col="red") 
lines (density(d_log_matrix[,8]), col="red") 
lines (density(d_log_matrix[,9]), col="red") 
dev.off() 
##MA plots 















# Quantile Normalise Illumina bead chip dta 
BSData.qnorm <- normaliseIllumina(BSData, method = "quantile", 
transform = "none") 
d <- exprs(BSData.qnorm) 
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## Principal Component Analysis for Quantile Normalised 
Activated and Non-activated OPC Data 




#Perform Principal Component Analysis using prcomp function 
pca <- prcomp(t(d), scale=T) 
#Specify which arrays belong to each sample group by numbering 
pca_names <- c(1,2,3,4,1,2,3) 
#Generate scatter plot showing variation between arrays for 





s3d.coords <- s3d$xyz.convert(pca$x[,1:3]) 
text(s3d.coords$x, s3d.coords$y, labels = pca_names,pos = 3, 
offset = 0.5) 
dev.off() 
# Check data object created using prcomp (an object of class 
prcomp), contains the correct information  
names(pca) 
# Calculate eigenvalues by raising the standard deviation for 
each principal component to the power of 2 
eig <- (pca$sdev)^2 
# Calculate the variance captured by each principal component 
using the eigenvalues 
variance <- eig*100/sum(eig) 
# Calculate the cumulative variances of the principal 
components using the variance 
cumvar <- cumsum(variance) 
eig.pca <- data.frame(eig = eig, variance = variance, 
                     cumvariance = cumvar) 
# Check eigenvalue, variance and cumulative variance 
calculations were successful 
head(eig.pca) 
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#Use the function summary() to extract the eigenvalues and 
variances from an object of class prcomp. 
pca_eigenval_var <- summary(pca) 
pca_eigenval_var 
# Visualise the importance of principal components (PCs) by 
generating a bar plot. 
png("PCA_hj_plot.png") 
barplot(eig.pca[, 2], names.arg=1:nrow(eig.pca),  
       main = "Variances", 
       xlab = "Principal Components", 
       ylab = "Percentage of variances", 
       col ="steelblue") 
dev.off() 
# Generate table of eigenvectors for each feature(Entrez gene 
RNA or control probe) 
rotations <- pca$rotation 
write.table(rotations,file="PCA_act_vs_nonact.txt", 
quote=F,sep="\t",col.names=NA) 
# Differential Gene Expression Analysis Using Limma 
# Extract expression values from normalised data 
d <- exprs(BSData.qnorm) 
#Define groups within the set of arrays 
groups <- 
c('d28','d28','d28','d5','d5','d5','d14','d14','d14') 
design <- model.matrix(~0+factor(groups)) 
colnames(design) <- levels(factor(groups)) 
#Differential Gene Expression Analysis using Limma 
fit <- lmFit(d, design) 
cont.dif <- makeContrasts( 
  d28.vs.d5 = "d28-d5", 
  d28.vs.d14 = "d28-d14", 
  d14.vs.d5 = "d14-d5", 
  d14.vs.d28 = "d14-d28", 
  d5.vs.d14 = "d5-d14", 
  d5.vs.d28 = "d5-d28", 
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       levels=design) 
fit2 <- contrasts.fit(fit, cont.dif) 
fit2 <- eBayes(fit2) 
# get results for all contrasts: 
topTable28.vs.5<-topTable(fit2, adjust="BH", n=nrow(d), 
coef="d28.vs.d5") 
topTable28.vs.14<-topTable(fit2, adjust="BH", n=nrow(d), 
coef="d28.vs.d14") 
topTable14.vs.5<-topTable(fit2, adjust="BH", n=nrow(d), 
coef="d14.vs.d5") 
topTable14.vs28<-topTable(fit2, adjust="BH", n=nrow(d), 
coef="d14.vs.d28") 
topTable5.vs.14<-topTable(fit2, adjust="BH", n=nrow(d), 
coef="d5.vs.d14") 
topTable5.vs.28<-topTable(fit2, adjust="BH", n=nrow(d), 
coef="d5.vs.d28") 
TiptopTable<-cbind(topTable28.vs.5, topTable28.vs.14, 
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Moyon et al., 2015, Agilent Array Chip Data Analysis 










#Set working directory 
setwd("C:\\Users\\Cat\\Documents\\scrm misc\\Agilent 
analysis\\Agilent analysis start 16032016") 
getwd() 
 
#Read in targets file which defines the names of the arrays, 
targets <- readTargets("targets.txt") 
targets <- readTargets("targets.txt", row.names="SampleName") 
 
#Read in mean foreground (F532 Mean) and background (B532 
Mean) values  
Data<-read.maimages(targets, path=getwd(),columns=list(E = 
"F532 Mean", Eb = "B532 Mean"),green.only=TRUE) 
 
#Generate boxplot from foreground values 
png("boxplot_test_15122016.png") 
boxplot(log(Data$E,2), las=2, range=1.5, 
names=targets$SampleName, col=c( rep("blue",3), 
rep("orange",4), rep("red",4),  




#Convert foreground values to log2 transformed matrix 
Data_E_matrix <- as.matrix(Data$E,2) 
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#Generate density plot of foreground values 
png("density_plot_all_data_pre_background_correct.png") 
plot (density(log(Data_E_matrix[,2])), col="blue", xlim=c(4, 
12)) 
lines (density(log(Data_E_matrix[,1])), col="blue") 
lines (density(log(Data_E_matrix[,3])), col="blue") 
lines (density(log(Data_E_matrix[,4])), col="orange") 
lines (density(log(Data_E_matrix[,5])), col="orange") 
lines (density(log(Data_E_matrix[,6])), col="orange") 
lines (density(log(Data_E_matrix[,7])), col="orange") 
lines (density(log(Data_E_matrix[,8])), col="red") 
lines (density(log(Data_E_matrix[,9])), col="red") 
lines (density(log(Data_E_matrix[,10])), col="red") 
lines (density(log(Data_E_matrix[,11])), col="red") 
lines (density(log(Data_E_matrix[,12])), col="green") 
lines (density(log(Data_E_matrix[,13])), col="green") 
lines (density(log(Data_E_matrix[,14])), col="green") 
lines (density(log(Data_E_matrix[,15])), col="green") 
lines (density(log(Data_E_matrix[,16])), col="dark green") 
lines (density(log(Data_E_matrix[,17])), col="dark green") 
lines (density(log(Data_E_matrix[,18])), col="dark green") 
dev.off() 
 
#Generate MA plots from foreground values 
 





#Activated OPC replicate 2 vs Non-activated OPC replicate 1 
png("mva.pairs_foreground_act2_vs_Nonact1.png") 
mva.pairs(log(Data_E_matrix,2)[,c(13,16)]) 
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dev.off() 
 





#Generate boxplot from background features 
png("boxplot_background_15122016.png") 
boxplot(log(Data$Eb,2), las=2, range=1.5, 
names=targets$SampleName, col=c( rep("blue",3), 
rep("orange",4), rep("red",4),  
rep("green",4), rep("dark green",3))) 
dev.off() 
 
#Convert background values to log2 transformed matrix 
Data1_Eb_matrix <- as.matrix(Data$Eb,2) 
 
#Density plot of background values 
png("density_plot_all_data_background_probes.png") 
plot (density(log(Data1_Eb_matrix[,2])), col="blue", xlim=c(4, 
12)) 
lines (density(log(Data1_Eb_matrix[,1])), col="blue") 
lines (density(log(Data1_Eb_matrix[,3])), col="blue") 
lines (density(log(Data1_Eb_matrix[,4])), col="orange") 
lines (density(log(Data1_Eb_matrix[,5])), col="orange") 
lines (density(log(Data1_Eb_matrix[,6])), col="orange") 
lines (density(log(Data1_Eb_matrix[,7])), col="orange") 
lines (density(log(Data1_Eb_matrix[,8])), col="red") 
lines (density(log(Data1_Eb_matrix[,9])), col="red") 
lines (density(log(Data1_Eb_matrix[,10])), col="red") 
lines (density(log(Data1_Eb_matrix[,11])), col="red") 
lines (density(log(Data1_Eb_matrix[,12])), col="green") 
lines (density(log(Data1_Eb_matrix[,13])), col="green") 
lines (density(log(Data1_Eb_matrix[,14])), col="green") 
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lines (density(log(Data1_Eb_matrix[,15])), col="green") 
lines (density(log(Data1_Eb_matrix[,16])), col="dark green") 
lines (density(log(Data1_Eb_matrix[,17])), col="dark green") 
lines (density(log(Data1_Eb_matrix[,18])), col="dark green") 
dev.off() 
 
#Perform background correction by subtracting background 
values from foreground values 
backCorMatrix <- backgroundCorrect.matrix(matrixE, matrixEb, 
method="auto", offset=0) 
##This generates a matrix of background corrected probes in 
which some values are negative 
##Negative values cannot be logged to make MA plots etc 
##find out the lowest value in backCorMatrix 
min(backCorMatrix) 
#[1] -19994.54 
#Therefore add 20,000 to the pre-background corrected values  
backCorMatrix <- backgroundCorrect.matrix(matrixE, matrixEb, 
method="auto", offset=20000) 
 
##Density Plot Post Background Corrected values 
png("density_plot_all_data_Background_corrected_16122016.png") 
plot (density(log(backCorMatrix[,2])), col="blue", xlim=c(4, 
12)) 
lines (density(log(backCorMatrix[,1])), col="blue") 
lines (density(log(backCorMatrix[,3])), col="blue") 
lines (density(log(backCorMatrix[,4])), col="orange") 
lines (density(log(backCorMatrix[,5])), col="orange") 
lines (density(log(backCorMatrix[,6])), col="orange") 
lines (density(log(backCorMatrix[,7])), col="orange") 
lines (density(log(backCorMatrix[,8])), col="red") 
lines (density(log(backCorMatrix[,9])), col="red") 
lines (density(log(backCorMatrix[,10])), col="red") 
lines (density(log(backCorMatrix[,11])), col="red") 
lines (density(log(backCorMatrix[,12])), col="green") 
lines (density(log(backCorMatrix[,13])), col="green") 
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lines (density(log(backCorMatrix[,14])), col="green") 
lines (density(log(backCorMatrix[,15])), col="green") 
lines (density(log(backCorMatrix[,16])), col="dark green") 
lines (density(log(backCorMatrix[,17])), col="dark green") 
lines (density(log(backCorMatrix[,18])), col="dark green") 
dev.off() 
 
#Generate boxplot from background corrected values 
png("boxplot_background_corrected_16122016.png") 
boxplot(log(backCorMatrix,2), las=2, range=1.5, 
names=targets$SampleName, col=c( rep("blue",3), 
rep("orange",4), rep("red",4),  




Data2<- normalizeBetweenArrays(Data1, method="quantile") 
 









## Principal Component Analysis for Quantile Normalised 
Activated and Non-activated OPC Data 




#Perform Principal Component Analysis using prcomp function 
pca <- prcomp(t(Data2$E), scale=T) 
#Specify which arrays belong to each sample group by numbering 
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pca_names <- c(1,2,3,4,1,2,3) 
#Generate scatter plot showing variation between arrays for 





s3d.coords <- s3d$xyz.convert(pca$x[,1:3]) 
text(s3d.coords$x, s3d.coords$y, labels = pca_names,pos = 3, 
offset = 0.5) 
dev.off() 
 
# Check data object created using prcomp (an object of class 
prcomp), contains the correct information  
names(pca) 
# Calculate eigenvalues by raising the standard deviation for 
each principal component to the power of 2 
eig <- (pca$sdev)^2 
# Calculate the variance captured by each principal component 
using the eigenvalues 
variance <- eig*100/sum(eig) 
# Calculate the cumulative variances of the principal 
components using the variance 
cumvar <- cumsum(variance) 
eig.pca <- data.frame(eig = eig, variance = variance, 
                     cumvariance = cumvar) 
# Check eigenvalue, variance and cumulative variance 
calculations were successful 
head(eig.pca) 
#Use the function summary() to extract the eigenvalues and 
variances from an object of class prcomp. 
pca_eigenval_var <- summary(pca) 
pca_eigenval_var 
 
# Visualise the importance of principal components (PCs) by 
generating a bar plot. 
png("PCA_moyon_plot.png") 
barplot(eig.pca[, 2], names.arg=1:nrow(eig.pca),  
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       main = "Variances", 
       xlab = "Principal Components", 
       ylab = "Percentage of variances", 
       col ="steelblue") 
dev.off() 
 
# Generate table of eigenvectors for each feature(Entrez gene 
RNA or control probe) 




## Differential Gene Expression Analysis 






design <- model.matrix(~0+factor(groups)) 
colnames(design) <- levels(factor(groups)) 
 
#Differential Gene Expression Analysis using Limma 
d <- Data_quantilenorm 




fit2 <- contrasts.fit(fit, cont.dif) 
fit2 <- eBayes(fit2) 
 
 
# get results: 
limma_table <- topTable(fit2, adjust="BH", n=nrow(d), 
coef="Activated_OPCs.vs.Nonactivated_OPCs") 
#order limma table by rowname 
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limma_table <- limma_table[ 
order(as.numeric(row.names(limma_table))),] 
#add columns for IDs and Gene Names 
limma_table["GeneName"] <- All_rownames$GeneName 
limma_table["ID"] <- All_rownames$ID 
#average replicate probes for the same gene 
limma_table_avereps <- avereps(limma_table, ID=limma_table$ID) 
 
#write table of limma output 
write.table(limma_table_avereps,file="Limma_output_act.vs.nona
ct_avereps.txt", quote=F, 
sep="\t",col.names=NA) 
